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demonstrated that conditional H2AX deletion results in accumulation of genomic instability in cells, but
delays tumor onset in a mouse thymic lymphoma model, presumably due to increased death of cells with
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deficient in both H2AX and ATM to examine whether ATM-independent H2AX functions downstream of
other kinases are essential for proper DSB repair. I found that thymocyte-specific ablation of H2AX in
ATM-deficient mice results in a 50% reduction in thymus cellularity but does not accelerate or delay
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response factors likely depend on the cellular context. Additionally, I discovered a novel function of ATM
in regulating mono-allelic recombination at the immunoglobulin light chain locus. ATM could orchestrate
the signaling pathways enforcing allelic exclusion to provide a time window to test whether the
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insights into how DNA damage and repair factors coordinately regulate V(D)J recombination, lymphocyte
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ABSTRACT

FUNCTIONS OF DNA DAMAGE RESPONSE FACTORS IN LYMPHOCYTE
DEVELOPMENT AND TRANSFORMATION
Bu Yin
Advisor: Craig H. Bassing
DNA double strand breaks (DSBs) can activate cell cycle checkpoints or apoptosis,
and lead to genomic alterations that drive malignant transformation. The H2AX core
histone variant is phosphorylated in chromatin around DSBs by kinases such as ATM and
DNA-PKcs. However, how H2AX suppresses chromosome breaks and translocations in
cells and prevents tumorigenesis in mice and humans is not well understood. V(D)J
recombination is a genetically programmed DNA damage and repair process that
assembles the variable region exons of antigen receptor genes in developing
lymphocytes. Using an inducible V(D)J recombination system, I found that H2AX is
phosphorylated along cleaved antigen receptor loci DNA strands, prevents their
irreversible separation in G1 phase, and reduces chromosome breaks and translocations in
subsequent cell cycles. Consistent with H2AX functions in DSB repair, I also
demonstrated that conditional H2AX deletion results in accumulation of genomic
instability in cells, but delays tumor onset in a mouse thymic lymphoma model,
presumably due to increased death of cells with synthetic loss of multiple repair factors.
To further test this possibility, I generated cells and mice deficient in both H2AX and
ATM to examine whether ATM-independent H2AX functions downstream of other
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kinases are essential for proper DSB repair. I found that thymocyte-specific ablation of
H2AX in ATM-deficient mice results in a 50% reduction in thymus cellularity but does
not accelerate or delay tumorigenesis. My results suggest that the outcomes of functional
interactions between DNA damage response factors likely depend on the cellular context.
Additionally, I discovered a novel function of ATM in regulating mono-allelic
recombination at the immunoglobulin light chain locus. ATM could orchestrate the
signaling pathways enforcing allelic exclusion to provide a time window to test whether
the rearrangement on the first allele is productive. In summary, my work has provided
novel mechanistic insights into how DNA damage and repair factors coordinately
regulate V(D)J recombination, lymphocyte development and neoplastic transformation.
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Chapter I
Introduction

1

DNA Damage and Repair Mechanisms Are Essential for Tumor Suppression
The existence of most life forms depends on the stability of the genomes and the
fidelity of genomic replication, despite constant assaults to the genetic materials by
endogenous and exogenous agents (Lindahl and Barnes, 2000). To counter these threats,
multiple layers of DNA damage recognition and repair mechanisms have evolved, and
defects in these pathways are closely related to cellular and organism survival and aging,
and development of human diseases including cancers (Rouse and Jackson, 2002;
Harrison and Haber, 2006; Harper and Elledge, 2007; Jackson and Bartek, 2009).

DNA damage is common and constantly occurring. It is estimated that each of the
cells in the human body (approximately 1013 cells in total) receives thousands of DNA
lesions every day (Lindahl and Barnes, 2000). These lesions can arise during DNA
replication in S phase, in which abortive topoisomerase activities can lead to DNA strand
breaks. They can also arise in any cell cycle phases from exogenous factors like ionizing
radiation (IR) and ultraviolet light (UV), or endogenous processes such as oxidative
stress and DNA hydrolysis. Attacks on DNA can generate base losses, adducts that
impair base pairing, or DNA single-strand breaks (SSBs). In addition, double-strand
breaks (DSBs) can result from two SSBs in close proximity, replication through SSBs or
other DNA lesions, collapsed replication forks, or endonuclease cleavage. If left unrepaired or erroneously repaired, DNA lesions can block transcription and genome
replication, leading to impaired celllar functions, cell cycle arrest or cell death (Figure 1).
Such persistent DNA lesions may also result in mutations or large-scale genome
aberrations, such as chromosome breaks or translocations, that can confer growth
2

advantages to incipient cells, leading to their malignant transformation. Indeed,
chromosome translocations that activate oncogenes and chromosome deletions that
inactivate tumor suppressor genes are frequently found in many human tumors (van Gent
et al., 2001; Hoeijmakers, 2001; Thompson and Schild, 2002; Mills et al., 2003; Jackson
and Bartek, 2009).

DSBs are among the most hazardous forms of DNA lesions, since liberated DNA
ends are difficult to repair and can separate irreversibly or join promiscuously (Khanna
and Jackson, 2001). Mutations of DSB repair factors result in increased cellular
sensitivity to DSBs, elevated levels of spontaneous genomic instability, and are closely
associated with an increased predisposition to cancers in both mice and humans (Mills et
al., 2003). In addition, many cancer cells also have subverted the cell cycle checkpoint
activation and cell death mechanisms to allow survival and proliferation of premalignant
cells and further neoplastic transformation (Dasika et al., 1999). Thus, understanding how
the DNA damage response (DDR) coordinates DNA repair with cell fate determination is
crucial to better prevent, diagnose and treat human malignancies.

DNA Bouble Strand Break Response and Repair within Chromatin
DNA in eukaryotic cells is packaged into chromatin, a highly organized and
dynamic DNA/protein polymer. Since chromatin is the native environment in which
DNA damage and repair must occur, how chromatin dynamics contributes to the
initiation, propagation and termination of the DDR has been the focus of recent studies
(Downs et al., 2007).
3

The most basic pattern of chromatin organization is ~147 base pairs of DNA
wrapped around a histone octomer core, which is composed of two of each core histones
H2A, H2B, H3 and H4, to form a nucleosome (Downs et al., 2007). Each of these
histones has a globular core domain, as well as an unstructured N-terminal tail domain
that protrude from the nucleosome core. Histones H2A and H2B also possess
functionally important C-terminal tails. In higher eukaryotes, each histone subtype, with
the possible exception of histone H4, contains a family of genes encoding multiple
variants that have altered amino acid sequences that may confer unique functions
(Brown, 2001). Core histones, including their variants, can be covalently modified by a
myriad of histone marks, including phosphorylation, acetylation, methylation,
ubiquitylation and sumoylation (Strahl and Allis, 2000). These covalent modifications
can alter chromatin structure via selectively allowing binding of non-histone effector
proteins. The combination of the covalent histone marks and the non-covalently bound
effector proteins constitute a code that regulates diverse processes such as transcription,
DNA replication, and DNA damage and repair (Strahl and Allis, 2000; Downs et al.,
2007). Between nucleosomes there are nucleosome-free regions where linker histones
and high-mobility group proteins can bind to regulate chromatin configuration and
compaction. In addition, a number of chromatin-remodeling complexes can alter histoneDNA contacts by histone eviction, exchange of histone variants, nucleosome sliding and
changing the accessibility of particular DNA elements (Downs et al., 2007). Thus, DNA
damage within chromatin may elicit chromatin remodeling, unmask constitutive histone
marks normally concealed in unperturbed cells, or induce additional histone
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modifications, making damaged DNA more accessible and coordinating DNA damage
response and repair.

In all mammalian cells, DSBs can arise accidentally following collapse of stalled
replication forks during DNA replication, or by exogenous factors such as IR. During
lymphocyte development, DSBs are also imperative intermediates during antigen
receptor gene rearrangement reactions such as V(D)J recombination (Figure 2) and B cell
class switch recombination (CSR), which are essential processes for the generation of
fully functional adaptive immune systems (Bassing et al., 2002a; Chaudhuri et al., 2007).
Whichever source they are from, DSBs pose a major threat to genome integrity since they
can lead to mutations, chromosome deletions and oncogenic translocations. Thus,
eukaryotic cells have evolved sophisticated and redundant genome surveillance
mechanisms to rapidly signal the presence of DSBs, initiate DNA repair, and coordinate
repair with cell cycle progression and cell survival decisions (Figure 1) (Rouse and
Jackson, 2002; Harrison and Haber, 2006; Harper and Elledge, 2007; Jackson and Bartek,
2009).

The DDR is executed coordinately by a constellation of sensor, transducer and
mediator/effector proteins (Figure 1). While the mechanisms by which DNA breaks are
initially sensed remain elusive and may vary depending on the context, the recognition of
DNA damages generally leads to rapid activation of the transducer kinases Ataxia
Telangiectasia Mutated (ATM) (Andegeko et al., 2001; Burma et al., 2001), DNAdependent protein kinase catalytic subunit (DNA-PKcs) (Park et al., 2003) and/or
5

ATM/Rad3-like (ATR) (Furuta et al., 2003; Zou and Elledge, 2003). These three kinases
belong to the phosphoinositide 3-kinase (PI3K) superfamily, and optimal kinase
activation/function following DNA damage critically depends on their interactions with
the DNA ends and/or chromatin and associated factors. Active ATM/ATR/DNA-PKcs
kinases can then activate, among others, effector kinases such as Chkl or Chk2 (Dasika et
al., 1999; Matsuoka et al., 2007). Together with ATM and ATR, Chk1 and Chk2 act to
reduce cyclin-dependent kinase (CDK) activity by various mechanisms, slowing down or
arresting cell cycle progression (Jackson and Bartek, 2009). In mammalian cells, Chk1 is
the primary effector to activate intra-S and G2/M phase checkpoints, while Chk2
contributes to intra-S and G1/S checkpoint activation. ATM/Chk2-mediated stabilization
of the p53 transcription factor is essential for effective G1/S checkpoint activation
(Bartek and Lucas, 2007). The consequences of DDR signaling include cell cycle arrest
to allow time for repair of such breaks, or cell death in cases where DSB repair cannot be
easily accomplished.

Mammalian cells have evolved distinct yet complementary DSB repair pathways
that are conserved among species to ensure genomic stability. DSBs generated in postreplicative cell cycle phases are primarily repaired by homologous recombination (HR),
whereas DSBs generated in G1-phase cells are repaired through non-homologous end
joining (NHEJ) (Lieber et al., 2003; Rooney et al., 2004b; Wyman et al., 2004). HR
involves two major sub-pathways, sister chromatid recombination (SCR) and single
strand annealing (SSA). SCR is generally limited to late S and G2 phases of the cell cycle
and uses information from sister chromatids, which are readily available homologous
6

templates, to accurately repair breaks (Wyman et al., 2004). In contrast, NHEJ mediates
the joining of DSB ends independent of extensive homology, and is the principle
mechanism used in G1 phase although it is functional throughout the cell cycle (Lieber et
al., 2003; Rooney et al., 2004b). SSA also involves ssDNA intermediates, but repair
proceeds through the annealing of complementary sequences on the same strand with
deletion of intervening sequences. Thus, SSA is error-prone; and, as it often utilizes
repetitive elements dispersed along a chromosome, SSA deletes much larger genomic
sequences than NHEJ. Although both HR and NHEJ are important for the well-being of
cells and organisms, only NHEJ is discussed in detail due to the focus of my thesis.

The NHEJ machinery is conversed from yeast to human and consists of factors
with functions such as end stabilization, end processing and end ligation. In yeast, the
Mre11/Rad50/Xrs2 (MRX) and Ku complexes are among the first to bind DSB ends,
where they serve to protect the ends from degradation and bridge the two termini to
prevent their irreversible separation (Daley et al., 2005). In vertebrates Ku70/80 forms a
trimeric complex with the catalytic subunit DNA-PKcs, and the holoenzyme DNA-PK is
activated upon loading onto DSB ends. Besides its DNA end-bridging role, DNA-PK
may also recruit, stabilize and stimulate the ligase complex LigIV/XRCC4/XLF and
allow end re-joining to occur (Mahaney et al., 2009). It is estimated that approximately
10-15% of IR-induced DSBs are dependent on the exonuclease Artemis, whose
endonuclease activity is activated through phosphorylation by DNA-PKcs, to process
hairpin-like structures that are incompatible with end-joining (Riballo et al., 2004). Other
DNA nucleases and polymerases can also be mobilized to delete or add nucleotides
7

before ends are ligated, making NHEJ an inherently imprecise way of DNA repair
(Lieber et al., 2003).

One of the earliest events and an important component of eukaryotic DSB response
is the phosphorylation of the C-terminal SQE motif (phosphorylation site Ser139) on the
histone variant H2AX within chromatin around DSB sites, forming γH2AX that can be
visualized microscopically as foci with phospho-specific antibodies or detected by
chromatin immunoprecipitation (ChIP) around site specific DSBs (Rogakou et al., 1998;
Rogakou et al., 1999; Bonner et al., 2008; Savić et al., 2009). H2AX represents 2-25% of
the cellular H2A pool and can be incorporated into nucleosomes together with other core
histones (Rogakou et al., 1998; Bewersdorf et al., 2006). H2AX phosphorylation and
γH2AX foci formation is of fundamental importance to further signaling at the break
(Figure 1) (Downs et al., 2007; Bonner et al., 2008). An attractive model has been
proposed to emphasize the importance of this phosphorylation event. Upon DNA
damage, sensors such as the MRE11/RAD50/NBS1 (MRN, homolog of the yeast MRX
complex) complex can recognize un-repaired DSBs (Paull et al., 2000; Carson et al.,
2003; Difilippantonio et al., 2005; Horejsí et al., 2004; Lee and Paull, 2005; Uziel et al.,
2003), to which ATM is recruitmented and activated within chromatin (Bakkenist and
Kastan, 2003). Phosphorylation of H2AX by ATM then provides a binding site for DDR
factors including MRN, MDC1 and 53BP1, all of which can be phosphorylated and
activated by ATM (Downs et al., 2007; Bonner et al., 2008). The accumulation of these
DDR factors and chromatin conformation changes around the breaks may potentiate
activation of ATM, which in turn, phosphorylates more H2AX in adjacent chromatin,
8

leading to a propagation of γH2AX signal into chromatin around the breaks and
amplification of DDR signals (Figure 1) (Lou et al., 2006).

H2AX Phosphorylation Is a Hallmark of Chromosomal DSB Response
Formation of γH2AX foci after DNA damage has been widely used as an indicator
of DSB induction. Recent studies of protein-protein/protein-DNA interactions have
started to unravel the molecular architectures of the multi-component complexes within
the DNA damage foci. Among the many molecular interactions with γH2AX, the tandem
BRCA1 carboxyl-terminal (BRCT) domain of MDC1 appears to be the primary γH2AX
recognition module in higher eukaryotes (Stucki and Jackson, 2006). MDC1 mediates
effcient foci formation by other DDR factors including the MRN complex, BRCA1, PITP
and likely also 53BP1 (Stucki and Jackson, 2006; Gong et al., 2009). However, there are
factors, such as MCPH1/BRIT1, that form DNA damage-induced foci in an H2AXdependent but MDC1-independent manner (Wood et al., 2007). In this regard, although
H2AX is not required for the initial recruitment of DDR factors, γH2AX can facilitate
DSB repair by retention of repair factors at the breaks sites (Celeste et al., 2003a). The
chromatin changes conferred by the γH2AX-recruited DDR complexes have been
proposed to anchor broken DNA ends in proximity, thus function more directly in end
joining (Bassing and Alt, 2004). When repair is completed, removal of γH2AX might be
crucial for restarting the cell cycle, and this could be accomplished by nucleosome
exchange or eviction from chromatin, or dephosphorylation via phosphatases such as
PP2A and PP4 (Chowdhury et al., 2005; Nakada et al., 2008).
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The MRN complex is required for the initial detection of DSBs and several effector
pathways, in agreement with its role as an upstream activator and a downstream target of
ATM (Uziel et al., 2003; Lee and Paull, 2004; Lee and Paull, 2005; Difilippantonio et al.,
2005). Although a direct function of ATM in HR remains controversial, the involvement
of MRN compents in HR has been documented. First, the endonuclease and exonuclease
activities of Mre11 might be involved in DNA end processing (D'Amours and Jackson,
2002; Stracker et al., 2004). Second, Rad50 has ATPase and adenylate kinase activities
that may be required for DNA tethering (D'Amours and Jackson, 2002; Stracker et al.,
2004; Bhaskara et al., 2007). Besides, Rad50 has N- and C-terminal Walker A and B
nucleotide binding motifs, respectively, that form a DNA binding domain upon their
intra-molecular association. This association also leads to the formation of a central
Rad50 hook domain (D'Amours and Jackson, 2002; Stracker et al., 2004), which can
facilitate the tethering of two distinct MRN-bound DNA molecules through an intermolecular interaction of two Rad50 hook domains (Anderson et al., 2001; de Jager et al.,
2001; Hopfner et al., 2002; Wiltzius et al., 2005; Moreno-Herrero et al., 2005). Since
ATM phosphorylates Mre11, RAD50 and NBS1 in response to DNA DSBs, ATM may
modulate HR repair by regulating MRN effector functions (Gatei et al., 2000; Wu et al.,
2000; Lim et al., 2000; Matsuoka et al., 2007). So far no enzymatic activities have been
attributed to NBS1; nevertheless, it’s an essential DDR mediator due to its interactions
with γH2AX, ATM and MDC1, among others. In light of the strikingly different
phenotypes of several NBS1 mutants, MRN might mediate checkpoint activation and
apoptosis induction in response to DSBs through distinct molecular domains on NBS1
(Difilippantonio et al., 2007; Stracker et al., 2007). Furthermore, the mammalian MRN
10

complex was recently shown to also play an important role in NHEJ, likely by bridging
and stabilizing DSB ends (Helmink et al., 2009; Deriano et al., 2009; Xie et al., 2009;
Dinkelmann et al., 2009; Rass et al., 2009).

MDC1 is a major γH2AX recognition module in higher eukaryotes. MDC1
modulates S-phase and G2/M checkpoint activation after DNA damage and mediates
efficient foci formation by other DDR factors (Stucki and Jackson, 2006). Importantly,
docking of MDC1 on γH2AX has been postulated to facilitate the local accumulation of
ATM in damaged chromatin, where activated ATM phosphorylates adjacent H2AX,
generating a positive feedback loop that leads to γH2AX spreading into surrounding
chromatin and amplification of DNA damage signals (Stucki and Jackson, 2006; Lou et
al., 2006). Recent work using an inducible V(D)J recombination system in mammalian
cells has show that the γH2AX densities equilibrate within a fixed distance from break
sites, and MDC1 is essential for γH2AX formation at high densities near DSBs (Savić et
al., 2009). This in part could be due to that MDC1 bound to γH2AX might prevent
phosphatase access to the phosphoepitope. Most recently the phosphorylated SDT repeats
of MDC1 have been shown to dynamically associate with NBS1 in undamaged cells, and
mediate chromatin retention of MRN after concentration of MDC1 around DSB sites
(Melander et al., 2008; Spycher et al., 2008; Chapman and Jackson, 2008). These results
confirmed a pivotal role of MDC1 in the relay and amplification of DDR signals.

γH2AX-dependent MDC1 accumulation at the breaks site also orchestrates the
subsequent phospho-dependent recruitment of RNF8-dependent proteins, linking histone
11

phosphorylation with ubiquitylation (Stewart, 2009). RNF8 is an E3 ubiquitin ligase and
through its FHA domain, interacts with a conserved TQXF motif on MDC1 following its
phosphorylation by ATM in chromatin. Recruitment of RNF8 to phosphorylated MDC1,
in conjunction with the E2 ubiquitin conjugating enzyme, UBC13, catalyses polyubiquitylation of H2AX and other H2A histones surrounding DSBs (Huen et al., 2007;
Kolas et al., 2007; Mailand et al., 2007; Wang et al., 2007). Another E3 ubiquitin ligase
RNF168 was recently found to function downstream of RNF8 to ubiquitylate more H2A
molecules (Stewart et al., 2009; Doil et al., 2009). The ubiquitylation events around DSB
sites may provide binding sites for additional factors, or configure the chromatin into a
more accessible conformation, allowing concealed epigenetic marks such as histone
methylation to recruit additional, albeit kinetically slower, component of the DDR
cascade (Stewart, 2009).

One such component of the DDR response is 53BP1, which is phosphorylated by
ATM and contains a potential γH2AX-binding motif. Curiously, this tandem BRCT
domain is not required for its repair function; instead, its tandem Tudor motifs bind to
methylated H3K79 or H4K20 and target 53BP1 to sites of DSBs. The chromatin
conformational changes following DSB induction, as discussed above, can expose these
constitutively methylated histone marks, providing sites for the initial recruitment of
53BP1 (van Attikum and Gasser, 2009). However, 53BP1 foci form at a slower kinetics
than those of γH2AX, MDC1 or NBS1, and absence of any of these factors impairs
53BP1 foci formation (van Attikum and Gasser, 2009), presumably because these factors
are necessary to potentiate 53BP1 retention on chromatin, either through direct protein
12

interaction or exposure of large numbers of methylated histones, or both.

Recently, it was discovered that in addition to the Ser139 phosphorylation, H2AX
is also phosphorylated at residue Tyr142. In unstressed cells, Tyr142 is already
phosphorylated by the kinase WSTF; upon DNA damage, Tyr142 becomes gradually
dephosphorylated through actions of the phosphatases Eya1 and Eya3. Tyr142
dephosphorylation may be required for Ser139 phosphorylation, since the dually
phosphorylated H2AX is incapable to retain MDC1 and elicit further signaling. Thus,
Tyr142 phosphorylation status determines the relative recruitment of either DNA repair
or pro-apoptotic factors to γH2AX tails, and functions as a switch of repair versus
apoptotic responses to DNA damage (Xiao et al., 2009; Cook et al., 2009).

In summary, H2AX phosphorylation, H2A(X) ubiquitylation and other histone
modifications surrounding the DNA breaks may be required to cooperatively promote
chromatin changes around the DSB sites, efficient DNA repair, effective checkpoint
activation, and/or apoptosis decisions.

Consistent with the important roles of H2AX in response to and/or repair of DSBs,
cells deficient in H2AX have been shown to display significant growth defects, IR
sensitivity, and increased levels of genomic instability (Bassing et al., 2002b; Celeste et
al., 2002). The genomic instability of H2ax–/– cells could be due to impaired HR and/or
NHEJ repair (Bassing et al., 2002b; Celeste et al., 2002; Xie et al., 2004; Franco et al.,
2006). In mammalian cells, H2AX Ser139 phosphorylation is important to enforce
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efficient HR and prevent the error-prone deletional repair through SSA (Xie et al., 2004).
One potential mechanism is provided by studies in yeast post-replicative DSB repair,
where cohesin binding to the γH2AX domains around the break sites ensures sister
chromatid cohesion, promoting proper HR that uses the adjacent intact sister chromatid
as a template (Unal et al., 2004). This role of H2AX in HR is consistent with the
observation of chromatid breaks that accumulate in H2ax–/– cells (Bassing et al., 2002b;
Celeste et al., 2002). Although H2AX does not seem to be essential for the joining step of
NHEJ using an extra-chromosomal V(D)J recombination assay (Bassing et al., 2002b),
H2ax–/– cells accumulate chromosome breaks either during normal proliferation in culture
or following treatment of DNA damaging agents, indicative of compromised prereplicative DSBs repair that does not depend on extensive homology (Bassing et al.,
2002b; Celeste et al., 2002). Futhermore, in CSR where DSB intermediates are joined
through the NHEJ pathways, H2ax–/– B cells show reduced CSR efficency and harbor
elevated levels of CSR-associated chromosome breaks/translocations independent of the
p53-mediated checkpoint, consistent with a role of H2AX in NHEJ (Reina-San-Martin et
al., 2003; Franco et al., 2006; Ramiro et al., 2006). In addition, H2AX-deficient cells
exhibit impaired G2/M checkpoint activation in response to low, but not high, doses of IR
(Fernandez-Capetillo et al., 2002), suggesting checkpoint signaling defects in response to
physiological levels of DNA breaks may also have contributed to the accumulation of
genomic aberrations in the absence of H2AX. Thus, the delineation of H2AX functions in
DSB repair would be facilitated by experimental systems in which break repair could be
separated from cell cycle progression.
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V(D)J Recombination is a Physiological DNA Damage and Repair Process
Although protocols that induce large amouts of cellular DNA damage have
provided important insights into the DDR mechanisms and the rationales of current
cancer therapies (chemotherapies and radiotherapies), cell responses to low,
physiologically relevant doses of DNA damage and mechanisms of DNA repair may be
different and are poorly understood. This knowledge is necessary to understand tumor
initiation during which somatic cells rarely receive large, but rather accumulate mutations
due to low, amounts of DNA damage. This knowledge may also form the basis for
improved cancer prevention strategies. Thus, systems where a few DSBs can be induced
and tracked in each cell would be extremely valuable for this purpose. For my thesis, I
have been using V(D)J recombination as a model to elucidate the mechanisms of
physiological DNA damage and repair.

The ability of adaptive immune systems to recognize and destroy a plethora of
pathogens depends on the immense repertoire of antigen receptor specificities of B and T
cells. Each antigen receptor is composed of a constant (C) region and a variable region,
whose extreme variability allows the antigen-binding site to recognize antigens with
specificity. In developing immature lymphocytes, the variable region exons of either Tcell receptor (TCR) or B-cell receptor (BCR) genes are assembled through cutting and
pasting of germ line variable (V), diversity (D) and joining (J) gene segments, in a
genetically programmed DNA recombination process termed V(D)J recombination
(Bassing et al., 2002a).
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In humans and mice, there are seven different antigen receptor gene loci that can
undergo V(D)J recombination. In B cells, the BCRs or immunoglobulins (Ig) are encoded
by the heavy chain (IgH) and light chain κ and λ (Igκ and Igλ) loci; in T cells, the TCRs
are encoded by the α and β chain loci in αβ T cells, or the γ and δ chain loci in γδ T cells.
Mature B cell and αβ T lymphocytes develop through a highly regulated stepwise
differentiation program that includes V(D)J recombination and periods of rapid cell
proliferation (Bassing et al., 2002a). V(D)J recombination is initiated by the lymphoid
specific endonuclease complex RAG1/2 (recombinase activating genes 1 and 2) in the
G0/G1 phase of slowly cycling immature lymphocytes. In the bone marrow, for example,
pro-B cells assemble IgH V genes and express the IgH µ chains together with the
surrogate light chains (VpreB and λ5) to form the pre-BCR, resulting in cell proliferation
and maturation into the pre-B cells stage. Early large pre-B cells turn off the
recombination machinery, and exit the cell cycle following several cell divisions. These
G0/G1 phase late small pre-B cells can now undergo IgL (IgLκ or λ) rearrangement,
becoming surface IgM+ immature B cells. The initial un-selected B cell repertoire
contains large numbers of cells with self-reactive antibodies or receptors. Further IgL
rearrangements such as secondary V(D)J recombination or receptor editing can occur in
these self-reactive B cells to rescue them from being selected against (Jankovic et al.,
2007). In parallel, in-frame VDJβ rearrangements in CD4–/CD8– (double negative, DN)
thymocytes generate TCRβ chains that, when expressed and paired up with pre-Tα
chains to form the pre-TCR on the cell surface, provide survival signals for DN
thymocytes and drive rapid cell proliferation and differentiation to the CD4+/CD8+
(double positive, DP) cell stage. TCRα variable region exons are then assembled in DP
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thymocytes. Successful VJα rearrangements generate TCRα chains that, when expressed
on the cell surface with TCRβ chains to form the αβ TCR, rescue DP cells from
apoptosis and signal differentiation to CD4+ or CD8+ (single positive, SP) thymocytes.
V(D)J recombination is an essential component of lymphocyte development, as
evidenced by the observations that Rag1–/– or Rag2–/– mice completely lack mature B and
T lymphocytes.

The combinations of joining between different V, J, and sometimes D, gene
segments generate the combinatorial diversity, which contributes to the final repertoire of
receptor specificities but by itself is not sufficient to account for the immense pool size.
Additional diversity is determined by the repair mechanisms of DSB intermediates during
V(D)J recombination. As shown in Figure 2, The RAG1/2 complex introduces DSBs at
recombination signal sequences (RSSs) that flank V, D and J gene segments. Upon
binding to the RSSs RAG proteins introduce a single stranded nick in the DNA and transesterification leads to two types of double strand breaks: blunt, 5’ phosphorylated signal
ends (SE) and covalently sealed hairpin coding ends (CE) (Fugmann et al., 2000). RAG
proteins hold V(D)J intermediates together in a synaptic complex (Agrawal and Schatz,
1997; Lee et al., 2004), facilitating their repair by seven known NHEJ factors, Ku70,
Ku86, XRCC4, ligase IV, DNA-PKcs, Artemis and XLF/Cernunnos (Lieber, 2008)
(Figure 2). All seven factors are required to process and join CEs together to form coding
joins (CJs) that encode antigen receptor exons, while all seven except DNA-PKcs and
Artemis are required to join SEs to form signal joins (SJs). In CJ formation, DNA-PKcs
phosphorylates Artemis and activates its endonuclease activity, which is required to open
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CE hairpins for repair (Ma et al., 2002). Hairpin opening often generates staggered DNA
ends from which nucleotides can be trimmed by the DNA-PKcs/Artemis complex (Figure
2). Before ligation of coding ends by the XLF/XRCC4/ligase IV complex, polymerase µ
and/or polymerase λ can fill in the gaps in a template-dependent manner (Nick
McElhinny and Ramsden, 2004). In addition, terminal transferase (TdT), a lymphocytespecific template-independent polymerase, can add nucleotides to the CEs. The imprecise
nature of NHEJ thus contributes to the junctional diversity.

NHEJ is essential for functional V(D)J recombination in both mice and humans.
Most NHEJ-deficient mice lack mature B and T cells due to their inability to form coding
joins, which are prerequisites for clonal expansion of B and T cell precursors (Rooney et
al., 2004b). In humans, nearly 30% of all T–B– SCID (severe combined
immunodeficiency) patients show hypersensitivity to IR, because the V(D)J
recombination deficiency results from defective NHEJ, rather than mutations in their
RAG1 and/or RAG2 genes (Revy et al., 2005). The majority of these patients harbor
mutations in ARTEMIS. Mutations of other NHEJ components are also associated with
human immunodeficiencies, including those of the DNA ligase IV gene (LIG4
Syndrome) and XLF/Cernunnos gene (O’Driscoll et al., 2004; Ahnesorg et al., 2006;
Buck et al., 2006). Phenotypes of knockout/mutant mice for Ku70, Ku80, XRCC4 and
DNA-PKcs genes suggest their mutations might also lead to SCID in humans (Rooney et
al., 2004b). Indeed, van der Burg et al. recently identified a DNA-PKcs mutation that
inhibits Artemis activation and NHEJ in a radiosensitive T–B– SCID patient (van der
Burg et al., 2009). In addition, the existence of RAG mutants that are able to induce
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DSBs but are defective in the joining reaction suggests that RAG may play roles in repair
itself (such as holding the DNA ends in proximity) or in recruitment of NHEJ DNA
repair factors (Agrawal and Schatz, 1997; Lee et al., 2004). In contrast to RAGs in V(D)J
recombination, the enzyme that introduces the DSBs in CSR, and the restriction enzymes
used in a number of in vitro studies, are not known to hold DSB ends with high affinity.

Not unlike general DSBs, lymphocytes are challenged to properly activate DDR in
response to programmed DSBs during V(D)J recombination and CSR (Figure 3). First,
γH2AX and NBS1 form RAG-dependent foci at the Tcrα locus in developing
thymocytes, indicative of ongoing V(D)J DSB induction and/or repair (Chen et al., 2000).
Second, RAG-induced breaks are restricted to the G1 cell cycle phase, since the Skp1Cul1-Skp2 (Skp2-SCF) polyubiquitylates RAG2 for the proteosome-dependent
degradation at G1/S transition (Lee and Desiderio, 1999) (Figure 3). Most DSB
intermediates are believed to be repaired before S-phase entry, since un-repaired DSBs
can activate the G1/S checkpoint, although it has been reported that in at least a small
percentage of lymphocytes with un-repaired V(D)J breaks can persist into S phase even
in wild type mice (Pedraza-Alva et al., 2006). An even higher percentage of cells with
un-repaired V(D)J breaks may be able to start DNA replication in NHEJ-deficient mice,
or in the absence of effective G1/S checkpoint activation, such as in p53–/– and Atm–/–
cells (Dujka et al., 2010) (Figure 3). This fraction of DNA breaks can be replicated to
form chromosome breaks, or participate in chromosome translocations after illegitimate
joining with other breaks such as those generated during collapsed replication forks.
Thus, combined deficiencies in NHEJ repair and G1/S checkpoint mechanisms may
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result in dramatically elevated genomic instability due to faulty V(D)J recombination
(Figure 3).

Consistence with the aforementioned idea, NHEJ-deficient mice rarely develop
lypmphomas because p53-mediated apoptosis can eliminate DN or pro-B cells with unrepaired RAG-generated DSBs (Rooney et al., 2004b). NHEJ/p53 compound deficiency
allows these cells to survive but does not rescue lymphocyte development. Furthermore,
most NHEJ/p53-deficient mice rapidly succumb to pro-B lymphomas with IgH
translocations, and some Artemis–/–p53–/– mice also develop thymic lymphomas with
potential TCRα/δ translocations (Rooney et al., 2004a, 2004b). Interestingly, over 10%
of peripheral T cells from Atm–/– mice contain Chr. 14 breaks or translocations that likely
involve the TCRα/δ locus, and Atm–/– mice invariably die from thymic lymphomas with
clonal TCRα/δ translocations (Liyanage et al., 2000). These abnormalities cannot be
fully explained by the checkpoint activation or apoptotic functions of ATM, suggesting
ATM may in addition function in the joining step of NHEJ, which is discussed later in
this chapter.

In summary, V(D)J recombination is highly regulated in a lineage-, developmental
stage-and cell cycle-specific manner. This V(D)J recombination program must
orchestrate chromatin conformation and DNA damage and repair proteins, in addition to
cis-acting DNA elements and trans-acting transcription factors.

Novel Cell Line Systems and Mouse Models to Study H2AX Functions
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Whether and how H2AX functions in NHEJ and V(D)J recombination is poorly
understood and existing results are contradictory. Similar to Atm–/– mice, H2ax–/– mice
are mildly lymphopenic and their primary αβ T cells harbor potential TCR translocations,
although the H2ax–/– defects are generally less severe than that of Atm–/– mice (Celeste et
al., 2002; Liyanage et al., 2000). Despite the dramatic genomic instability of H2ax–/–
cells, H2ax–/– mice are only slightly predisposed to thymic lymphomas, whereas H2ax–/–
p53–/– mice rapidly succumb to immature T and B lineage lymphomas and solid tumors
(Celeste et al., 2003b; Bassing et al., 2003). H2ax–/–p53–/– thymic lymphomas harbor
clonal translocations that predominantly do not involve TCR loci and, which, therefore
have been proposed to arise through the mis-repair of spontaneous DSBs. Nevertheless,
at very low frequencies, H2ax–/– and H2ax–/–p53–/– mice do develop thymic lymphomas
with clonal TCR translocations, which are not observed in p53–/– mice (Celeste et al.,
2003b; Bassing et al., 2003). Moreover, the majority of H2ax–/–p53–/– pro-B lymphomas
contain Igh/c-myc translocations, similar to those in NHEJ/p53-deficient pro-B
lymphomas (Mills et al., 2003), suggesting a role of H2AX in resolution of DSB
intermediates during V(D)J recombination. Indeed, the subset of thymic lymphomas and
pro-B lymphomas with clonal antigen receptor translocations are absent in H2ax–/–p53–/–
Rag2–/– mice, though RAG2-deficiency does not significantly alter lymphoma
development of H2ax–/–p53–/– mice (Bassing et al., 2008). Thus, among its more general
functions as a genome caretaker, H2AX may play a role in suppressing aberrant
processing of RAG-initiated DSBs, though compelling experimental evidence assaying
the repair of tractable breaks are still lacking.
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On the other hand, H2AX-deficient cells support normal signal and coding end
formation on transiently introduced extra-chromosomal V(D)J recombination substrates
(Bassing et al., 2002b), suggesting H2AX might not be required for NHEJ per se,
contradicting aforementioned phenotypes of H2ax–/– mice. Such discrepancies also
existed for the upstream kinase ATM until a novel cell line base system was developed to
assay chromosomal V(D)J recombination. Treatment of v-Abl transformed (Abelson)
pre-B cells with STI571, a small molecule Abl kinase inhibitor, results in rapidly upregulation of RAG expression and induction of DSBs at the endogenous Jκ locus and
within chromosomally-integrated recombination substrates (Figure 4) (Muljo and
Schlissel, 2003; Bredemeyer et al., 2006). A concomitant G1 arrest independent of V(D)J
recombination provides large populations of synchronized cells. To prevent elimination
of DSB-bearing cells through apoptosis, these Abelson cells were also engineered to
express the anti-apoptotic Bcl2 protein (Bredemeyer et al., 2006). Thus, RAG-generated
chromatin DSBs can be induced with high efficiency, and their repair tracked, in large
populations of G1-arrested Abelson cells. Using this system, a previously unappreciated
role of ATM was unraveled: dependent on its kinase activity, ATM stabilizes
chromosomal V(D)J recombination DSB intermediates, facilitates coding join formation,
and prevents broken DNA ends from participating in chromosome deletions, inversions,
and translocations (Bredemeyer et al., 2006). This is consistent with both the lymphoid
tumor-prone phenotype in ataxia telangiectasia (A-T) patients and the development of
thymic lymphomas harboring RAG-dependent Tcrα/δ translocations in Atm–/– mice
(Liyanage et al., 2000), neither of which could be explained solely by ATM’s checkpoint
and apoptosis functions. Thus, abrogation of ATM not only impairs end joining, but also
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allows immature lymphocytes with un-repaired chromosome breaks to develop and
persist into the periphery, where in the case of B cells, these RAG-initiated breaks can
join to AID-dependent breaks during CSR (Callén et al., 2007).

Definite evidence that the MRN complex components play a role in NHEJ and
V(D)J recombination was also obstained for the first time using the Abelson cells. In
humans, mutations of the ATM gene cause A-T, mutations of NBS1 cause Nijmegen
breakage syndrome (NBS) and mutations of MRE11 cause ataxia-telangiectasia-like
disease (ATLD), and all three syndromes are genetic disorders exhibiting multiple
phenotypes that include genomic instability, immunodeficiency, and increased
predisposition to lymphoid malignancies associated with antigen receptor locus
translocations. Consistent with the similarities between A-T and NBS/ATLD patient
symptoms, MRN also functions in the NHEJ-mediated repair of DNA DSBs generated
during V(D)J recombination (Helmink et al., 2009). The defects observed in MRN
mutant lymphcoytes are strikingly similar to those observed in ATM-deficient
lymphocytes, suggesting that MRN and ATM function in the same pathway in NHEJmediated repair of RAG-mediated DSBs in G1-phase cells. Both ATM and NBS1
localize to V(D)J DSB ends and may function to tether ends in proximity in addition to
the RAG complex (Chen et al., 2000; Perkins et al., 2002). Normally, the RAG postcleavage complex prevents V(D)J DSBs from being repaired through alternative NHEJ,
an error-prone mechanisms for joining DSBs in mammalian cells (Corneo et al., 2007).
Using certain RAG mutants that allow destabilization of the post-cleavage complex and
alternative NHEJ, NBS1, and likely the MRN complex, is shown to regulate repair
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pathway choice by enhancing the stability of DNA end complexes and participate in
alternative NHEJ of coding ends (Deriano et al., 2009). Thus, I reasoned that the Abelson
inducible V(D)J recombination system would allow me to uncover novel H2AX
functions.

Based on the model of γH2AX nucleating foci formation in response to general
DSBs (Bonner et al., 2008), Chapter II of my thesis focuses on testing the hypothesize
that one specific function of γH2AX is to serve as an anchor for the assembly of multiple
protein-protein/protein-DNA interactions involving MDC1, MRN and 53BP1, among
others, around chromosomal V(D) breaks. These complexes would prevent irreversible
dissociation and subsequent mis-repair of broken V, D, and J segments. Thus, by
inducing V(D)J recombination in H2ax–⁄– Abelson cells, I speculate there might be
accumulation of un-repaired DSB ends that have escaped from the post-synaptic
complex, and they are capable of participating in illegitimate end joining either in G1 or
subsequent cell cycles. Indeed, H2AX has been shown to prevent AID-dependent DNA
breaks from progressing into chromosome breaks/translocations in cells undergoing CSR,
where H2AX and ATM are required for long-range switch region synapsis (Franco et al.,
2006; Ramiro et al., 2006). However, it is equally possible that no V(D)J end joining
defects would be observed within G1-arrested H2ax–⁄– Abelson cells, either due to high
affinity of RAG proteins to DNA ends evidenced at least in vitro, or the rapid kinetics of
NHEJ as soon as breaks are induced, or a combination of both. If this is the case, H2AXdeficiency might need to be coupled with continued cell cycle progression in order to
erroneously process RAG-initiated G1 breaks. To this end, H2ax–⁄– and H2ax–⁄–p53–⁄–
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Abelson cells are released from G1-arrest, allow RAG2 degradation upon S-phase entry,
and monitor fates of RAG-generated DSBs (Figure 4). Since in the context of rapid
NHEJ the level of RAG-initiated breaks persisting into S-phase might be below detection
even in the absence of p53-mediated checkpoint activation, I’ve also generated and
utilized Artemis–⁄–H2ax–⁄– and Artemis–⁄–H2ax–⁄–p53–⁄– Abelson cells, where NHEJ kinetics
of coding ends is nearly down to zero due to inability to open hairpins. In these
NHEJ/p53-deficeint cells, H2AX deficiency might severely compromise positional
stability of persistent broken DNA ends even in G1 phase, and after G1/S transition, lead
to enhanced chromosome breaks/translocations involving ends that are permanently
separated from their legitimate partners. Thus, when Artemis–⁄–H2ax–⁄– and Artemis–⁄–
H2ax–⁄–p53–⁄– Abelson cells are released from cell cycle arrest, H2AX deficiency may
lead to more un-repaired V(D)J DSBs being replicated to form chromosome breaks or
translocations (Figure 4).

Previous comparative genomic hybridization analysis of NHEJ/p53-deficient mice
pro-B cell tumors show that the majority of these tumors carry a mono-allelic deletion of
a region spanning the H2ax gene on chromosome 9, suggesting H2ax haploinsufficiency
may have contributed to genomic instability and tumor development in NHEJ/p53 mice
(Bassing et al., 2003). Artemis–⁄–p53–⁄– mice can develop thymic lymphomas with clonal
TCRα/δ locus translocations (Rooney et al., 2004a), and provide a model to test the roles
of H2AX during V(D)J recombination in vivo and in subsequent lymphomagenesis. To
characterize the tumor phenotype of Artemis–⁄–p53–⁄– and Artemis–⁄–H2ax–⁄–p53–⁄– mice is
the focus of Chapter III of my thesis.
25

Extensive studies summarized above have placed H2AX, ATM and MRN into
highly cooperative yet non-overlapping regulatory networks during DDR. ATM and
MRN clearly have H2AX-independent functions, including roles in cell cycle
checkpoints and p53-mediated apoptosis, the impairment of ATM or MRN components
results in unique phenotypes associated with each disorder. On the other hand, H2AX is
downstream of other kinases such as DNA-PKcs and ATR, and is shown to be critical for
HR. The organization of H2AX and ATM genes in a syntenic group across species
suggests their functional interactions could be particularly relevant in tumor suppression.
The human H2AX gene (H2AFX) maps 11 Mb telomeric of ATM on Chr. 11 at 11q23,
which frequently exhibits LOH or deletion spanning both gene loci in a number of human
cancers, including immature T cell and mature B cell lymphomas (Stilgenbauer et al.,
1996, 1999). By comparing G1-arrest H2ax–/–, Atm–/– and H2ax–/–Atm–/– Abelsons cells
undergoing V(D)J recombination, I can test the hypothesis that H2AX and ATM occupy
distinct chromatin regions around break sites to promote DNA ends stability. Moreover,
haploinsufficient H2AX expression dramatically predisposes mice to genomic instability
and cancer in a p53-deficient background (Bassing et al., 2003). In this context, it will be
of particular interest to determine whether loss of one or both H2AX genes modifies the
ATM-deficient phenotype in mice. In Chapter IV of my thesis, I present some
preliminary results examining whether there are functional interplays between H2AX and
ATM in V(D)J recombination, lymphocyte development and transformation.

DNA Damage Signals and Mono-allelic V(D)J Recombination
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In the absence of any regulatory control mechanisms, both alleles of each antigen
receptor locus in diploid human and mouse lymphocytes would be available for V(D)J
recombination. However, most B and T cells express a unique antigen receptor encoded
by V-to-(D)J rearrangements of only one of the two alleles for each individual TCR/Ig
gene (Cedar and Bergman, 2008). The functional exclusion of the non-expressed alleles,
also known as allelic exclusion, is observed at the TCRβ locus in T cells and the IgH,
IgLκ and IgLλ light chain loci in B cells. Despite extensive efforts, the precise
mechanisms of how allelic exclusion is initiated and maintained remain largely unknown,
partly due to asynchronous V(D)J recombination in populations of cells in vivo.

Allelic exclusion can be achieved at multiple levels, such as locus accessibility,
DNA rearrangement, differential expression and cellular selection. For example, both
IgH and TCRβ loci exhibit allelic exclusion at the V-to-DJ step but not at the D-J step.
First, due to the imprecise nature of V(D)J end joining and 2/3 of the time each joining is
out of frame, it is suggested that the chances of both alleles undergoing productive V-toDJ recombination simultaneously are small, assuming the choice of which allele to
rearrange is stochastic. Second, once a productive rearrangement on one allele occurs, the
pre-BCR/TCR can send a feedback signal to suppress further V-to-DJ recombination on
the remaining allele. The pre-BCR/TCR signaling also drives proliferation and
differentiation until the IgL or TCRα rearrangements, during which further IgH or TCRβ
rearrangements need to be suppressed. This suppression could be achieved in a number of
ways, which are not mutually exclusive: down-regulation of the recombination
machinery, changes in V chromatin structure that limit RAG1/2 access, decontraction of
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chromatin between V and (D)J segments, and association of alleles with nuclear
periphery or pericentromeric heterochromatic regions (Cedar and Bergman, 2008). In
contrast to the stochastic model for the initiation if allelic exclusion, it has been suggested
at least for Igκ, the two alleles are differentially marked as early and late replicating
alleles. This regulated or deterministic model argue that in pre-B cells the early
replicating allele becomes more transcriptionally accessible through DNA demethylation
and thus is predisposed to rearrange first. However, this model still cannot explain why
D-to-J recombination occurs on both TCRβ and IgH alleles. Since both TCRβ alleles are
accessible by RAGs (Carpenter et al., 2009) and germ line transcription occurs biallelically (Jia et al., 2007), allelic exclusion must be initiated through other mechanisms.

Although V(D)J recombination is widely recognized as a physiological DNA
damage response, surprisingly, the possibility of DNA damage signals in coordinating biallelic V(D)J recombination has never been explored. This lack of interest presumably
comes from the observation that not all antigen receptor loci exhibit allelic exclusion, and
for those that do, for example, IgH and TCRβ, D-J rearrangements can happen on both
alleles in the same cell, as evidenced by Southern blot analysis of mature T cell
hybridomas. However, it was never shown that the bi-allelic D-J rearrangements take
place simultaneously. Thus it remains possible that DNA damage signals emanating from
one allele can repress simultaneous break induction on the other allele. Intuitively, this
intra-nucleus suppressive signal would work faster than the feedback signal following
productive rearrangement on one allele.
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In Chapter V of my thesis, I attempt to uncover roles of the DDR machinery in
allelic exclusion. In Artemis–/– Abelson cells un-repaired Igκ locus DNA ends
accumulate, and mono-allelic recombination is not violated. On the contrary, both Igκ
alleles undergo rearrangement in a substantial portion of Artemis–/–Atm–/– cells. DSBs
generated on both alleles can persist and separate in G1 phase nuclei, and form
chromosome breaks and/or translocations upon cell cycle re-entry. These data are
consistent with the notion that ATM-mediated DNA damage signals emanating from one
rearranging Igκ allele can prevent initiation of V(D)J recombination on the second allele,
to provide a time window to test whether the first VJκ rearrangement is functional.

29

Figure 1. Model for signal propagation and amplification in DDR. Presence of DNA
lesions are detected by sensors, and H2AX can be rapidly phosphorylated by kinases such
as ATM. Recruitment of mediators through γH2AX and/or chromatin conformation
changes around the breaks can potentiate ATM activation, which leads to more H2AX
phosphorylation. DDR signals are relayed and amplified through activation of
transducer/effector proteins, which can impact a wide variety of cellular processes.

30

Figure 2. Model for the chromosomal V(D)J recombination reaction. RAG1/2
(green) binds to the RSSs (triangles) of the two segments that are to be joined, in this case
a V and a J, and brings the two segments into a synaptic complex, generating two types
of DNA DSBs. The blund signal ends a re joined through NHEJ with minimal processing
to form an extra-chromosomal circle. The hairpin coding ends need to be opened by
DNA-PKcs/Artemis, before they are joined through NHEJ. The required core NHEJ
factors for coding join and signal join formation are listed. Distabilization of the postsynaptic complex may allow escape of the DNA ends, which can participate in
potentially oncogenic translocations.
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Figure 3. Defective repair of DSB intermediates in V(D)J recombination can lead to
chromosome breaks/translocations. Normally, RAG1/2-mediated breaks are induced in
G1 since RAG2 is targeted for proteosome-mediated degradation upon G1/S transition.
Most V(D)J breaks are repaired before S phase entry, and un-repaired breaks can ativate
the G1/S checkpoint to arrest cell cycle progression. Low percentages of wild type
lymphocytes can occasionally enter S phase with un-repaired V(D)J breaks. However,
when the NHEJ repair pathway is defective, more un-repaired V(D)J DSB intermediates
may accumulate in G1, and with concurrent defects in checkpoint activation, these DNA
breaks can persist into S/G2 phases where they can be replicated to form chromosome
breaks, or joined to other breaks in the genome to form translocations. Since some DDR
factors (such as ATM and MRN) may have roles both in DNA repair and in checkpoint
activation, mutations or deficiencies in these factors can result in elevated levels of
genomic alterations.
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Figure 4. Inducible V(D)J recombination in the Abelson cell lines. STI571 treatment
of v-abl transformed B cells leads to G1 cell cycle arrest and upregulation of RAG1/2
expression. RAG can introduce breaks at the endogenous Igκ locus (red arrows) and
chromosomally integrated recombination substrates (not shown). Artemis–⁄– Abelson cells
are used as an example to show that DSB intermediates can be monitored by Southern
blot. After break induction, STI571 can be withdrawn to allow cell cycle re-entry. DSBs
induced during G1 arrest can progress into chromosome breaks and/or translocations.
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Chapter II
Histone H2AX Stabilizes Broken DNA Strands to Suppress Chromosome Breaks
and Translocations in V(D)J Recombination

Part of this chapter has been published in:
© Yin et al., 2009. J. Exp. Med. doi:10.1084/jem.20091320
With permission from the Rockefeller University Press

35

ABSTRACT
The H2AX core histone variant is phosphorylated in chromatin around DSB and
functions through unknown mechanisms to suppress antigen receptor locus translocations
during V(D)J recombination. Formation of chromosomal coding joins and suppression of
translocations involve the ATM and DNA-PKcs serine/threonine kinases, each of which
phosphorylates H2AX along cleaved antigen receptor loci. Using Abelson transformed
pre-B cell lines, I now demonstrate that H2AX is not required for coding join formation
within chromosomal V(D)J recombination substrates. Yet, I show that H2AX is
phosphorylated along cleaved Igκ DNA strands and prevents their separation in G1 phase
cells and their progression into chromosome breaks and translocations following cellular
proliferation. I also show that H2AX prevents chromosome breaks emanating from unrepaired RAG endonuclease generated TCRα/δ locus coding ends in primary thymocytes.
My data indicate that histone H2AX suppresses translocations during V(D)J
recombination by creating chromatin modifications that stabilize disrupted antigen
receptor locus DNA strands to prevent their irreversible dissociation. I propose that such
H2AX dependent mechanisms could function at additional chromosomal locations to
facilitate the joining of DNA ends generated by other types of DSBs.
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INTRODUCTION
The rapid phosphorylation of histone H2A proteins in chromatin for large distances
around DSBs is a conserved feature of the cellular DNA damage response. In mammalian
cells, the H2AX histone variant comprises 2-25% of the H2A pool and is non-uniformly
incorporated into chromatin (Rogakou et al., 1998; Bewersdorf et al., 2006). Upon DSB
induction, the ATM, DNA-PKcs, and ATR protein kinases phoshorylate H2AX on a
conserved carboxyl terminal serine residue to form γH2AX around DNA breakage sites
(Rogakou et al., 1999; Paull et al., 2000; Burma et al., 2001; Ward and Chen, 2001; Stiff
et al., 2004). Generation of γH2AX creates binding sites for repair and checkpoint
proteins, some of which catalyze other covalent modifications of γH2AX to generate
binding sites for additional repair and checkpoint proteins, all of which assemble into
complexes in chromatin surrounding DNA breaks (Downs et al., 2007; Bonner et al.,
2008). H2ax–/– cells exhibit increased sensitivity to agents that cause DSBs, elevated
levels of spontaneous and DSB-induced genomic instability, and defective repair of
chromosomal DSBs (Bassing et al., 2002b; Celeste et al., 2002; Xie et al., 2004; Franco
et al., 2006). Although H2ax–/– cells display apparent normal activation of p53-dependent
cell cycle checkpoints and apoptotic responses (Bassing et al., 2002b; Celeste et al.,
2002), H2ax–/– cells are defective in the G2/M checkpoint following induction of only a
few DSBs (Fernandez-Capetillo et al., 2002). The phenotypes of H2ax–/– cells suggest
that the ability of γH2AX to retain repair and checkpoint proteins around DSBs may
promote accessibility of DNA ends, stabilize disrupted DNA strands, and/or amplify
checkpoint signals (Bassing and Alt, 2004; Stucki and Jackson, 2006; Bonner et al.,
2008; Kinner et al., 2008).
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The health and survival of humans and mice depends upon the ability of their
adaptive immune systems to generate lymphocytes with receptors capable of recognizing
and eliminating large varieties of pathogens. In developing lymphocytes, Ig and TCR
variable region exons are assembled from germline variable (V), diversity (D) and
joining (J) gene segments by the lymphoid-specific RAG1/RAG2 endonuclease and the
ubiquitously-expressed NHEJ DSB repair factors (Bassing et al., 2002a). The RAG
proteins catalyze the coupled cleavage of DNA strands between a pair of gene segments
and their flanking RSSs to generate covalently sealed coding ends (CEs) and blunt signal
ends (SEs) (Fugmann et al., 2000). RAG mediated cleavage occurs only in G1 phase due
to cell cycle phase restricted expression of RAG2 (Lee and Desiderio, 1999). The DNAPKcs/Artemis endonuclease opens CEs (Ma et al., 2002), which are then processed by
nucleases and polymerases (Nick McElhinny and Ramsden, 2004); core NHEJ factors
join together CEs and SEs to form coding joins (CJs) and signal joins (SJs) respectively
(Bassing et al., 2002a). RAG1/RAG2 can hold CEs and SEs within stable synaptic
complexes (Agrawal and Schatz, 1997; Lee et al., 2004), however ATM, and likely the
MRN complex, maintains chromosomal CEs in proximity to facilitate end-joining in G1
phase cells (Bredemeyer et al., 2006; Deriano et al., 2009; Helmink et al., 2009). The
large combination of V(D)J joining events and the imprecision in CJ formation cooperate
to generate a diverse repertoire of antigen receptor specificities.

Despite its benefits, V(D)J recombination poses substantial threats to the viability
and genomic integrity of lymphocytes and lymphoma predisposition in host organisms.
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DNA-PKcs-deficient mice lack mature lymphocytes due to inability to repair RAG
generated DSBs, but only occasionally develop lymphoma (Bosma et al., 1983; Gao et
al., 1998; Taccioli et al., 1998). However, DNA-PKcs/p53-deficient mice rapidly
succumb to pro-B lymphomas with RAG-dependent IgH/c-myc translocations (Vanasse
et al., 1999; Gladdy et al., 2003), demonstrating that p53 protects organisms from
oncogenic translocations during V(D)J recombination. RAG generated DSBs activate
ATM (Perkins et al., 2002; Bredemeyer et al., 2008), which is required for both coding
join formation and p53 activation (Perkins et al., 2002; Bredemeyer et al., 2006).
Consequently, Atm–/– mice exhibit impaired lymphocyte development, increased
frequencies of antigen receptor locus translocations in non-malignant lymphocytes, and
marked predisposition to thymic lymphomas with RAG dependent TCRα/δ
translocations (Barlow et al., 1996; Elson et al., 1996; Xu et al., 1996; Borghesani et al.,
2000; Liyanage et al., 2000; Petiniot et al., 2000, 2002; Callén et al., 2007; Matei et al.,
2007; Vacchio et al., 2007). The observation that RAG dependent γH2AX foci colocalized with TCRα/δ loci suggested that H2AX may coordinate DSB repair, signaling,
and surveillance during V(D)J recombination (Chen et al., 2000). Consistent with this
notion, αβ T cells of H2ax–/– mice contain elevated frequencies of TCRα/δ translocations
and H2ax–/–p53–/– mice develop pro-B lymphomas with RAG dependent IgH/c-myc
translocations (Celeste et al., 2002, 2003b; Bassing et al., 2003, 2008). ATM and DNAPKcs generate γH2AX along RAG cleaved DNA strands (Savić et al., 2009). However,
H2ax–/– mice do not exhibit impaired or blocked lymphocyte development, as observed in
mice deficient for ATM or DNA-PKcs, respectively, suggesting that H2AX is not
required for the processing and/or joining of chromosomal coding ends. Yet, H2AX
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prevents the progression of IgH locus DNA breaks into chromosome breaks and
translocations during CSR (Franco et al., 2006; Ramiro et al., 2006), consistent with the
notion that H2AX does function in chromosomal end-joining (Reina-San-Martin et al.,
2003; Bassing and Alt, 2004). Consequently, the mechanisms by which H2AX
suppresses antigen receptor locus translocations during V(D)J recombination remain
unknown.

Based upon the disparate phenotypes of Atm–/– and H2ax–/– mice, I hypothesized
that formation of γH2AX for long distances along RAG cleaved antigen receptor loci
promotes chromatin changes that hold together broken DNA strands (Bassing and Alt,
2004). I proposed that this stabilization of disrupted DNA strands would not be required
for coding join formation in the G1 phase of developing lymphocytes, but that this
H2AX dependent function would be important for preventing the irreversible
dissociation of un-repaired coding ends persisting into S phase (Bassing and Alt, 2004).
Quantitative analysis of DNA end-joining during V(D)J recombination of endogenous
loci in developing lymphocytes is difficult due to asynchronous induction of RAG DSBs
at multiple genomic locations in cycling cells and expansion of lymphocytes in which
functional coding joins have been assembled. Consequently, I utilized a cell line based
system that enables the controlled induction of RAG DSBs at single defined
chromosomal locations in G1 arrested cells.

RESULTS
H2AX deficient cells exhibit normal coding join formation within chromosomal
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substrates
Although H2AX is not required for coding join formation in extra-chromosomal
substrates (Bassing et al., 2002b), the phosphorylation of H2AX could function
downstream of ATM to facilitate chromosomal coding join formation. To investigate
potential H2AX function in chromosomal end-joining during V(D)J recombination, I
generated multiple independently derived abl pre-B cell lines from two different H2axF/F
mice containing "floxed" H2ax loci on both alleles. H2axF/F cells express normal
amounts of H2AX and exhibit phenotypes indistinguishable from wild-type cells
(Bassing et al., 2002b). Treatment of abl pre–B cells with
STI571, an inhibitor of the abl kinase, causes G1 arrest, induction of RAG expression,
and robust rearrangement of endogenous Igκ loci and V(D)J recombination substrates
(Muljo and Schlissel, 2003; Bredemeyer et al., 2006).

To evaluate potential H2AX function in chromosomal end-joining during V(D)J
recombination by inversion, I first transduced H2ax+/+ and H2ax–/– Abelson cells with the
pMX-INV retroviral substrate and used human CD4 as a marker for sorting out
populations of cells with pMX-INV integrated into the genome. V(D)J recombination of
the chromosomally-integrated pMX-INV substrate results in formation of a CJ and an SJ
whin the same chromosome, placing the inverted GFP sequence in the sense orientation.
Illegitimate V(D)J recombination, however, either joins one SE and one CE to form a
hybrid join (HJ) and deletes the intervening GFP sequence, or leaves the CE un-repaired
(Figure 5A). The induction and repair of RAG generated DSBs within integrated pMXINV substrates can then be monitored by GFP+ cells. Treatment of populations of H2ax–/–
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:INV cells with STI571 for up to 96 hours induced robust recombination, as indicated by
a high percentage of GFP+ cells (data not shown); however, neither the degree nor
kinetics of successful recombination was significantly different between H2ax–/–:INV and
H2ax+/+:INV cells (data not shown). In addition, Southern blot analysis can distinguish
between un-rearranged (UR) substrates, cleaved but not repaired (CE) substrates, cleaved
and repaired coding join (CJ), signal join (SJ) and hybrid join (HJ) substrates (Figure
5A). Thus, I conducted Southern blot of populations of H2ax–/–:INV and H2ax+/+:INV
cells treated with STI571 for increasing amounts of time. Again, recombination by
inversion was robust in both H2ax–/–:INV and H2ax+/+:INV cells as indicated by the
formation of CJ substrates, but no defects of recombination efficiency or kinetics were
observed in H2ax–/–:INV cells (Figure 5B). Consistent with this, neither HJs nor unrepaired CEs were detected at any appreciable level in the absence of H2AX (Figure 5B).
These data demonstrate that, unlike deficiency in ATM, Artemis or DNA-PKcs
(Bredemeyer et al., 2006), H2AX deficiency does not lead to an observable accumulation
of CEs or HJs during V(D)J recombination of pMX-INV within G1 phase cells.
However, since sorted cells include clones with integrants of various copy numbers and
at heterogenous genomic locations, defects of RAG-induced DSB repair at individual
substrate may be masked by analysis of this mixed population. Indeed, DSBs in different
chromatin compartments may differentially require certain factors for efficient repair
(Goodarzi et al., 2008). Different genetic backgrounds and clonal variations between the
parental H2ax+/+ and H2ax–/– mice and cells may also have interfered with my analysis.

Most V(D)J recombination reactions occur by deleting the intervening sequences
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between the two coding segments. To more rigorously test whether this form of V(D)J
recombination requires H2AX, I transduced H2axF/F abl pre-B cell lines with the pMXDELCJ retroviral recombination substrate and used limiting dilution to isolate
independent H2axF/F clones with single pMX-DELCJ substrates integrated into their
genome (H2axF/F:DELCJ cells). V(D)J recombination of the chromosomally-integrated
pMX-DELCJ retroviral substrate results in formation of a coding join within the
chromosome and generation of a signal join on an extrachromosomal circle (Figure 6A). I
next incubated individual H2axF/F:DELCJ lines with TAT-Cre protein to delete the
"floxed" H2ax alleles and again used limiting dilution to recover H2axF/F:DELCJ and
H2ax∆/∆:DELCJ clones with pMX-DELCJ substrates integrated at identical genomic
locations. The genotypes of these clones were confirmed by both PCR and Southern blot
analyses that distinguish between the H2axF and H2ax∆ alleles (data not shown).

To evaluate potential H2AX function in chromosomal end-joining during V(D)J
recombination by deletion, I sought to monitor the repair of RAG generated CEs within
identical pMX-DELCJ integrants in two different H2axF/F:DELCJ and H2ax∆/∆:DELCJ
clones of the same passage. The induction and repair of RAG generated DSBs within
integrated pMX-DELCJ substrates can be monitored by Southern blot analysis that
distinguishes between un-cleaved (GL) substrates, cleaved but not repaired (CE)
substrates, and cleaved and repaired (CJ) substrates (Figure 6A). Thus, I conducted
Southern blotting of identical pMX-DELCJ integrants in two H2axF/F:DELCJ and
H2ax∆/∆:DELCJ clones treated with STI571 for increasing amounts of time. As a control
for the accumulation of un-repaired chromosomal CEs, I also conducted Southern blot
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analysis of Artemis–/–:DELCJ clones. At 48 hours STI571 treatment, I observed loss of the
pMX-DELCJ GL fragment and appearance of the pMX-DELCJ CJ fragment to similar
extents in the two H2axF/F:DELCJ and H2ax∆/∆:DELCJ clones assayed (Figure 6B). In
contrast, I detected loss of the pMX-DELCJ GL fragment and appearance of the pMXDELCJ CE fragment at 24 hours STI571 treatment in Artemis–/–:DELCJ cells (Figure 6B).
At each time-point assayed between 48-96 hours STI571 treatment, I observed similar
increasing loss of the pMX-DELCJ GL fragment and appearance of the pMX-DELCJ CJ
fragment in H2axF/F:DELCJ and H2ax∆/∆:DELCJ cells (Figure 6B), but increasing loss of
the pMX-DELCJ GL fragment and appearance of the pMX-DELCJ CE fragment in
Artemis–/–:DELCJ cells (Figure 6B). Notably, despite conducting Southern analysis on
twice as much genomic DNA for H2axF/F:DELCJ and H2ax∆/∆:DELCJ cells than for
Artemis–/–:DELCJ cells, I was unable to detect the pMX-DELCJ CE fragment in
H2ax∆/∆:DELCJ cells. These data again demonstrate that H2AX deficiency does not lead
to an observable accumulation of un-repaired coding ends during V(D)J recombination of
chromosomal substrates within G1 phase cells.

Since lymphomas with RAG dependent antigen receptor locus translocations arise
at a higher frequency in H2ax–/–p53–/– mice than in H2ax–/– mice (Bassing et al., 2003;
Celeste et al., 2003b), I considered the possibility that p53 deficiency might reveal a role
of H2AX in formation of chromosomal coding joins in G1 phase cells. To investigate this
issue, I generated two independently derived abl pre-B cell lines from different H2axF/F
mice also containing "floxed" p53 exons on both alleles. I used the same approach as
above to generate H2axF/Fp53F/F:DELCJ and H2ax∆/∆p53∆/∆:DELCJ clones of the same
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passage with pMX-DELCJ substrates integrated at identical genomic locations. Southern
blot analysis of identical pMX-DELCJ integrants in two different H2axF/Fp53F/F:DELCJ
and H2ax∆/∆p53∆/∆:DELCJ clones treated with STI571 for increasing amounts of time
revealed similar increasing loss of the pMX-DELCJ GL fragment and appearance of the
pMX-DELCJ CJ fragment in the two H2axF/Fp53F/F:DELCJ and H2ax∆/∆p53∆/∆:DELCJ
cells (Figure 6C). Again, despite conducting Southern analysis on twice as much genomic
DNA for H2axF/Fp53F/F:DELCJ and H2ax∆/∆p53∆/∆:DELCJ cells than for Artemis-/-:DELCJ
cells, I did not observe detectable levels of the pMX-DELCJ CE fragment in
H2ax∆/∆p53∆/∆:DELCJ cells (Figure 6C). These data further support the notion that H2AX
is not required for end-joining of chromosomal coding ends in G1 phase lymphocytes.

Since RAG dependent formation of γH2AX occurs at Jκ segments and over
adjacent sequences telomeric to the Igκ locus (Savić et al., 2009), I also considered that
H2AX might be required for resolution of Jκ CEs. The mouse Igκ locus resides on
chromosome 6 and is composed of 140 Vκs spanning 3 Mb and four functional Jκs
spanning 2 kb and residing 60 kb from the Vκs. Igκ locus V(D)J recombination occurs
through the coupled cleavage and subsequent joining of a Vκ and Jκ segment. Due to the
small size of the Jκ cluster, Southern blot analysis with a 3' Jκ probe can be used to
monitor and quantify the induction of RAG generated Igκ locus DSBs (Figure 7A, 7B).
Thus, I next conducted Southern blotting of H2ax–/– pre-B cells either un-treated or
treated with STI571 for 72 hours. As a control for the accumulation of un-repaired Jκ
CEs, I also conducted Southern blot analysis of previously described Artemis–/– cells
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(Helmink et al., 2009). I observed decreased intensity of the Jκ GL band in both H2ax–/–
and Artemis–/– cells treated with STI571, and appearance of bands corresponding to Jκ
CEs in STI571-treated Artemis–/– cells, but not in STI571-treated H2ax–/– cells (Figure
7B). These data indicate that H2AX deficiency does not result in the detectable
accumulation of un-repaired Igκ coding ends in G1 phase cells. Consequently, I conclude
that H2AX function is not required for chromosomal end-joining during V(D)J
recombination in G1 phase lymphocytes.

H2AX dependent chromatin changes prevent separation of RAG cleaved Igκ DNA
strands in G1 phase cells
I first sought to define the entire γH2AX chromatin domain formed along Igκ loci
during V(D)J recombination in G1 phase cells. For this purpose, I conducted chromatin
immunoprecipitation (ChIP) to measure γH2AX densities in nucleosomes on DNA
strands located within and adjacent to Igκ loci in Artemis–/– pre-B cells, either un-treated
or treated with STI571 for 96 hours to ensure complete RAG mediated cleavage. I used
Artemis–/– cells rather than wild-type cells since the accumulation of un-repaired coding
ends enhances ability to detect γH2AX along RAG cleaved antigen receptor loci (Savić et
al., 2009). Using ChIP, I detected significant increases in γH2AX densities within Igκ
and for ~500 kb on both sides of Igκ in STI571-treated Artemis–/– pre-B cells (Figure 7C).
The numbers of Vκ and Jκ DSBs within the experimental population of cells must be
equal because V(D)J recombination proceeds through coupled cleavage. Because the Igκ
locus contains a cluster of 140 Vκ segments spanning 2 Mb and a cluster of four
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functional Jκ segments spanning 1.8 kb, the chromosomal density of Vκ cluster DSBs
should be less than the chromosomal density of Jκ cluster DSBs within my experimental
population of cells. Thus, the simplest explanation for the observed γH2AX pattern
across the Igκ locus is that it reflects the density of DSBs induced at the assayed genomic
locations. However, these observations are also consistent with the notion that different
features of local chromatin environment among the Vκ segments and downstream of the
Jκ segments may influence γH2AX dynamics. Regardless, my data demonstrate that a
γH2AX chromatin domain forms along chromosomal DNA strands containing RAGcleaved Igκ loci for distances extending at least 500 kb from Igκ coding ends.

To test my hypothesis that H2AX mediated chromatin changes function to hold
together broken DNA strands, I sought to monitor the positional stability of RAG cleaved
Igκ loci in G1 phase cells. I used two-dimensional two-color DNA fluorescent in situ
hybridization (2D-2C-FISH) with a 5' Vκ BAC (RP24-243E11) and a 3' Cκ BAC (RP23341D5) probe to monitor the positional stability of RAG cleaved Igκ locus DNA strands
in STI571-treated Artemis–/–p53–/– and Artemis–/–Atm–/– abl pre-B cells (Hewitt et al.,
2009). These 5' Vκ and 3' Cκ probes hybridize to genomic sequences located near the
ends of γH2AX domain that forms along RAG cleaved Igκ loci within STI571 treated
pre-B cells (Figure 7C). 2D-FISH cannot distinguish between signals that appear on top
of each other that are really separate, and therefore likely underestimates the numbers of
cells with un-stabilized Igκ locus DNA ends. However, since this should be equal across
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cells of different genotypes, conclusions about different genotypes relative to each other
are still possible with 2D-2C-FISH.

I first conducted 2D-2C-FISH using these 5' Vκ and 3' Cκ probes on G1 interphase
nuclei prepared from three independent Rag2–/– abl pre-B cells treated with STI571 for 96
hours (Figure 8A). I measured the distances between 5' Vκ (red) and 3' Cκ (green)
signals on both alleles in ~200 nuclei of each cell line assayed, designated the shorter
distance from "Allele 1" and the longer distance from "Allele 2", and plotted these values
onto scatter plots. I observed overlapping or coincident probe hybridization signals (<1
µm apart) on both alleles in greater than 95% of nuclei and non-coincident signals on one
allele in less than 4% of nuclei (Figure 8B). Using three independent Artemis–/– cell lines,
I observed overlapping or coincident probe signals on both alleles in ~80% of nuclei and
non-coincident probe signals on a single allele in ~20% of nuclei (Figure 8B). With three
independent Artemis–/–H2ax–/– cell lines, I observed overlapping or coincident probe
signals on both alleles in ~60% of nuclei and non-coincident probe signals on a single
allele in ~40% of nuclei (Figure 8B). Although similar levels of un-repaired Igκ locus
CEs accumulated in all Artemis–/– and Artemis–/–H2ax–/– cells assayed, I also normalized
the percentage of nuclei with non-coincident probe hybridization signals to the extent of
Igκ locus cleavage (Figure 8C, Figure 9). These data show that RAG cleaved Igκ locus
DNA strands physically separate in a significantly higher percentage of Artemis–/–H2ax–/–
cells than in Artemis–/– cells. Similar results were obtained using a larger distance (>1.5
µm) to score non-coincident hybridization (Figure 8C). Consequently, I conclude that

48

γH2AX mediated chromatin changes suppress physical separation of RAG cleaved
antigen receptor loci in G1 phase cells to prevent their irreversible disassociation or
aberrant joining.

H2AX prevents transition of RAG cleaved DNA strands into chromosome breaks
and translocations during cellular proliferation
Molecular characterization of IgH/c-myc translocations in H2ax–/–p53–/– pro-B
lymphomas revealed that these lesions occurred following the replication of
chromosomes containing un-repaired RAG initiated IgH locus DNA breaks (Bassing et
al., 2003; Celeste et al., 2003b). Thus, I hypothesized that γH2AX formation along RAG
cleaved antigen receptor loci promotes chromatin changes that hold together broken
DNA strands to prevent un-repaired coding ends from transitioning into chromosome
breaks and translocations during S phase (Bassing and Alt, 2004). To test my hypothesis,
I sought to quantify the frequency of Igκ chromosome breaks and translocations in H2ax–
/–

, Artemis–/–, and Artemis–/–H2ax–/– abl pre-B cell lines treated with STI571 and then

released back into cell cycle by STI571 removal. For this purpose, I used whole
chromosome painting (WCP) for Chr. 6 (red) and conducted FISH with the 5' Vκ and 3'
Cκ BACs (green) on metaphase spreads prepared from untreated cells or cells that had
been treated with STI571 and then released back into cell cycle (Figure 10A). I found
chromosome 6 chromosome breaks or translocations in less than 1% of metaphases
prepared from untreated H2ax–/–, Artemis–/–, or Artemis–/–H2ax–/– cells of three different
cell lines for each genotype (Figure 10A, 10B). These data indicate that structural
abnormalities of chromosome 6 are not frequent occurrences in abl pre-B cells with
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deficiencies in H2AX and/or Artemis. I also detected chromosome 6 abnormalities in less
than 1% of metaphases prepared from H2ax–/– or Artemis–/– cells treated and then released
from STI571 (Figure 10A, 10B). However, I observed chromosome 6 breaks or
translocations involving Igκ in 4-5% of metaphases prepared from Artemis–/–H2ax–/– cells
treated and then released from STI571 (Figure 10A, 10B). Southern blot analysis of
STI571-treated cells before removal of the STI571 revealed similar levels of unrepaired
Igκ locus DSBs in all cells (data not shown). These data suggest that unrepaired Igκ locus
coding ends progress into chromosome breaks and translocations at a significantly higher
frequency in Artemis–/–H2ax–/– cells than in Artemis–/– or H2ax–/– cells after STI571
treatment and release. I also found chromosome 6 breaks and translocations involving
Igκ in a significantly higher percentage of ST1571-treated and released Artemis–/–H2ax–/–
p53–/– abl pre–B cells, as compared with H2ax–/–p53–/– and Artemis–/–p53–/– abl pre–B
cells (data not shown). Although these data are consistent with a role of H2AX in
promoting chromatin changes that hold together un-repaired coding ends persisting into S
phase, potential effects of mutations in cell cycle checkpoints that arise during v-abl
mediated immortalization more frequently or profoundly in H2ax–/– cells than in H2ax+/+
cells could contribute to this observation.

H2AX prevents chromosome breaks emanating from un-repaired TCRα/δ locus
coding ends
I next sought to test the hypothesis that H2AX prevents un-repaired coding ends
from transitioning into chromosome breaks and translocations during continued cell cycle
progression using primary lymphocytes. This approach also enables assessment of this
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potential H2AX function during a physiologic cell cycle, rather than during recovery
from the prolonged G1 arrest associated with STI571 treatment and release. Although a
small fraction of un-repaired coding ends persists into S phase in normal primary
thymocytes (Pedraza-Alva et al., 2006), I decided to dramatically increase the percentage
of cells with un-repaired coding ends for analyses by using Artemis–/– thymocytes.
Because Artemis–/– cells with un-repaired coding ends are eliminated by p53-mediated
apoptosis (Rooney et al., 2004a), I also needed to use p53-deficiency allow thymocytes
with un-repaired coding ends to survive and proliferate. I first generated germline H2ax–/–
p53–/–, Artemis–/–p53–/–, and H2ax–/–Artemis–/–p53–/– mice to test my hypothesis;
unfortunately H2ax–/–Artemis–/–p53–/– mice rapidly succumbed to multiple malignancies
preventing analysis of un-repaired coding ends in non-malignant thymocytes. I reasoned
that the specific deletion of H2ax and/or p53 in Artemis–/– thymocytes should prevent
early onset of lymphomas and provide the requisite in vivo experimental system.
Transgenic mice expressing Cre under control of the proximal Lck promoter (Lck-Cre
mice) direct excision of target genes such as "floxed" p53 (p53F) in thymocytes prior to
the initiation of V(D)J recombination (Orban et al., 1992; Lee et al., 2001). Thus, I
generated Lck-CreArtemis–/–p53F/F (LAP), Lck-CreH2axF/Fp53F/F (LHP) and LckCreArtemis–/–H2axF/Fp53F/F (LAHP) mice. All mice were created heterozygous for LckCre to avoid potential complications associated with transgene integration site. The low
cellularity of LAP and LAHP thymocytes posed an insurmountable obstacle for
quantitative cytogenetic analyses, thus I prepared metaphase spreads from c-kit–
CD25+CD4–CD8– thymocytes, in which normal TCR rearrangements occur, from
cultured bone marrow of LHP, LAP, and LAHP mice on OP9-DL1 stromal cells (Schmitt
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and Zúñiga-Pfl̈ücker, 2002). Occasionally the OP9 feeder cells gave rise to metaphases
that were scattered among lymphocyte metaphases; I demonstrated that the OP9 feeder
cell metaphases can be easily separated from those of lymphocytes based on distinct
features, such as four copies of Chr. 6 and four copies of Chr. 14, as shown by spectral
karyotyping (SKY) and WCP/FISH (Figure 11).

In mouse thymocytes, V(D)J recombination occurs at TCRα/δ loci on chromosome
14, TCRβ loci on chromosome 6, TCRγ loci on chromosome 13, and to a limited extent
IgH loci on chromosome 12. TCRγ translocations are rarely observed in human and
mouse αβ T cells and T lineage lymphomas. Thus, to assay for potential chromosome
breaks and translocations initiating from un-repaired RAG generated coding ends, I
hybridized whole chromosome 14, 6, and 12 paints and conducted FISH with BAC
probes that hybridize to genomic sequences 5' or 3' of TCRα/δ, TCRβ, or IgH loci on
metaphase spreads prepared from LHP, LAP and LAHP thymocytes (Figure 12A). For
this purpose, I prepared metaphase spreads from independent thymocyte cultures from
two different three to five week old mice of each genotype. I analyzed 200 or greater
numbers of metaphases for each chromosome paint and FISH probe set on each culture.
Chromosome breaks or translocations involving antigen receptor loci were scored when
the 5' and 3' FISH probe signals were non-coincident (Figure 12A). Through this
approach, I did not find any chromosome 12 or IgH locus breaks or translocations in
metaphases prepared from LAHP, LHP, or LAP thymocytes (Figure 12A). However, I
observed a modest increase in the frequency of chromosome 6 breaks and translocations
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involving TCRβ loci in metaphases prepared from LAHP thymocytes, as compared to in
metaphases prepared from LHP or LAP thymocytes (Figure 12A, 12B). These findings
indicate that structural abnormalities of chromosome 6 and 12 are not frequent
occurrences in primary thymocytes deficient in H2AX and/or Artemis, but suggest that
H2AX may suppress TCRβ translocations. Notably, I observed a substantial increase in
the frequency of chromosome 14 abnormalities involving TCRα/δ loci in metaphases
prepared from LAHP thymocytes, as compared to those prepared from LHP or LAP
thymocytes (Figure 12A, 12B). All chromosome 14 abnormalities in LAHP cells were
replicated TCRα/δ chromosome breaks and, among the metaphases with these lesions,
~90% contained replicated breaks on a single copy of chromosome 14 (Figure 12C).
Although I cannot exclude the possibility that these TCRα/δ chromosome abnormalities
represent rare events in a few DN thymocytes that preferentially expand, my data still
support a role of H2AX in preventing accumulation of such cells. Based upon these data,
I conclude that H2AX mediated chromatin changes along RAG cleaved antigen receptor
loci prevent un-repaired coding ends from transitioning into chromosome breaks during
continued cell cycle progression.
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DISCUSSION
The mechanisms by which H2AX suppresses translocations during V(D)J
recombination have remained enigmatic since the findings that a significant percentage of
H2ax–/– αβ T cells contain TCRα/δ locus translocations and H2ax–/–p53–/– mice develop
pro-B lymphomas with RAG initiated IgH/c-myc translocations (Bassing et al., 2003;
Celeste et al., 2003b). I have demonstrated here that H2AX is not required for the joining
of chromosomal coding ends during V(D)J recombination in G1 phase lymphocytes. In
this context, I have shown that H2AX deficiency in abl pre-B cells does not lead to
accumulation of un-repaired coding ends during the rearrangement of chromosomal
substrates, as previously observed in abl pre-B cells deficient for ATM or DNA-PKcs
(Bredemeyer et al., 2006). These data are consistent with the observations that
lymphocyte development in H2ax–/– mice is not blocked or impaired at stages in which
antigen receptor variable region genes are assembled, as is the case in DNA-PKcs–/– and
Atm–/– mice (Bosma et al., 1983; Barlow et al., 1996; Elson et al., 1996; Xu et al., 1996;
Gao et al., 1998; Taccioli et al., 1998; Borghesani et al., 2000; Matei et al., 2007;
Vacchio et al., 2007). Consequently, I conclude that γH2AX formation is not critical for
ability of DNA-PKcs and ATM to process and join chromosomal coding ends during
variable region gene assembly in G1 phase cells. Although generation of γH2AX has
been proposed to facilitate DSB repair kinetics by promoting accessibility of broken
DNA ends and recruiting repair factors (Rogakou et al., 1998), I did not observe a
difference in the kinetics of chromosomal coding join formation between H2ax+/+ and
H2ax–/– abl pre-B cells. However, potential accessibility and recruitment functions of
γH2AX might not be evident during V(D)J recombination since initiation of RAG
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generated DSBs requires prior opening of chromosomal substrates and the RAG proteins
may recruit end-joining factors (Agrawal and Schatz, 1997; Bassing et al., 2002a; Lee et
al., 2004; Raval et al., 2008). Thus, I conclude that impaired coding join formation in G1
phase cells is not the predominant mechanism through which translocations arise during
V(D)J recombination in H2AX deficient lymphocytes.

Despite no obvious requirement for H2AX in coding join formation, the data that
IgH/c-myc translocations arise by identical mechanisms in H2ax–/–p53–/– mice and
NHEJ/p53-deficient mice suggested that H2AX serves critical functions during endjoining in G1 phase cells. One advantage of STI571-treated abl pre-B cells is that
molecular events associated with V(D)J recombination can be studied in G1 arrested
cells; NHEJ-deficient abl pre-B cells offer additional advantages by enabling analysis of
particular DSB intermediates and amplification of DNA damage responses. Through the
use of Artemis–/– and Artemis–/–H2ax–/– abl pre-B cells, I have demonstrated here that
H2AX-mediated chromatin changes suppress the physical separation of RAG cleaved Igκ
locus strands in G1 phase cells. This could be due to the γH2AX mediated anchoring of
proteins (such as 53BP1 or cohesins) that hold broken DNA ends together (Bassing and
Alt, 2004), limit flexibility of DNA strands (Difilippantonio et al., 2008; Dimitrova et al.,
2008), and/or promote interactions of chromatin with components of the nuclear matrix
(Rogakou et al., 1998). Based upon the impaired joining and progression of IgH locus
DNA breaks into chromosome breaks and translocations during class switch
recombination in H2ax–/– B lymphocytes (Reina-San-Martin et al., 2003; Franco et al.,
2006; Ramiro et al., 2006), H2AX has been concluded to function in NHEJ by promoting
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synapsis of DNA ends. Yet, considering that class switch recombination occurs in rapidly
proliferating cells (Chaudhuri et al., 2007), these phenotypes could be attributable to
H2AX mediated activation of p53-independent cell cycle checkpoints. Thus to my
knowledge, the data presented here that H2AX suppresses separation of RAG cleaved
DNA strands in G1 arrested cells is the first direct evidence that H2AX exhibits synaptic
functions during NHEJ.

Since RAG1/RAG2 can hold CEs and SEs within stable synaptic complexes in
vitro (Agrawal and Schatz, 1997; Lee et al., 2004) and ATM maintains chromosomal CEs
in proximity (Bredemeyer et al., 2006), my finding that Igκ locus strands with unrepaired CEs separated in Artemis–/– cells was unexpected. In this context, ATM alone is
not sufficient to prevent disassociation of CEs that that are held much less tightly than
SEs in the RAG post-cleavage complex. However, this observation is in accord with live
cell imaging experiments demonstrating mobility of DNA ends at DSBs generated in
Ku80-deficient cells (Soutoglou et al., 2007). My data could reflect baseline mobility of
un-repaired Igκ locus DSBs or indicate a role of Artemis in maintaining RAG generated
DNA ends within synaptic complexes, either directly or indirectly through Ku70/Ku80,
DNA-PKcs, and/or other end-binding factors. My finding that H2AX suppresses the
physical separation of broken Igκ locus strands appears in contrast with experiments
demonstrating a role of Ku80, but not H2AX, in promoting immobility of DSBs
(Soutoglou et al., 2007). Upon DSB induction, more unrepaired DNA ends should
accumulate in Ku80–/– cells as compared with H2ax–/– cells as a result of the differential
functions of these proteins in end joining. In my study, I used Artemis deficiency to
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compare the positional stability of disrupted chromosomal DNA strands between H2ax+/+
and H2ax–/– cells that have accumulated equivalent levels of unrepaired DSBs. Thus, I
believe that the disparate conclusions regarding the role of H2AX in maintaining broken
chromosomal DNA ends in proximity is the result of a greater level of unrepaired DNA
ends that can physically separate in cells deficient for Ku80 versus H2AX.

Although V(D)J recombination occurs in G1 phase cells, some fraction of
developing lymphocytes with un-repaired CEs progress into S phase (Pedraza-Alva et al.,
2006). I have shown here that H2AX prevents accumulation of chromosome breaks from
RAG initiated antigen receptor locus DNA breaks that are not repaired prior to DNA
replication. In this context, I have demonstrated that H2AX deficiency in Artemis/p53deficient thymocytes leads to a substantial increase in the percentage of cells with
replicated TCRα/δ chromosome breaks. Replication through hairpin sealed CEs should
lead to either dicentric or ring chromosomes in metaphase cells. The absence of such
chromosome abnormalities in metaphases prepared from LAP or LAHP thymocytes
suggests that TCRα/δ CEs persisting into S phase are opened prior to DNA replication.
Detection of replicated TCRα/δ chromosome breaks in LAHP, but not LAP, metaphases
indicates that H2AX holds together DNA strands with un-repaired TCRα/δ CEs to
facilitate end-joining and/or activates the G2/M checkpoint to prevent mitosis. ATM
similarly prevents the continued proliferation of lymphocytes with un-repaired RAG
generated coding ends (Callén et al., 2007). Thus, I conclude that ATM-mediated H2AXdependent chromatin changes along RAG cleaved antigen receptor loci prevent un-
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repaired coding ends from transitioning into chromosome breaks during continued cell
cycle progression.

The data presented in this chapter further contribute to understanding the
mechanisms by which chromosomal DSBs are repaired through NHEJ in G1 phase
mammalian cells (Figure 13). My findings that H2AX, but not ATM or the MRN
complex (Bredemeyer et al., 2006; Helmink et al., 2009), is dispensable for end-joining
of chromosomal CEs in G1 phase cells is consistent with the lower frequency of interlocus V(D)J recombination events and the milder lymphopenia of H2ax–/– mice, as
compared to Atm–/–, Nbs1m/m and Mre11ATLD/ATLD mice (Kang et al., 2002; Theunissen et
al., 2003). ATM (Bredemeyer et al., 2006), and likely MRN (Deriano et al., 2009;
Helmink et al., 2009), facilitates end-joining by maintaining chromosomal CEs within
RAG post-cleavage synaptic complexes, which engage the proximal ends of cleaved
DNA strands. My observations that γH2AX densities are low near Jκ CEs, but elevated
over sequences extending at least 500 kb on both sides of Igκ CEs, indicates that γH2AX
formation stabilizes broken DNA strands at locations distal to breakage sites (Bassing
and Alt, 2004). During V(D)J recombination, this ATM dependent formation of γH2AX
along RAG cleaved DNA strands (Savić et al., 2009) is dispensable for end-joining of
chromosomal CEs in G1 phase cells due to cooperation between the DNA end synaptic
functions of RAG1/RAG2 and ATM/MRN. In contrast, the ATM dependent generation
of γH2AX along DNA strands would be more critical for the NHEJ mediated repair of
DSBs generated by genotoxic insults such as IR or nucleases lacking DNA end synaptic
functions such as those that initiate IgH locus CSR (Figure 13).
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Figure 5. H2AX is not required for normal resolution of V(D)J recombination
intermediates of chromosomally integrated pMX-INV in G1-arrested abl cells. A)
The non-rearranged (NR), coding joined (CJ) and hybrid joined (HJ) configurations, and
the 3' coding end (CE) generated by Rag cleavage of the pMX-INV retroviral
recombination substrate are shown, with the IRES-human CD4 cDNA (I-hCD4), the GFP
cDNA and the recombination signals (triangles). Also indicated are the relative positions
of the EcoRV (E) and NcoI (N) restriction sites. The relative position of the C4 probe
used for Southern blot analysis and sizes of different DNA fragments after EcoRV/NcoI
digestion is also shown. B) Coding joint and 3' coding end formation in H2ax+/+ and
H2ax–/– cells transfected with the pMX-DELCJ recombination substrate was monitored by
Southern blot on cells treated with STI571 for the indicated time (hrs). Fragments of the
correct size for pMX-INV NR, CJ, HJ, and CE are indicated, along with the restriction
enzyme used for digestion.
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Figure 6. H2AX deficient cells exhibit normal coding join formation within
chromosomal substrates. A) Shown are schematic diagrams of the pMX-DELCJ V(D)J
recombination substrate in the un-cleaved (GL), cleaved but not repaired (CE), and
cleaved and repaired (CJ) configurations. The recombination signal sequences are
represented by triangles. Arrows represent the LTR sequences. Indicated are the relative
positions of the EcoRV sites (E) and C4 probe used for Southern blot analysis and the
sizes of the C4-hybridizing EcoRV fragments in pMX-DELCJ substrates of the GL, CE,
and CJ configuration. B-C) Southern blot analysis of recombination products generated
in cells of two different B) H2axF/F:DELCJ and H2axΔ/Δ:DELCJ abl pre-B cell lines or C)
H2axF/Fp53F/F:DELCJ and H2axΔ/Δp53Δ/Δ:DELCJ abl pre-B cell lines treated with STI571
for the indicated times. EcoRV-digested genomic DNA was hybridized with the C4 probe.
The bands corresponding to pMX-DELCJ substrates of the GL, CE, and CJ configurations
are indicated. Blots were stripped and then probed with a TCRβ probe as a control for
DNA content. Artemis–/–:DELCJ abl pre-B cell lines were used as a positive control for
detection of pMX-DELCJ CEs, with half as much genomic DNA loaded to increase the
sensitivity of detection for pMX-DELCJ CEs in experimental cells. These data are
representative of experiments performed more than three independent times.
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Figure 7. No accumulation of Jκ coding ends in the absence of H2AX
phosphorylation along RAG cleaved Igκ DNA strands. A) Shown are schematic
diagrams of the Jκ cluster of the Igκ locus in the un-cleaved (GL) and cleaved but not
repaired (CE) configurations. Open boxes represent the Jκ segments and triangles their
recombination signal sequences. Indicated are the relative positions of the EcoRI and
SacI sites and 3'Jκ probe used for Southern blot analysis. B) Southern blot analysis of
recombination products generated in H2ax–/– and Artemis–/– abl pre-B cell lines, either
untreated or treated with STI571 for 72 hours. EcoRI/SacI-digested genomic DNA was
hybridized with the 3'Jκ probe. The bands corresponding to Jκ loci of the GL and CE
configurations are indicated. The STI571 treated H2ax–/– cells harbor a band that likely
represents a predominant VκJκ rearrangement. Blots were stripped and then probed with
a TCRβ probe as a control for DNA content. These data are representative of experiments
performed more than ten independent times. C) Schematic diagram of the mouse Igκ
locus and graphical representation of γH2AX densities as determined by ChIP at
locations along DNA strands within and adjacent to Igκ in Artemis–/– abl pre-B cells
treated with STI571 for 96 hours. The 0 kb value of the X axis corresponds to the 3' end
of the Jκ5 coding segment. Red and green lines indicate the approximate genomic
locations to which the 5' Vκ (RP24-243E11) and 3' Cκ (RP23-341D5) BACs hybridize.
The lengths of these lines are not drawn to scale. These data are representative of
experiments performed more than twenty independent times.
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Figure 8. H2AX suppresses separation of RAG cleaved Igκ locus DNA strands. A)
Shown are representative fluorescent light microscopy images of 2C-FISH analysis
conducted on G1 phase nuclei of abl pre-B cells treated with STI571 for 96 hours. Nuclei
were hybridized with the 5' Vκ (red) and 3' Cκ (green) BAC and stained with DAPI to
visualize DNA. The representative Rag2–/– image shows a nucleus with coincident probe
hybridization signals on both Igκ alleles; the top nucleus contains paired Igκ alleles and
the bottom un-paired Igκ alleles. The representative Artemis–/– and Artemis–/–H2ax–/–
images each shows nuclei with coincident probe signals on both Igκ alleles and paired
Igκ alleles (top images); or non-coincident probe signals on one Igκ allele, overlapping
probe hybridization on the other Igκ allele, and un-paired Igκ alleles (bottom images).
Bars, ~3µm. B) Shown are representative scatter plots depicting the distances between
red and green signals on Allele 1 (shorter distance) and Allele 2 (longer distance) in G1
phase nuclei of abl pre-B cells treated with STI571 for 96 hours. The numbers (n) of
nuclei assayed to generate the representative data are indicated. These data are
representative of experiments performed three independent times for each genotype. C)
Shown are bar graphs depicting in arbitrary units the nuclei with separated RAG cleaved
Igκ DNA strands normalized to the extent of cutting in three experiments conducted on
cells of independent Artemis–/–, and Artemis–/–H2ax–/– abl pre-B cells treated with STI571
for 96 hours. The graphs use either 1µm (left) or 1.5µm (right) as the cutoff for
distinction between coincident or overlapping versus non-coincident probe hybridization
signals. Three independent experiments were conducted for each genotype.
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Figure 9. Quantification of Igκ cutting following STI571 induction of the three
Artemis–/– and three Artemis–/–H2ax–/– cell lines used in 2D-2C-FISH. Southern blot
analysis of recombination products generated in Artemis–/– and Artemis–/–H2ax–/– abl preB cell lines, either untreated or treated with STI571 for 96 hours. BamHI- or EcoRI/SacIdigested genomic DNA was hybridized with the 3'Jκ probe. The bands corresponding to
Jκ loci of the GL and CE configurations are indicated. Blots were stripped and then
probed with a TCRβ probe as a control for DNA content. The percentages of Igκ cutting,
the percentages of FISH signal separation and the numbers of cells examined are listed
for each cell line. 2D-2C-FISH for the BamHI-digested samples were conducted blind,
while that for the EcoRI/SacI-digested sample was not.
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Figure 10. H2AX prevents transition of RAG cleaved Igκ DNA strands into
chromosome breaks and translocations during cellular proliferation. A) Shown are
representative fluorescent light microscopy images of whole chromosome (Chr.) 6 paints
(red) and FISH analysis using the 5' Vκ and 3' Cκ BACs (both green) and DAPI (blue) to
visualize DNA on metaphases prepared from STI571-treated and released Artemis–/–
H2ax–/– abl pre-B cells. Below each image is a schematic representation of the observed
Chr. 6 configurations. Bars, ~1µm. B) Shown is a bar graph with quantification of RAG
initiated Igκ chromosome breaks or translocations in metaphases prepared from cells of
three independent H2ax–/–, Artemis–/–, and Artemis–/–H2ax–/– pre-B cell lines released
from STI571 treatment. Metaphases prepared from cells of the same lines without
STI571 treatment were assayed for Igκ chromosome breaks or translocations to control
for potential spontaneous rearrangement and genomic instability accumulated during cell
culture. The data represent the percentage of total metaphases analyzed that contained
Igκ chromosome abnormalities. The numbers of metaphases assayed are indicated. The
values of 0 mean that no Igκ abnormalities were observed, while n.d. means not
determined. The p values for comparison between cells of the indicated different
genotypes are shown. These data were obtained from three independent experiments.
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Figure 11. OP9-DL1 feeder cell metaphases can be separated from lymphocyte
spreads. A) Representative SKY of the OP9-DL1 feeder cell line, note that the clonal
translocations and aneuploidy (multiple copies of certain chromosomes, totally
chromosome number >40) make it easy to separate them from metaphase spreads of
primary lymphocytes. B) WCP/FISH (Chr. 6, red; TCRβ FISH, green; Chr. 14, green)
image of the OP9-DL1 feeder cell line. Note there are 4 copies of Chr. 6, one of which
engages in a t(11;6) translocation, and one dicentric Chr. 6 fragment. There are also 4
copies of full length Chr. 14.
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Figure 12. H2AX prevents chromosome breaks emanating from un-repaired
TCRα/δ locus coding ends in primary thymocytes. A) Shown are representative
fluorescent light microscopy images of whole chromosome paints and FISH analysis of
antigen receptor loci on metaphases prepared from LAHP primary thymocytes. The
inserts contain schematics depicting the chromosome abnormalities within each
metaphase. Shown in the top images is Chr. 14 paints (green) and FISH with 5' Vα and 3'
Cα BACs (both red) and DAPI (blue) to visualize DNA. Shown in the bottom left image
is Chr. 6 paint (red) and FISH with 5' Vβ and 3' Cβ BACs (both green) and DAPI (blue)
to visualize DNA. Shown in the bottom right image is Chr. 12 paint (red) and FISH with
a 5' VH BAC (green) and DAPI (blue) to visualize DNA. Bars, ~2µm. B) Shown are bar
graphs with quantification of chromosome abnormalities involving TCRα/δ loci (left) or
TCRβ loci (right) in metaphases prepared from primary thymocytes of two independent
LHP, LAP, and LAHP mice. The numbers of metaphases assayed to generate the data are
indicated. The values of 0 mean that no TCR abnormalities were observed. These data
were obtained from experiments performed two independent times. C) Shown are pie
charts depicting the percentages of LAHP cells with TCRα/δ chromosome breaks that
contain these abnormalities on either one (white) or both (black) allelic copies of Chr. 14.
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Figure 13. Models of H2AX function during end-joining repair of chromosomal
DSBs. Schematic diagrams depicting the potential positional stability of broken
chromosomal DNA strands during V(D)J recombination, CSR, or general DSB repair in
G1 phase wild-type and H2AX-deficient cells. Boxes and triangle represent RAGgenerated coding and signal ends, respectively. H2AX-mediated stabilization of broken
DNA strands would be dispensable for end-joining during V(D)J recombination due to
DNA end stabilization by ATM/MRN and RAG post-cleavage synaptic complexes.
However, this H2AX function would be important for end-joining during CSR and
general DSB repair.

73

Chapter III
Cellular Context Dependent Effects of H2ax and p53 Deletion upon the
Development of Thymic Lymphomas
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ABSTRACT
Histone H2AX and Artemis each cooperate with p53 to suppress lymphomas
harboring clonal translocations. Germline H2ax–/–p53–/– mice succumb to TCRβ– thymic
lymphomas with genomic lesions characteristic of human T-cell acute lymphoblastic
leukemia (T-ALL). Here, I demonstrate that mice with somatic inactivation of H2ax and
p53 in thymocytes succumb at later ages to TCRβ– or TCRβ+ thymic lymphomas
containing a similar pattern of translocations as H2ax–/–p53–/– tumors. Germline Artemis–
/–

p53–/– mice succumb to lymphomas with antigen receptor locus translocations, while

germline Artemis–/–H2ax–/–p53–/– mice die at earlier ages from multiple malignancies. I
show here that Artemis–/– mice with p53 deletion in thymocytes succumb to TCRβ–
thymic lymphomas containing clonal Tcrα/δ translocations, other clonal translocations,
or aneuploidy. Strikingly, Artemis–/– mice with combined H2ax and p53 deletion in
thymocytes exhibit a lower rate of mortality from TCRβ– thymic lymphomas, which
harbor significantly elevated levels of chromosome fragments and detached centromeres.
My data reveal that the cellular origin of H2ax and p53 loss impacts the rate of mortality
from and developmental stage of thymic lymphomas, and also indicate that ARTEMIS
inhibition might provide more specific and less toxic therapies for T-ALL and other
cancers with loss of H2AX and p53 function.
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INTRODUCTION
The accumulation of genomic instability can result in genetic changes that prevent
cell death, enable self-renewal, and drive uncontrolled proliferation of somatic cells. Such
transforming lesions include inter-chromosomal translocations, intra-chromosomal
deletions, and gene amplifications that arise from the aberrant repair of DNA double
strand breaks (DSBs). Inactivating mutations in genes encoding DSB repair/response
proteins frequently lead to increased genomic instability in cells and cancer
predisposition in mice and humans (Hakem, 2008). Thus, investigating pathological
consequences of defects in DSB repair/response mechanisms is important for
understanding etiologies of human cancers. Combined defects in DSB repair/response
factors can result in substantially elevated levels of genomic instability and prevent
sustained cellular proliferation (Gladdy et al., 2006). Targeted inhibition of particular
DNA repair/response factors can inhibit the growth of transformed cells with deficiencies
in complementary mechanisms, while not affecting normal cells (Bryant et al., 2005;
Farmer et al., 2005). Consequently, elucidating functional cooperation between DSB
repair/response factors is important for development of more specific and less toxic
cancer therapies, and identification of candidate patients. Since TP53 is inactivated in
~50% of human malignancies (Hollstein et al., 1991), investigating potential physiologic
interactions between DSB repair/response factors on TP53-deficient backgrounds is
paramount.

T-ALL is an aggressive cancer caused by the accumulation of genetic changes that
block differentiation of thymocytes and drive their transformation (Armstrong and Look,
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2005; Grabher et al., 2006; Pui et al., 2008). Thymocytes mature through differentiation
programs that involve cellular proliferation and RAG mediated recombination of TCR
genes (von Boehmer, 2004). Early thymocyte progenitors seed the thymus and
differentiate into CD4–CD8– double-negative (DN) thymocytes that progress through four
successive stages: c-kit+CD25– DNI cells, c-kit+CD25+ DNII cells, c-kit–CD25+ DNIII
cells, and c-kit–CD25– DNIV cells (Allman et al., 2003; Bhandoola et al., 2007; Godfrey
et al., 1993). Assembly of in-frame TCRγ and TCRδ genes in DNII/III cells leads to γδ
TCRs that promote survival and signal differentiation into γδ T cells without cellular
proliferation (Raulet et al., 1991). In contrast, assembly of in-frame TCRβ genes in DNIII
cells generates TCRβ chains that associate with pre-Tα chains to form pre-TCRs, which
promote survival, drive proliferation, and signal differentiation into CD4+CD8+ doublepositive (DP) thymocytes (von Boehmer, 2004). Assembly of functional TCRα genes in
β-selected DP cells leads to αβ TCRs that promote survival and signal differentiation into
CD4+ or CD8+ single-positive (SP) thymocytes, which emigrate to the periphery as
mature CD4+ or CD8+ αβ T cells (von Boehmer, 2004). T-ALL tumors frequently harbor
translocations, deletions, and amplifications that arise from the aberrant repair of RAGgenerated and/or spontaneous DSBs (Armstrong and Look, 2005; Grabher et al., 2006;
Pui et al., 2008). These genomic lesions cause genetic changes that block differentiation
at the DN, DP, or SP stages, prevent apoptosis, enable self-renewal, and drive
uncontrolled proliferation of TCRβ– or TCRβ+ cells (Armstrong and Look, 2005;
Grabher et al., 2006; Pui et al., 2008).

77

Current T-ALL treatments consist of chemotherapy with multiple genotoxic agents,
which lead to survival rates of ~80% in pediatric patients, but less than 30% in adults
(Linker et al., 2002; Pui and Evans, 2006; Silverman et al., 2001). Development of novel
treatment strategies clearly is important for T-ALL patients with recurrent or nonresponding malignancies. In addition, considering that adult survivors of pediatric
cancers treated with genotoxic agents are predisposed to chronic health conditions
(Oeffinger et al., 2006), more specific and less toxic therapies are desirable for all T-ALL
patients. Molecular profiling of T-ALL cell lines and primary malignancies has revealed
four major tumor subtypes (Ferrando et al., 2002). Although somatic changes associated
with T-ALL have been identified, the pathogenesis of these tumors remains undetermined
(Pui et al., 2008). This lack of knowledge and the paucity of physiologically comparable
animal models provide obstacles for the development of more effective and less toxic TALL treatment strategies (Armstrong and Look, 2005; Grabher et al., 2006; Pui et al.,
2008).

One T-ALL subtype involves TCRβ+ cells with activating NOTCH1 mutations,
H2AFX deletions, and inactivation of the p53 pathway (Armstrong and Look, 2005;
Ferrando et al., 2002). H2AFX encodes the H2AX histone that functions in DSB
repair/responses (Downs et al., 2007). H2ax–/– cells accumulate genomic instability
(Celeste et al., 2002; Bassing et al., 2002b), but H2ax–/– mice only exhibit a slightly
increased cancer predisposition (Celeste et al., 2003b; Bassing et al., 2003). In contrast,
H2ax–/–p53–/– mice rapidly succumb to aggressive TCRβ– thymic lymphomas with
chromosome translocations that occasionally involve Tcrα/δ loci, chromosome deletions,
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amplifications, and activating Notch1 mutations (Bassing et al., 2003; Celeste et al.,
2003b). The accumulation of genomic instability in H2AX/p53-deficient cells occurs
through aberrant repair of RAG-generated or spontaneous DSBs and leads to genetic
changes that block thymocyte differentiation and drive transformation of TCRβ– cells
(Bassing et al., 2008). Although H2ax–/–p53–/– thymic lymphomas harbor genomic lesions
characteristic of T-ALL, the tumors that arise in germline H2AX/p53-deficient mice are
TCRβ–, while the malignancies that develop in humans with somatic inactivation of
H2AFX and TP53 predominantly express TCRβ (Ferrando et al., 2002). This phenotypic
difference suggests that loss of H2AX and p53 functions in cells during embryogenesis or
prior to lineage commitment may influence the developmental stage (pre versus post βselection) at which thymocyte malignancies arise.

ARTEMIS is an endonuclease required for the repair of DSBs that require endprocessing, such as coding ends generated by RAG cleavage (Moshous et al., 2001; Ma
et al., 2002). Despite increased genomic instability of Artemis–/– cells (Rooney et al.,
2002), Artemis –/– mice are not tumor prone (Rooney et al., 2003). However, Artemis–/–
p53–/– mice succumb to pro-B lymphomas with IgH translocations and occasionally
thymic lymphomas with Tcrα/δ translocations (Rooney et al., 2004a). Germline Artemis–
/–

H2ax–/–p53–/– mice die shortly after birth from multiple malignancies, while Artemis–/–

mice with conditional deletion of both H2ax and p53 in thymocytes survive tumor-free
into adulthood (Yin et al., 2009), revealing that the developmental timing of H2ax and
p53 inactivation influences the rate of cancer mortality in Artemis–/– mice. Non-malignant
Artemis–/– thymocytes with combined H2ax and p53 deletion contain an increased
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frequency of Tcrα/δ chromosome breaks and translocations, as compared to Artemis–/–
thymocytes with p53 deletion and Artemis+/+ thymocytes with H2ax/p53 deletion (Yin et
al., 2009). Collectively, these data suggest that somatic inactivation of H2ax and Artemis
in p53-deficient thymocytes may increase spontaneous genomic instability to levels that
decrease tumor predisposition and mortality. Based on these results, targeted inhibition of
ARTEMIS function might provide more specific and less toxic therapies for T-ALL and
other human cancers with loss of H2AX and p53 function.

RESULTS
Somatic inactivation of H2ax and p53 in thymocytes predisposes mice to clonal
TCRβ + thymic lymphomas
To evaluate whether germline and somatic loss of H2AX and p53 functions have
different effects upon the rate of mortality from thymic lymphomas and/or the
developmental stage at which these malignancies arise, I sought to characterize the
cancer predisposition of mice with conditional deletion of H2ax and p53 in lineagecommitted thymocytes. I previously bred together Lck-Cre mice, "floxed" H2ax mice,
and "floxed" p53 mice to establish Lck-CreH2axF/Fp53F/F (LHP) mice (Yin et al., 2009).
In addition to my previous cytogenetic analysis of LHP thymocytes generated ex vivo
(Yin et al., 2009), I have also characterized thymocyte development and quantified H2ax
and p53 deletion in T lineage cells of LHP mice. I conducted flow cytometric analysis of
αβ T cell development in 4-6 week old LHP mice and normal control H2axF/Fp53F/F
(HP) mice. Similar to previous analysis of H2ax–/–p53–/– mice (Bassing et al., 2003), I
found that LHP mice contain normal populations of DNI, DNII, DNIII, DNIV, DP, and
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SP thymocytes (Figure 14A). I next performed Southern blot analysis on genomic DNA
isolated from LHP thymocytes using restriction enzyme digests and probes that
distinguish between un-deleted "floxed" and Cre-deleted alleles. I found near complete
Cre-mediated deletions of H2ax and p53 alleles in thymocytes isolated from three
different 4-6 week old LHP mice (Figure 14B). The un-deleted "floxed" H2ax and p53
alleles could represent contaminating thymic epithelial cells, DN thymocytes in which
Cre has not yet been expressed, and/or thymocytes that have developed in the absence of
H2ax and p53 deletion. I favor one or both of the former two possibilities since H2AX
was not detectable by Western blot analysis of proteins isolated from LHP total
thymocytes (Figure 14C).

To determine the effect of H2ax and p53 deletion in thymocytes on tumor
predisposition, I generated and characterized a cohort of 34 LHP mice. These mice
survived tumor-free between 64-269 days with a median age of mortality at 143 days,
which is significantly longer than the lifespan of H2ax–/–p53–/–mice (Figure 14D)
(Bassing et al., 2003; Celeste et al., 2003b). All 34 LHP mice developed thymic
lymphomas without obvious dissemination to peripheral lymphoid organs during
necropsy (Table 1). LHP cohort mice did not develop other malignancies or display any
other obvious phenotypes. FACS analysis of 28 LHP tumors revealed that 14 were
TCRβ+, nine were TCRβ–, and five contained a mixture of TCRβ+ and TCRβ– cells
(Figure 14E, Table 1), demonstrating that most LHP tumors arose from the
transformation of TCRβ-selected thymocytes, rather than TCRβ– cells as in H2ax–/–p53–/–
thymic lymphomas (Bassing et al., 2003; Celeste et al., 2003b). Some LHP lymphomas
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were comprised of CD4–CD8–, CD4+CD8+, or CD4–CD8+ cells, while others contained
mixed populations of CD4–CD8–, CD4+CD8+, CD4–CD8+, and/or CD4+CD8+ cells
(Figure 14E, Table 1). This pattern of CD4 and CD8 cell surface expression is similar to
that observed on H2ax–/–p53–/– thymic lymphomas (Bassing et al., 2003; Celeste et al.,
2003b). Thus, as compared to mice with germline H2ax/p53 deletion, mice with somatic
inactivation of H2ax and p53 in lineage-committed thymocytes exhibit a lower rate of
mortality from thymic lymphomas and generally succumb to tumors of a later
developmental stage.

Since LHP thymic lymphomas often exhibited mixed populations of cells as
assessed by TCRβ, CD4, and CD8 expression, I conducted Southern blot analysis to
determine whether these tumors arose from transformation of one or more thymocyte.
The Tcrβ locus consists of 35 Vβ segments and two Dβ-Jβ clusters (Dβ1-Jβ1 and Dβ2Jβ2) (Figure 14F). To characterize Tcrβ rearrangements, I conducted Southern blot
analysis of HindIII-digested genomic DNA with a 3'Jβ1 probe and a 3'Jβ2 probe (Figure
14F). I found that 22 of 25 LHP tumors analyzed contained two rearranged Tcrβ alleles
and therefore arose through the clonal expansion of a single thymocyte (Figure 14F). The
remaining three LHP thymic lymphomas (#461, #527, and #667) harbored three Tcrβ
alleles, revealing these tumors either developed from the expansion of two distinct cells
or continued to rearrange Tcrβ gene segments after transformation of a single thymocyte.
Collectively, my data indicate that LHP malignancies predominantly develop from the
clonal expansion of a single thymocyte with subsequent changes leading to
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heterogeneous cell surface expression of TCRβ, CD4, and/or CD8.

Somatic inactivation of H2ax and p53 suppress lymphoma by preventing
spontaneous genomic instability in lineage-committed cells
To evaluate whether lymphomas caused by conditional deletion of H2ax and p53 in
lineage-committed thymocytes exhibit genomic instability, I conducted SKY on
metaphases prepared from LHP tumor cells. LHP tumor #111 contained clonal and nonclonal translocations (Figure 15A, arrows), chromosome fragments/detached centromeres
(Figure 15A, circles) and chromosome gains or losses (Figure 15A, karyotype table). I
analyzed in total five LHP thymic lymphomas by SKY and found that all contained at
least one clonal translocation, none of which was observed in more than one tumor
(Figure 15B; Table 2). All LHP thymic lymphomas analyzed by SKY also contained five
or more non-clonal translocations, with three tumors harboring 15 or more (Table 2). In
addition, all five LHP tumors exhibited clonal whole chromosome gains or losses (Table
2). LHP thymic lymphoma (#67) contained a t(14;15) translocation along with normal
copies of chromosomes 14 and 15 in approximately 50% of metaphases (Figure 15B;
Table 2). One published H2ax–/–p53–/– thymic lymphoma contained a clonal t(14;15)
translocation involving Tcrα/δ and c-myc (Celeste et al., 2003b). I conducted
fluorescence in situ hybridization (FISH) using Tcrα/δ or c-myc probes combined with
chromosome 14 or 15 specific paints on metaphases from LHP tumor #67 and found that
the t(14;15) translocation juxtaposed Tcrα/δ and c-myc (Figure 15C). These cytogenetic
data demonstrate that LHP thymic lymphomas develop in association with clonal
translocations that arise predominantly from the aberrant repair of spontaneous DSBs and
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occasionally from V(D)J recombination errors. This pattern of genomic instability is
similar to that observed in H2ax–/–p53–/– thymic lymphomas (Bassing et al., 2003; Celeste
et al., 2003b).

Combined inactivation of H2ax and Artemis in p53-deficient thymocytes reduces the
rate of mortality of mice from thymic lymphoma
As a means to investigate whether ARTEMIS inhibition might provide an effective
therapy for human cancers with H2AFX and TP53 inactivation, I evaluated whether
inactivation of H2ax and Artemis in p53-deficient thymocytes would reduce rate of
mortality of mice from thymic lymphoma as compared to inactivation of H2ax or Artemis
alone in p53-deficient thymocytes. I previously established Lck-CreArtemis–/–p53F/F
(LAP) and Lck-CreArtemis–/–H2axF/Fp53F/F (LAHP) (Yin et al., 2009). In addition to my
previous cytogenetic analysis of LAP and LAHP thymocytes generated ex vivo (Yin et al.,
2009), I also characterized thymocyte development and quantified p53 and/or H2ax
deletion. I conducted flow cytometric analysis of αβ T cell development and Southern
blot analysis of thymocytes from 4-6 week old LAP and LAHP mice. As expected, due to
inability of Artemis–/– cells to assemble functional Tcrβ chains (Rooney et al., 2002), I
found that LAP and LAHP mice each contain a block in thymocyte development at the
DNIII stage (Figure 16A). I also found that the majority of H2ax and/or p53 alleles were
deleted in total thymocytes isolated from three different 4-6 week old LAHP and LAP
mice (Figure 16B). The lower extent of H2ax and p53 deletion in LAP and LAHP
thymocytes, as compared to LHP thymocytes, likely reflects a greater percentage of
thymic epithelial cells and DN thymoctyes with germline "floxed" alleles in the total
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thymocyte population due to lack of TCRβ-mediated expansion in Artemis–/– thymuses.
Importantly, the significant deletion of H2ax in LAHP thymocytes and the comparable
deletion of p53 between LAP and LAHP thymocytes enables us to evaluate whether
combined inactivation of H2ax, Artemis, and p53 in thymocytes reduces the rate of
mortality of mice to lymphoma, as compared to inactivation of Artemis and p53 or H2ax
and p53 in thymocytes.

To determine the effect of combined Artemis and H2ax inactivation in p53deficient thymocytes on tumor mortality, I generated and characterized parallel cohorts of
38 LAP mice and 35 LAHP mice for one year. These cohorts were generated and aged at
the same time as the LHP cohort described above. Of the 24 LAP cohort mice that died
from tumors, 23 (96%) succumbed to thymic lymphomas and one to a sarcoma (Table 3).
All 16 LAHP cohort mice that died from tumors succumbed to thymic lymphomas, three
of which spread into peripheral lymphatic tissues (Table 4). The remaining 14 LAP mice
and 19 LAHP mice developed prolapsed rectums, succumbed to opportunistic infection,
or appeared sick and were subject to euthanasia (Table 3, Table 4). No visual evidence of
lymphoma was evident in any of these mice upon necropsy. LAP cohort mice survived
tumor-free between 105-285 days with a 50% survival time of 185 days (Figure 16C).
The tumor-free survival of LAP mice was significantly longer than that of LHP mice
(Log-rank test p = 0.0062). LAHP mice survived tumor-free between 112 days and one
year of age, with a 50% survival time of 262 days (Figure 16C). The tumor-free survival
of LAHP mice was significantly longer than that of both LAP (Log-rank test p = 0.0017)
and LHP mice (Log-rank test p < 0.0001). These data demonstrate that Artemis–/– mice
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with somatic inactivation of H2ax and p53 in lineage-committed thymocytes exhibit
significantly lower rate of mortality from thymic lymphomas, as compared to Artemis–/–
mice with p53 deletion in thymocytes and Artemis+/+ mice with combined H2ax and p53
deletion in thymocytes.

I also determined the developmental stage and clonality of LAP and LAHP thymic
lymphomas. The 16 LAP and 13 LAHP tumors analyzed were all TCRβ– and comprised
of CD4–CD8–, CD4+CD8+, CD4–CD8+, and/or CD4+CD8– cells (Figure 16D, Table 3).
Almost all LAP and LAHP thymic lymphomas contained two rearranged Tcrβ alleles and
therefore arose through the clonal expansion of a single thymocyte (Figure 16E). Thus,
LAP and LAHP tumors each mainly develop from the transformation of a single TCRβ–
thymocyte with subsequent genetic or epigenetic changes leading to heterogeneous CD4
and/or CD8 expression.

LAP and LAHP thymic lymphomas harbor different patterns of genomic instability
Germline Artemis–/–p53–/– mice occasionally develop thymic lymphomas with
clonal Tcrα/δ translocations (Rooney et al., 2004a), while p53–/– mice reproducibly
succumb to thymic lymphomas lacking clonal translocations (Liao et al., 1998). To
evaluate whether Artemis–/– mice with somatic deletion of p53 in thymocytes develop
tumors harboring translocations, I conducted SKY on metaphases prepared from seven
LAP thymic lymphomas. SKY revealed that five LAP tumors (#34, #51, #91, #144, and
#734) contained one or more one clonal translocation and whole chromosome
gains/losses (Figure 17A, Table 5). LAP tumors #51 and #144 gave rise to metaphases
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with two distinct patterns of clonal translocations. The LAP tumor #51 translocation
pattern is consistent with transformation of a single thymocyte involving a t(13;15)
translocation and accumulation of additional translocations in daughter cells derived from
the parental clone. The LAP tumor #144 pattern is consistent with the clonal expansion of
two distinct thymocytes, one containing a t(11;14) translocation and a chromosome 15
short arm fusion (SAF) and the other a chromosome 5 SAF. Southern blot analyses of
LAP tumors #51 and #144 showing three and two Tcrβ alleles, respectively, support this
notion (Figure 17E). In addition to clonal translocations, LAP tumors #34 and #144 also
contained short arm fusions (Figure 17A, Table 5). All seven LAP tumors also harbored
either clonal whole chromosome gains and losses or aneuploidy involving numerous
chromosomes (Figure 17A, Table 5). Notably, LAP tumors #246 and #688 exhibited
aneuploidy but lacked clonal chromosomal aberrations (Figure 17A, Table 5). These
SKY data demonstrate that inactivation of p53 in lineage-committed Artemis–/–
thymocytes leads to thymic lymphomas that harbor clonal translocations and/or
aneuploidy.

Three of the analyzed LAP thymic lymphomas (#34, #51, and #144) contained
clonal translocations involving chromosome 14 on which Tcrα/δ resides. LAP tumor #34
contained clonal reciprocal t(14;6) and t(6;14) translocations, one t(14;4) translocation,
and one t(12;14) translocation (Figure 17A, Table 5). LAP tumor #51 contained clonal
t(19;14;19) and t(7;14) translocations and multiple other chromosome 14 derivatives or
fragments (Figure 17A, Table 5). LAP tumor #144 contained a clonal t(11;14)
translocation and a chromosome 14 fragment with centromere (Figure 17A, Table 5). To
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determine whether these translocations involved Tcrα/δ loci, I conducted FISH using
Tcrα/δ probes combined with chromosome 14 specific paints. These analyses indicated
that the t(11;14) translocation of tumor LAP tumor #144, the t(7;14) translocations of
tumor LAP tumor #51, and the reciprocal t(14;6) and t(6:14) translocations, t(12;14) and
t(14;4) of LAP tumor #34 each involved Tcrα/δ loci (Figure 17B). Since the Tcrβ locus
resides on chromosome 6, I also conducted FISH using Tcrβ probes combined with
chromosome 6 specific paints on LAP tumor #34. This analysis revealed that the clonal
reciprocal t(14;6) and t(6:14) translocations also involve one allelic copy of the Tcrβ
locus and formed through fusion of Tcrα/δ and Tcrβ DNA breaks (Figure 17B). These
FISH data demonstrate that LAP tumors frequently harbor clonal translocations that arise
through the aberrant repair of RAG-generated Tcrα/δ locus DSBs.

H2AX prevents Tcrα/δ DNA breaks from progressing into chromosome breaks
and translocations in non-malignant Artemis/p53-deficient thymocytes (Yin et al., 2009).
To evaluate whether combined inactivation of H2ax and p53 in Artemis–/– thymocytes
leads to a corresponding increased frequency of Tcrα/δ translocations in transformed
cells, I conducted SKY on metaphases prepared from seven LAHP thymic lymphomas.
All LAHP tumors contained one or more one clonal translocation (Figure 17C, Table 6);
however, clonal chromosome 14 translocations were observed in only one LAHP tumor
(#300). This tumor contained clonal reciprocal t(14;6) and t(6;14) translocations, one
t(14;1) translocation, and one t(11;14) translocation (Figure 17C, Table 6), consistent
with a reciprocal translocation involving Tcrα/δ and Tcrβ loci and non-reciprocal Tcrα/δ
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translocations. Six of the seven LAHP thymic lymphomas analyzed also harbored whole
chromosome gains and losses like LAP and LHP tumors, but none lacked clonal
translocations or contained short arm fusions (Table 6) as were observed in LAP thymic
lymphomas (Table 5). These data demonstrate that inactivation of H2ax and p53 in
lineage-committed Artemis–/– thymocytes leads to tumors harboring a different pattern of
genomic instability than inactivation of p53 in lineage-committed Artemis–/– thymocytes.
Strikingly, despite the seven-fold greater frequency of chromosome breaks involving
Tcrα/δ loci in non-malignant LAHP thymocytes as compared to LAP cells (Yin et al.,
2009), LAHP thymic lymphomas develop in association with clonal translocations that
arise predominantly from spontaneous DNA breakage and only occasionally from
aberrant Tcrα/δ rearrangements.

LAHP thymic lymphomas contain substantially elevated levels of chromosome
fragments and detached centromeres as compared to LAP and LHP tumors
To evaluate whether the reduced rate of mortality from thymic lymphomas of
LAHP mice as compared to LAP and LHP mice could be attributed to increased genomic
instability, I conducted extensive SKY analysis of LHP, LAP, and LAHP tumors to
identify and quantify all non-clonal chromosomal abnormalities. I found that all five LHP
tumors contained non-reciprocal and reciprocal translocations, chromosome fragments,
and detached centromeres (Table 2). The five LAP thymic lymphomas with clonal
translocations also contained among them non-clonal abnormalities including reciprocal
and non-reciprocal translocations, chromosome fragments, detached centromeres,
dicentric chromosome translocations, elongated chromosomes, and short arm fusions
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(Table 5). All LAHP thymic lymphomas analyzed contained among them non-reciprocal
and reciprocal translocations, chromosome fragments, detached centromeres, dicentric
chromosome translocations, and elongated chromosomes (Figure 18A, Table 6). The
average number of non-clonal translocations per metaphase was similar between LHP
and LAHP tumors and higher in LHP and LAHP tumors than in LAP tumors (Figure
18B), consistent with ability of H2AX to stabilize broken DNA strands and prevent
chromosome breaks from progressing into translocations (Franco et al., 2006; Ramiro et
al., 2006; Yin et al., 2009). In contrast, the average number of chromosome fragments
and detached centromeres per metaphase was higher in LAHP tumors as compared to
LAP and LHP tumors (Figure 18C), revealing that H2AX and Artemis cooperate to
prevent spontaneous DNA breaks from progressing into chromosome breaks. Based upon
these data, I conclude that the higher levels of spontaneous genomic instability in LAHP
cells as compared to LAP or LHP cells, contributes to the slower rate of mortality of
LAHP mice from thymic lymphoma as compared to LAP and LHP mice.
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DISCUSSION
In this chapter, I have characterized LHP mice with H2ax/p53 deletion in lineagecommitted thymocytes to evaluate the effect that somatic inactivation of H2ax and p53
has upon tumor predisposition and phenotype. These mice invariably succumbed to
thymic lymphomas demonstrating that cooperation of H2AX and p53 in lineagecommitted thymocytes is essential for inhibiting transformation. Yet, LHP mice died
from thymocyte malignancies at a later median age than germline H2ax–/–p53–/– mice
(143 days versus 79 days), indicating that cooperation of H2AX and p53 during
embryogenesis and/or in cells prior to lineage-commitment contributes to the suppression
of thymocyte malignancies in adult mice. Most LHP thymic lymphomas expressed cell
surface TCRβ chains, whereas almost all H2ax–/–p53–/– tumors are TCRβ– (Bassing et al.,
2003; Celeste et al., 2003b), revealing that somatic inactivation of H2ax and p53
predisposes mice to thymocyte malignancies of a later developmental stage than germline
H2ax/p53 deletion. Notably, LHP mice succumb to a similar spectrum of TCRβ– and
TCRβ+ tumors as human T-ALL patients with somatic inactivation of H2AFX and TP53,
thereby providing a more physiologic T-ALL model than H2ax–/–p53–/– mice. All LHP
thymic lymphomas harbored clonal translocations not involving T-cell receptor loci,
though one tumor contained a Tcrα/δ:c-myc translocation in approximately 50% of cells.
This pattern of genomic instability indicates that cooperation of H2AX and p53 in
lineage-committed thymocytes is essential for preventing translocations that arise from
the aberrant repair of spontaneous and programmed DNA breakage. Spontaneous DSBs
could be induced by intrinsic factors such as DNA replication errors in proliferating
DNII, DNIV, and ISP cells or reactive oxygen species generated by cellular metabolism
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in thymocytes of any developmental stage. The resultant translocations likely cause
genetic changes that block differentiation of thymocytes and drive their transformation.

In parallel, I characterized LAP and LAHP mice with p53 or H2ax/p53 deletion in
lineage-committed Artemis–/– thymocytes to evaluate the effect that combined
inactivation of H2ax and Artemis in p53-deficient cells has upon tumor predisposition
and phenotype. LAHP mice exhibited a significantly reduced rate of mortality from
spontaneous thymocyte malignancies as compared to LAP and LHP mice. In theory, a
smaller thymocyte pool for transformation and/or lack of DN-to-DP expansion and
differentiation for the accumulation or activation of oncogenic translocations could
influence the slower rate of mortality from thymic lymphoma of LAHP versus LHP mice.
However, the slower rate of mortality from thymocyte malignancies of LAHP mice as
compared to LAP mice must be due to cell-intrinsic effects of H2ax deletion. Loss of
H2AX functions may provide additional selection pressures that limit tumor initiation
and/or affect transformed thymocytes in a manner that inhibits tumor progression. LAP
tumors harbored clonal translocations that arose from the aberrant repair of DNA
breakage, or whole chromosome gains/losses most likely generated from chromosome
segregation errors during mitosis. In contrast, all LAHP thymic lymphomas contained
clonal translocations and exhibited higher levels of random chromosome fragments and
detached centromeres than LAP and LHP tumors. These data demonstrate that H2AX and
Artemis cooperate to suppress chromosome lesions arising from spontaneous DNA
breakage in p53-deficient thymocytes, with the elevated levels of genomic instability
reducing the rate of mortality from thymic lymphomas.
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How does combined inactivation of H2AX and Artemis in p53-deficient cells lead
to substantially elevated levels of spontaneous genomic instability? H2AX is subject to
biochemical modifications in chromatin around DSBs, which creates binding sites for
DNA repair/response factors (Kinner et al., 2008). Assembly of these proteins into
complexes around DNA breakage sites may stabilize broken DNA strands, promote
accessibility of DNA ends, and amplify intracellular signaling pathways to activate the
G2/M checkpoint (Bassing and Alt, 2004; Kinner et al., 2008; Rogakou et al., 1998;
Stucki and Jackson, 2006; Yin et al., 2009). Artemis functions in the repair of
spontaneous and radiation-induced DSBs (Moshous et al., 2001; Rooney et al., 2003),
likely those with damaged nucleotides at DNA ends that need to be removed prior to endjoining or homology-mediated repair (Beucher et al., 2009; Ma et al., 2002). Artemis also
is required for normal maintenance of the G2/M checkpoint (Zhang et al., 2004). I
previously demonstrated that H2AX stabilizes broken DNA strands that require Artemisdependent end-processing prior to repair in G1 phase cells and prevents these DNA ends
from physically separating and progressing into chromosome breaks and translocations
during cell cycle progression (Yin et al., 2009). Such H2AX-mediated structural
functions also could maintain disrupted DNA strands adjacent to their undamaged sister
chromatids in late S and G2 phases of the cell cycle and thereby suppress translocations
and intra-chromosomal deletions (Bassing and Alt, 2004; Unal et al., 2004). Artemis
endonuclease activity is required for end-resection and homology-mediated repair of a
subset of DSBs induced in G2 phase cells (Beucher et al., 2009). Thus, it seems likely
that the elevated levels of spontaneous chromosome breaks and detached centromeres in
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p53-deficient cells with combined inactivation of H2ax and Artemis is due to an
increased frequency in the physical separation of DNA ends that require end-processing,
coupled with an inability to activate and maintain the G2/M checkpoint in cells with such
persistent lesions.

My observations that combined inactivation of H2AX and Artemis in p53-deficient
thymocytes reduces the incidence and rate of mortality from thymic lymphomas
identifies Artemis as a potential therapeutic target for T-ALL, and possibly other
malignancies with inactivation of H2AFX and TP53. The availability and accessibility of
in vitro and cell-line based assays for Artemis endonuclease function (Bredemeyer, 2008;
Ma et al., 2002; Moshous et al., 2001; Rooney et al., 2003; Rooney et al., 2002) should
enable identification of potential lead compound inhibitors through the screening of
available small molecule libraries. In addition, ongoing analyses of the metallo-βlactamase family of proteins (Dominski, 2007), in which Artemis is a member, should
facilitate subsequent rationale-based drug design to improve efficacy and selectivity of
candidate drugs. Inactivating mutations of ARTEMIS cause radiation sensitive severe
combined immunodeficiency (RS-SCID) that leads to early death from opportunistic
infections (Moshous et al., 2001). Artemis mutation causes a similar phenotype in mice,
however Artemis–/– mice housed under pathogen-free conditions exhibit no other obvious
phenotypes including increased predisposition to cancer (Rooney et al., 2002).
Accordingly, systemic administration of Artemis inhibitors should not affect the
proliferation of normal cells throughout the body. Moreover, since the carboxy-terminus
of Artemis is dispensable for V(D)J recombination but required for sensing/repair of
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radiation-induced DSBs (Poinsignon et al., 2004), it is conceivable that an inhibitor of
Artemis functions in general DSB responses but not V(D)J recombination could be
developed. The functional interaction of H2AX with known human tumor suppressors,
such as the ATM and BRCA1 proteins (Kinner et al., 2008), suggests that ARTEMIS
inhibitors could be effective for the treatment of human malignancies in addition to those
with H2AFX and TP53 inactivation.

95

96

Figure 14. Mice with somatic inactivation of H2ax and p53 in thymocytes succumb
to clonal thymic lymphomas. A) LHP mice exhibit normal thymocte development.
Shown are representative anti-CD4 and anti-CD8 flow cytometric analysis of total LHP
and HP thymocytes, and anti-c-kit and anti-CD25 flow cytometric analysis of lineagenegative LHP and HP thymocytes. The percentage of cells within each quadrant is
indicated. B) H2ax and p53 are deleted in LHP thymocytes. Southern blot analyses of
H2ax and p53 status in genomic DNA isolated from thymocytes (Thy) or kidneys (Kid)
of LHP or HP mice. Bands corresponding to the floxed (F) and deleted (Δ) alleles are
indicated. C) H2AX expression is lost in LHP thymocytes. Western blot analysis of
H2AX and α-tubulin protein levels in total thymocytes of LHP and HP mice. D) LHP
mice succumb to thymic lymphomas. Kaplan-Meier curves showing the percentage of
tumor-free survival of LHP and H2ax–/–p53–/– mice. The H2ax–/–p53–/– cohort was
characterized previously (Bassing et al., 2008). Log-rank test p<0.0001. E) LHP mice
develop TCRβ– and TCRβ+ thymic lymphomas. Shown are anti-TCRβ and anti-CD4 and
anti-CD8 flow cytometric analyses of LHP tumor #111 and #222. The gates used to
determine TCRβ, CD4, and CD8 status of tumors are depicted. F) LHP tumors arise from
the clonal expansion of single thymocytes. Shown is a schematic diagram of the Tcrβ
locus with gene segments represented by open boxes, the locations of the 3'Jβ1 and 3'Jβ2
probes indicated by black bars, the HindIII sites indicated by arrows, and the sizes of the
HindIII fragments depicted. Southern blot analyses of Tcrβ rearrangements in HindIIIdigested genomic DNA isolated from LHP thymic lymphomas. The locations of bands
corresponding to un-rearranged germline (GL) Jβ1 and Jβ2 segments are indicated.
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Table 1: Characterization of LHP Cohort Mice
Age at
FACS Analysis
Mouse
Cause of Death
Death
TCRβ Stain
CD4/CD8 Stain
(Days)
64
Thymic Lymphoma
TCRβ+
71
CD4+CD8+
79
Thymic Lymphoma
TCRβ–
523
CD4–CD8+
86
Thymic Lymphoma
TCRβ+
CD4+CD8+,
312
CD4+CD8–
168
97
Thymic Lymphoma
n.d.
n.d.
173
100
Thymic Lymphoma
n.d.
n.d.
100
Thymic Lymphoma
TCRβ–
CD4–CD8+, CD4–
CD8–
169
102
Thymic Lymphoma
TCRβ+
CD4+CD8–,
CD4+CD8+
891
111
Thymic Lymphoma
TCRβ–
313
CD4–CD8+
117
Thymic Lymphoma
TCRβ+
CD4+CD8+,
CD4+CD8–,
84
CD4–CD8–
CD4+CD8+,
CD4+CD8–,
TCRβ–
16
117
Thymic Lymphoma
CD4–CD8+, CD4–
CD8–
125
Thymic Lymphoma
TCRβ+
213
CD4–CD8+
203
125
Thymic Lymphoma
n.d.
n.d.
+
126
Thymic Lymphoma
TCRβ
167
CD4+CD8+
+
130
Thymic Lymphoma
TCRβ
CD4–CD8+, CD4–
520
CD8–
–
131
Thymic Lymphoma
TCRβ
111
CD4+CD8+
136
Thymic Lymphoma TCRβ–, TCRβ+
311
CD4–CD8+
143
Thymic Lymphoma
TCRβ+
661
CD4–CD8–
143
Thymic Lymphoma TCRβ+, TCRβ– CD4–CD8–, CD4–
667
CD8+
144
Thymic Lymphoma
TCRβ+
CD4–CD8–,
CD4+CD8–,
649
CD4–CD8+
–
147
Thymic Lymphoma
TCRβ
199
CD4+CD8+
147
Thymic Lymphoma
TCRβ–
461
CD4–CD8+
149
Thymic Lymphoma
TCRβ+
CD4+CD8+, CD4–
333
CD8–
149
Thymic Lymphoma TCRβ+, TCRβ–
67
CD4+CD8+
150
Thymic Lymphoma
TCRβ+
648
CD4–CD8–
150
Thymic Lymphoma
TCRβ–
CD4–CD8+, CD4–
CD8–
647
98

316
527
517

150
155
155
166

Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma

n.d.
TCRβ–, TCRβ+
TCRβ–
TCRβ+

674

212

Thymic Lymphoma

TCRβ+, TCRβ–

530
515
444

222
237
258
269

Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma

n.d.
TCRβ+
n.d.
TCRβ+

659

222
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n.d.
CD4–CD8+
CD4+CD8+
CD4–CD8+, CD4–
CD8–,
CD4+CD8+
CD4+CD8+,
CD4+CD8–
n.d.
CD4+CD8+
n.d.
CD4–CD8+, CD4–
CD8–
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Figure 15. LHP thymic lymphomas harbor translocations that arise from
spontaneous and programmed DNA breakage. A) LHP tumors exhibit clonal and nonclonal chromosome abnormalities. Shown are spectral and DAPI images of a
representative metaphase spread prepared from LHP tumor #111 (top panels) and the
karyotype table (bottom panel) of this metaphase. Arrows indicate clonal and non-clonal
translocations. Circles indicate chromosome fragments. B) LHP thymic lymphomas
harbor clonal translocations. Shown are spectral and computer classified images of the
clonal translocations observed in each of the five LHP tumors (#312, #891, #111, #649,
and #67) analyzed by SKY. The identities of the chromosomes participating these
translocations are indicated. C) LHP thymic lymphoma #67 contains a Tcrα/δ:c-myc
translocation. Shown are representative FISH and chromosome paint analyses of LHP
tumor #67 for potential involvement of Tcrα/δ and c-myc loci in the clonal t(2;14) and
t(14;15) translocations. Depicted in each set of panels are green paints specific for
chromosome 14 or chromosome 15, the same metaphases with red Tcrα/δ or c-myc FISH
probes, and merged images. Slides were counterstained with DAPI to visualize
chromosomes.
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Table 2: SKY Analysis of LHP Tumors
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Figure 16. Combined inactivation of H2ax and Artemis in p53-deficient thymocytes
reduces the rate of mortality of mice from thymic lymphoma. A) LAP and LAHP
mice exhibit a block in thymocte development. Shown is a representative anti-c-kit and
anti-CD25 flow cytometric analysis of lineage-negative LAP and LAHP thymocytes. The
percentage of cells within each quadrant is indicated. B) p53 and H2ax/p53 are deleted in
LAP and LAHP thymocytes. Southern blot analyses of p53 and H2ax status in genomic
DNA isolated from thymocytes (Thy) or kidneys (Kid) of LAP or LAHP mice. Bands
corresponding to the floxed (F) and deleted (Δ) alleles are indicated. C) LAHP mice
exhibit a lower rate of mortality from thymic lymphomas than LAP and LHP mice.
Kaplan-Meier curves showing the percentage of tumor-free survival of LHP (n=34), LAP
(n=38), and LAHP (n=35) mice. A drop in the curve represents the sacrifice or death of
an animal diagnosed at necropsy with thymic lymphomas (except for one LAP mouse, a
sarcoma). Open circles represent the sacrifice or death of an animal due to prolapsed
rectum, infections, or no apparent tumors at necropsy. Log-rank test p(LAHP vs LHP) <
0.0001, p(LAHP vs LAP) = 0.0017, p(LHP vs LAP) = 0.0062. D) LAP and LAHP mice
only develop TCRβ– thymic lymphomas. Shown are anti-TCRβ and anti-CD4 and antiCD8 flow cytometric analyses of LAP tumor #246 and LAHP tumor #215. The gates used
to determine TCRβ, CD4, and CD8 status of tumors are depicted. E) LAP and LAHP
tumors arise from the clonal expansion of single thymocytes. Southern blot analyses of
Tcrβ rearrangements in HindIII-digested genomic DNA isolated from LAP and LAHP
thymic lymphomas, as well as one LAHP tumor that spread into lymph nodes (#474 LN).
Kidney (Kid) DNA from non-tumor mice was used as controls. Tumors marked with an
asterisk (*) were of other genotypes (#880 and #883, Lck-CreArtemis+/–H2ax+/Fp53F/F;
104

#23 and #881, Lck-CreArtemis+/–H2ax+/+p53F/F). The locations of bands corresponding to
un-rearranged germline (GL) Jβ1 and Jβ2 segments are indicated.
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Table 3: Characterization of LAP Cohort Mice
Age at
Mouse
Death
Cause of Death
(Days)
170
105
Thymic Lymphoma
199
115
No Tumor
117
Thymic Lymphoma
144
119
Thymic Lymphoma
134
120
Thymic Lymphoma
198
146
123
Thymic Lymphoma
207
126
No Tumor
248
131
Prolapsed Rectum
251
131
Prolapsed Rectum
134
Thymic Lymphoma
91
127
136
Thymic Lymphoma
137
Thymic Lymphoma
727
125
34
20
24
21
739
753
246
199

n.d.
—
—
—
TCRβ–
n.d.
TCRβ–

137
140

Sarcoma
Thymic Lymphoma

—
TCRβ–

141
142
142
144
144

Prolapsed Rectum
Thymic Lymphoma
No Tumor
No Tumor
Thymic Lymphoma

—
n.d.
—
—
TCRβ–

147
147
148

Thymic Lymphoma
No Tumor
Thymic Lymphoma

TCRβ–
—
TCRβ–

148

Thymic Lymphoma

TCRβ–

150
179
183
183
185
187

Infection
Infection
Thymic Lymphoma
No Tumor
Thymic Lymphoma
Thymic Lymphoma

—
—
TCRβ–
—
TCRβ–
TCRβ–

25
126
769
117
196
343
26

TCRβ
Stain
n.d.
—
TCRβ–
TCRβ–
TCRβ–

688
106

FACS Analysis
CD4/CD8 Stain
n.d.
—
CD4–CD8+
CD4–CD8+
CD4–CD8–, CD4–
CD8+
n.d.
—
—
—
–
CD4 CD8+, CD4–
CD8–
n.d.
CD4+CD8+, CD4–
CD8–,
CD4–CD8+
—
CD4+CD8+, CD4–
CD8+,
CD4+CD8–
—
n.d.
—
—
CD4–CD8–, CD4–
CD8+
CD4–CD8–
—
–
CD4 CD8–, CD4–
CD8+
–
CD4 CD8+, CD4–
CD8–
—
—
CD4–CD8+
—
CD4–CD8–
CD4–CD8–, CD4–
CD8+

17
19
51

189
200
210
211

Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma

n.d.
n.d.
TCRβ–
TCRβ–

341
22
212
No Tumor
88
227
Prolapsed Rectum
698
237
Thymic Lymphoma
276
Thymic Lymphoma
734
18
285
No Tumor
Note: n.d., not determined; —, not applicable.

—
—
n.d.
TCRβ–
—
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n.d.
n.d.
CD4+CD8+
CD4–CD8+, CD4–
CD8–
—
—
n.d.
CD4–CD8–
—

Table 4: Characterization of LAHP Cohort Mice
Age at
Mouse Death
Cause of Death
(Days)
Thymic Lymphoma; Enlarged
215
112
Spleen and Lymph Nodes;
Sarcoma
785
117
Prolapsed Rectum
887
121
Thymic Lymphoma
Thymic Lymphoma; Enlarged
474
128
Spleen and Lymph Nodes

FACS Analysis
TCRβ
CD4/CD8
Stain
Stain
TCRβ–

CD4–CD8–

—
TCRβ–

—
CD4–CD8+

TCRβ–

CD4–CD8–

672

131

Thymic Lymphoma

TCRβ–

702
107
301
384
318

144
155
164
165
179

Thymic Lymphoma
Thymic Lymphoma
Infection
Infection
Thymic Lymphoma

TCRβ–
n.d.
—
—
TCRβ–

519

185

Thymic Lymphoma

TCRβ–

104

187

Thymic Lymphoma

TCRβ–

705

188

Thymic Lymphoma; Enlarged
Liver and Spleen

n.d.

902

190

Thymic Lymphoma

TCRβ–

706
303
300
231
559

198
199
199
203
203

Thymic Lymphoma
Prolapsed Rectum
Thymic Lymphoma
Prolapsed Rectum
No Tumor

n.d.
—
n.d.
—
—

521

207

Thymic Lymphoma

TCRβ–

706
705
358
664
111
205
355
492
352
349

218
218
220
221
234
236
237
247
262
262

No Tumor
No Tumor
Prolapsed Rectum
No Tumor
Prolapsed Rectum
Prolapsed Rectum
No Tumor
No Tumor
Thymic Lymphoma
Thymic Lymphoma

—
—
—
—
—
—
—
—
TCRβ–
TCRβ–
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CD4+CD8+,
CD4–CD8+
CD4–CD8+
n.d.
—
—
CD4–CD8–
CD4–CD8–,
CD4–CD8+
CD4–CD8+,
CD4–CD8–
n.d.
CD4+CD8–,
CD4–CD8+
n.d.
—
n.d.
—
—
+
CD4 CD8+,
CD4–CD8–
—
—
—
—
—
—
—
—
CD4–CD8–
CD4–CD8+

117
276
Prolapsed Rectum
—
561
277
No Tumor
—
544
280
No Tumor
—
471
294
No Tumor
—
317
373
No Tumor
—
TCRβ–
657
n.d.
Thymic Lymphoma
Note: LAHP #657 was not included in the Kaplan-Meier curve.
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—
—
—
—
—
CD4–CD8+
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Figure 17. LAP and LAHP thymic lymphomas exhibit distinct patterns of genomic
instability. A) LAP thymic lymphomas harbor clonal translocations. Shown are spectral
and computer classified images of the clonal translocations observed in five of the LAP
tumors (#144, #91, #34, #51, and #734) and the short arm fusions found in two of the
LAP tumors (#144 and #34) by SKY. Also shown is the karyotype table of one metaphase
from LAP tumor #688 demonstrating aneuploidy but no apparent translocations. The
identities of the chromosomes participating these translocations or fusions are indicated.
DAPI images are depicted for the chromosome fusions within LAP tumors #144 and #34
to reveal the structure of these chromosome lesions. DAPI images also are shown for the
normal chromosome 9 and t(9;16) translocation in LAP tumor #734 to reveal a
centromere-like structure on the chromosome 9 portion of the t(9;16) translocation. B)
LAP thymic lymphomas contain clonal Tcrα/δ translocations. Shown are representative
FISH and chromosome paint analyses of LAP tumors with clonal chromosome 14
translocations (#144, #51, and #34) to evaluate for potential involvement of Tcrα/δ loci
(tumors #144, #51, and #34) and Tcrβ loci (tumor #34). All images were counterstained
with DAPI to visualize chromosomes. Arrows indicate translocation sites that involve
Tcrα/δ or Tcrβ loci. C) LAHP thymic lymphomas harbor clonal translocations. Shown
are spectral and classified images of the clonal translocations observed in each of the
seven LHP tumors (#215, #887, #702, #519, #104, #300, and #521) analyzed by SKY.
The identities of the chromosomes participating these translocations are indicated. For
tumor #215, a normal chromosome 6 and a normal chromosome 12 are shown to reveal
the chromosome 6 fragment and the elongated chromosome 12.
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Table 5: SKY Analysis of LAP Tumors
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Table 6: SKY Analysis of LAHP Tumors
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Figure 18. LAHP thymic lymphomas exhibit increased genomic instability as
compared to LAP and LHP tumors. A) Spectral and DAPI images of a representative
metaphase spread prepared from LAHP tumor #702. Circles indicate chromosome
fragments and/or detached centromeres. B-C) Quantitative analyses of non-clonal
translocations B) or chromosome fragments and detached centromeres C) in LHP, LAP
and LAHP thymic lymphomas as analyzed by SKY. Graphs show the average number of
each type of chromosome abnormality observed per metaphase in tumors of each
genotype. Dots represent the values for each tumor. Lines indicate the mean values for
tumors of each genotype.
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Chapter IV
Functional Interactions Between ATM and H2AX in Lymphocyte Development,
Recombination, and Tumorigenesis
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ABSTRACT
The ATM kinase and H2AX, a core histone variant that is phosphorylated by ATM
in chromatin around DSBs, are each critical for normal DSB repair, maintenance of
genomic stability, and suppression of cancer. Mice with germ line deletions of both
factors are early embryonic lethal, and double knockout cells exhibit dramatically
increased genomic instability. Deletion or loss of heterozygosity (LOH) of both ATM and
H2AFX, which map to 11q23, occurs in a few types of human tumors. In this part of my
thesis, I hypothesized that ATM independent H2AX functions downstream of other
kinases are essential for proper DSB repair, genomic stability and tumor suppression. To
this end, I have utilized Atm–/–H2ax–/–, Atm–/–, and H2ax–/– cell lines and primary T cells
to test whether ATM independent H2AX functions prevent DSBs from progressing into
translocations, and whether they are important for T cell development and tumor
progression. H2ax deficiency and haplo-insufficiency cooperates with p53 loss to
enhance cancer predisposition in mice. Based on the interplay between H2AX and p53,
which is activated by ATM, and the fact that H2AX functions downstream of other
kinases independent of ATM, I also hypothesized that deletion of one or both alleles of
H2ax will synergize with Atm inactivation to increase tumor predisposition. To this end, I
have characterized the predisposition of both Atm–/– mice and Atm–/– mice with
conditional inactivation of H2ax in thymocytes to thymic lymphomas.
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INTRODUCTION
The observation that Atm–/– and H2ax–/– mice exhibited reduced numbers of
developing and mature lymphocytes suggested that ATM and H2AX may function in the
repair of RAG-generated DSBs. Subsequent studies showed that ATM kinase activity is
required to hold together RAG-generated DNA ends in G1 phase cells (Bredemeyer et
al., 2006). In contrast, I showed in Chapter II that H2AX is dispensable for this function
in G1 phase Atm+/+ cells (Yin et al., 2009). However, in case of defective NHEJ, for
example in Artemis–/– cells, H2AX is required to prevent irreversible separation of unrepaired RAG-induced DSBs ends in G1 phase, as well as antigen receptor loci
translocation formation during continued cell cycle progression. Although ATM
deficiency does not block NHEJ to the same extent as Artemis deficiency, Atm–/– cells are
less able to correctly join RAG-induced DSBs in G1 phase, presumably due to
destabilized post-synaptic complex. Thus, on the Atm–/– background, H2AX may also be
important to keep cleavage antigen receptor loci DNA ends in proximity for proper repair,
and to prevent their progression in to chromosome breaks or translocations during
subsequent cell proliferation.

Although ATM is the major kinase that phosphorylates H2AX around RAGgenerated DSBs induced in G1 phase cells, DNA-PKcs is also able to phosphorylate
H2AX (Savić et al., 2009). In addition, ATM and DNA-PK and, potentially ATR, can
phosphorylate H2AX at replication-associated DSBs during S phase, suggesting ATMindependent functions of H2AX (Furuta et al., 2003; Stiff et al., 2004; Ward and Chen,
2001). In Atm–/– B cell metaphases, many spontaneous chromosomal abnormalities are
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chromosome breaks, which likely are derived from pre-replication, G1 phase, lesions. In
contrast, the genetic abnormalities from H2ax–/– B cell metaphases are about equally
divided between chromosome and chromatid breaks, the later of which generally
represent post-replication lesions (Franco et al., 2006). Thus, during the proliferation of
Atm–/– thymocytes, DNA-PKcs- and ATR-mediated phosphorylation of H2AX at
replication-associated DSBs may function to prevent RAG-initiated translocations by
suppressing the accumulation of free DNA ends during DNA replication that could be
joined with RAG-generated DNA ends.

HR is not required to assemble TCR or Ig genes; however, mice with conditional
deletion of BRCA1 or BRCA2 in thymocytes exhibit a complete block at the DN stage,
phenotypically similar to NHEJ/p53-deficient mice. The developmental block is rescued
through introduction of p53 deficiency or over-expression of the anti-apoptotic Bcl2
protein (Mak et al., 2000; Cheung et al., 2002). Thus, HR is essential for TCRβ-triggered
proliferation and expansion of DN thymocytes. Combined BRCA1/p53 or BRCA2/p53
deficiency also results in the rapid development of T lineage lymphomas associated with
genomic instability that arises from the aberrant repair of replication-associated DSBs.
Since H2AX phosphorylation enforces efficient HR and prevents the error-prone
deletional repair (Xie et al., 2004), and ATM may modulate HR repair by regulating
MRN effector functions (Gatei et al., 2000; Wu et al., 2000; Lim et al., 2000; Matsuoka
et al., 2007), I would like to test whether deficiency of H2AX in ATM-null thymocytes
would exacerbate the developmental block, and if yes, whether the defects could result
from compromised HR repair.
118

Neither ATM nor H2AX is absolutely required for embryonic development;
nonetheless, combined ATM/H2AX loss leads to embryonic lethality and dramatically
increased cellular genomic instability compared to loss of either factor alone (Zha et al.,
2008). Since ATM suppresses the accumulation of intracellular reactive oxygen species
(ROS), ATM/H2AX double knockout embryonic stem (ES) cells and mouse embryonic
fibroblasts (MEFs) may fail to repair the oxidative DNA damages in the absence of
H2AX, leading to massive genomic instability and cell death.

Atm–/– mice are predisposed to thymic lymphomas with clonal TCRα/δ loci
translocations, while H2ax–/–p53–/– mice only occasionally develop these tumors
(Liyanage et al., 2000; Bassing et al., 2003; Celeste et al., 2003b). The ATM and H2AX
genes are very closely linked in both human and mouse and map to a cytogenetic region
(11q23) often deleted in some human cancers (Stilgenbauer et al., 1996, 1999),
suggesting possible synergistic effects between ATM and H2AX loss in tumor initiation
or development. Due to the early embryonic lethality in germ line Atm–/–H2ax–/– mice, a
mouse model that would allow characterization of tumor development is needed. In
addition, since DDR mechanisms in embryonic cells may differ from those in somatic
cells, I would like to examine the effects of somatic deleion of H2AX on ATM-deficient
mice with regard to lymphocyte development, V(D)J recombination and tumorigenesis.

RESULTS
Somatic inactivation of H2ax in Atm–/– mice leads to impaired lymphocyte
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development
To evaluate whether somatic loss of H2AX in Atm–/– mice can avoid the early
embryonic lethality in Atm–/–H2ax–/– mice and alter thymocyte development and
transformation, I sought to characterize Atm–/– mice with conditional deletion of H2ax in
lineage-committed thymocytes. To this end, I generated Lck-CreH2axF/F (LH), LckCreAtm–/– (LA), and Lck-CreAtm–/–H2axF/F (LAH) mice. All three genotypes of mice
survived into adulthood, permitting analysis of their lymphocyte development and tumor
predisposition. Cre recombinase-driven deletion of the "floxed" H2ax alleles was
confirmed by PCR of genomic DNA from total thymocytes in LH and LAH mice (Data
not shown).

I first characterized lymphocyte development in 4- to 6-week old mice. The
percentages of DN, DP, CD4 SP and CD8 SP thymocytes in LH mice were similar to
previously characterized germ line H2ax–/– and conditional Lck-CreH2axF/Fp53F/F mice
(Figure 19A). In the spleen, percentages of CD4 SP and CD8 SP mature T cells were also
comparable between LH and LHP mice, although both were slightly lower than those in
wild type mice, suggesting conditional H2ax leads to mild defects in development of
mature lymphocytes (Figure 19A). LA mice, compared to LH mice, showed increased
percentages of DN populations and a concomitant decrease in CD4 SP and CD8 SP
populations in the thymus, and a dramatic decrease in mature SP T cells in the spleen
(Figure 19A), consistent with previously described more severe lymphopenia in Atm–/–
than in H2ax–/– mice. Interestingly, conditional knockout of H2ax in LA mice did not
seem to significantly alter the CD4/CD8 profile in the thymus, or percentages of mature
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SP T cells in the spleen, although absolute numbers of total thymocytes in both LA and
LAH mice were significantly lower than those in LH mice (Figure 19A, 19B). In addition,
total thymocyte numbers in LAH mice were significantly reduced, to about 50% of those
in LA mice (Figure 19B). This is likely due to a significant reduction in the absolute
numbers of DP thymocytes in LAH mice compared to LA mice (Figure 19C). The
absolute numbers of DN, CD4 SP and CD8 SP cells did not significantly differ between
LAH and LA thymuses (Figure 19C). Thus, H2AX conditional deletion on the Atm–/–
background results in further reduction in cellularity, suggesting H2AX loss further
exacerbate the developmental defects in Atm–/– mice.

Genomic instability in mature LAH T cells
Based on known functions of ATM and H2AX in DNA damage response and
repair, I hypothesize that the ~50% reduction in total thymocyte and DP thymocyte
numbers in LAH mice compared to those in LA mice results from increased genomic
instability and decreased cellular survival. There are several possible underlying
mechanisms, which are not necessarily mutually exclusive. First, loss of H2AX in ATMnull lymphocytes may further destabilize the post-cleavage synaptic complex during
V(D)J recombination, or allow irreversible separation of cleaved DNA strands.
Consequently, more un-repaired V(D)J DSB intermediates or mis-repaired products, such
as TCR loci chromosome breaks translocations, would accumulate in Atm–/–H2ax–/–
thymocytes, while successful recombination events would be diminished. Since
productive TCRβ rearrangement and pre-TCR signals are required for DN-DP transition,
the reduction in DP thymocyte numbers could be explained by such a senario. Second,
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since H2AX Ser139 phosphorylation has been shown to enforce efficient homologous
recombination and prevent the error-prone deletional repair through SSA, Atm–/–H2ax–/–
thymocytes may be more comprised in HR repair of DNA breaks. Third, Atm–/– thymuses
exhibit elevated levels of oxidative damage (Barlow et al., 1999), and the inability of
Atm–/–H2ax–/– thymocytes to repair the DNA damages via H2AX-dependent mechanisms
would render cell more susceptible to overwhelming genomic instability and subsequent
cell death.

To test the hypothesis of increased genomic instability in ATM/H2AX-null
thymocytes, I first stimulated splenic T cells from LAH mice with IL-2 and ConA for two
days, and assayed for genomic instability by SKY (Figure 20A). A total of 98 metaphases
were examined, and nearly half of them (45/98=46%) contained at lease one type of
chromosome aberrations. Approximately 10% metaphases from stimulated splenic T cells
of germ line Atm–/– mice harbored Chr. 14 abnormalities, most of which likely involve
the TCRα/δ locus, reflecting a V(D)J recombination joining defect in the absence ATM.
A similar percentage of Chr. 14 abnormalities (8/98=8.2%) was observed in metaphases
from stimulated LAH splenic T cells. Although more experimental replicates with proper
controls from LA and LH mice are needed to draw a conclusion, this result suggests that
conditional ablation of H2AX in Atm–/– thymocytes does not lead to more accumulation
of chromosome breaks/translocations that result from aberrant V(D)J recombination.
Chromosome breaks, chromatid breaks, and both reciprocal and non-reciprocal
chromosome translocations were also observed in LAH T cells (Figure 20A). It’s
noteworthy that the incidences of chromosome breaks/fragments and chromatid breaks
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are about equal, consistent with the pattern of genomic instability in Atm–/–H2ax–/– MEFs
and ES cells. This observation would be consistent with the model that H2AX loss does
not significantly exacerbate the Atm–/– defects in pre-replication DNA repair, but causes
significant increase in errors of post-replication repair. This is also suggested by the
observation that 3/98 (3.1%) metaphases contained quadriradial structures (Figure 20B),
similar to those observed in BRCA2-deficient murine cells (Venkitaraman, 2002) but
were not observed in Atm–/– or H2ax–/– cells, suggesting HR might be further
compromised in LAH peripheral T cells. More independent LAH mice together with LA
and LH control mice would be examined by SKY to reach statistically sound conclusions.

Loss of H2AX does not change thymic lymphoma development or phenotype in
Atm−/− mice
To determine the effect of combined Atm and H2ax inactivation in thymocytes on
tumor development or phenotype, I generated and characterized parallel cohorts of 20 LA
mice and 35 LAH mice for up to 150 days. I also generated and aged approximately 10
LH mice, all of which lived without any signs of tumor to over 6 months (Data not
shown). In contrast, all LA and LAH mice succumb to tumors by the age of 5 months. All
20 LA cohort mice and 25 of the 27 LAH cohort mice died from thymic lymphomas
(Table 7). One of the remaining two LAH mice was diagnosed with a sarcoma; the other
exhibited enlarged lymph nodes and the spleen but not the thymus. LA cohort mice
survived tumor-free between 70-132 days with a 50% survival time of 89 days (Figure
21A). LAH mice survived tumor-free between 73-145 days, with a 50% survival time of
91 days (Figure 21A). The tumor-free survival between LA and LAH mice was not
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significantly different by Log-rank test, indicating that the key events during tumor
initiation and progression might be determined by ATM germ line deficiency. This
observation differs from what I showed in Chapter III (Figure 16C), where bi-allelic
deletion of H2AX in Artemis–/–p53–/– thymocytes significantly delays thymic
lymphomagenesis, suggesting that modification of tumor development by somatic loss of
H2AX depends on the cellular context.

Although conditional H2AX ablation did not alter tumor development, it could
modify tumor phenotypes such as clonality or patterns of genomic instability. Thus, I
determined the developmental stage and clonality of LA and LAH thymic lymphomas.
Most of the LA and LAH tumors analyzed were TCRβ– and comprised of CD4–CD8+,
CD4+CD8+, and less frequently CD4+CD8– and CD4–CD8– cells (Table 7, Table 8). This
result suggests that the tumors may have developed through the transformation of TCRβ–
thymocytes, or tumor cell surface expression of TCRβ has been down regulated in the
transformation process. Since Atm–/– mice invariably succumb to thymic lymphomas with
clonal TCRα/δ loci translocations that disrupt TCRα chain production, the TCRβ chain
on the cells targeted for transformation may be internalized due to lack of TCRα as a
pairing partner. Almost all LA and LAH thymic lymphomas contained two rearranged
Tcrβ alleles and therefore arose through the clonal expansion of a single thymocyte
(Figure 21B). Thus, LA and LAH tumors each mainly develop from the transformation of
a single thymocyte with subsequent genetic or epigenetic changes leading to
heterogeneous CD4 and/or CD8 expression.
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Thymic lymphomas from LA and LAH mice display similar clonal translocations
To evaluate whether LAH mice develop tumors harboring similar translocations as
those in LA mice, I conducted SKY on metaphases prepared from 4 LA thymic
lymphomas and 5 LAH thymic lymphomas. All nine tumors analyzed harbor clonal
translocations of Chr. 14, likely involving the TCRα/δ loci (Figure 21C). The more
frequent clonal translocations observed in these tumors are t(12;14) and t(14;15) (Figure
21C), both of which were seen in thymic lymphomas from Atm–/– mice (Liyanage et al.,
2000). In Chapter III (Figure 18B), I found that tumors developed from Artemis–/–p53–/–
thymocytes with bi-allelic H2ax deletion contained more non-clonal translocations,
chromosome breaks and detached centromeres, compared to those originated from
Artemis–/–p53–/– thymocytes. Thus, it remains possible that LAH tumors may have
accumulated more non-clonal chromosome aberrations than LA tumors, due to loss of
H2AX-dependent mechanisms of break repair. Therefore, somatic H2AX deletion does
not seem to change the patterns of genomic instability, at least for the type of clonal
translocations, in tumors that develop in mice with germ line ATM deficiency.
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DISCUSSION
Following expression of in-frame VDJβ rearrangements on the cell surface, DN
thymocytes are rescued from apoptosis and signal rapid cellular proliferation and
differentiation to the DP stage. In DP thymocytes, in-frame VJα rearrangements
generate TCRα chains that associate with TCRβ to form the αβ TCR that rescues DP
cells from apoptosis and promote further differentiation to CD4+ or CD8+ mature SP T
cells. In this chapter, I showed that conditional knockout of H2ax in LA mice did not to
lead to apparent development block at any particular stage, seem to significantly alter the
CD4/CD8 profile in the thymus, or percentages of mature SP T cells in the spleen,
although absolute numbers of total thymocytes in both LA and LAH mice were
significantly lower than those in LH mice. In addition, total thymocyte numbers in LAH
mice were significantly reduced, to about 50% of those in LA mice. This is likely due to a
significant reduction in the absolute numbers of DP thymocytes in LAH mice compared
to LA mice. The absolute numbers of DN, CD4 SP and CD8 SP cells did not significantly
differ between LAH and LA thymuses. Thus, H2AX conditional deletion on the Atm–/–
background results in further reduction in cellularity, suggesting H2AX loss further
exacerbate the developmental defects in Atm–/– mice.

Although data currently available suggest that the defects caused by H2AX
abaltion in lineage committed Atm–/– thymocytes are likely depended on the roles of
H2AX in post-replication DNA damage repair, the possibility of H2AX collaborating
with ATM in NHEJ has neither been proven or ruled out. Mapping of the γH2AX
chromatin domains around induced V(D)J DNA breaks in Abelson cells and HO
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recombination sites in yeast by ChIP suggests that H2AX, together with other histones,
may be cleared off the very ends of DSBs, while γH2AX signals extend at least ~500kb
along the chromatin fiber (Shroff et al., 2004; Savić et al., 2009). I have proposed a
“zipping” model to explain the functional importance of this pattern of γH2AX
distribution around the break sites, that it, to maintain the positional proximity of unrepaired DNA ends by tethering the flanking chromatin. ATM is the major kinase
mediating the long range γH2AX signal propagation in this model, and the contribution
of DNA-PKcs to H2AX phosphorylation, albeit much smaller compared to that of ATM,
might be evident in the absence of ATM or ATM kinase activity. In addition, Atm–/–
lymphocytes only show a partial defect in NHEJ of RAG-induced DSBs, suggesting
other factors exist to support the joining step. Previously, it was shown that Atm–/–:pINV
Abelson cells, as compared to Atm+/+:pINV cells, exhibited reduced ability to complete
successful V(D)J recombination, and accumulated illegitimate repair products (the hybrid
joins) and un-repaired RAG-generated DNA ends that physically separated (Bredemeyer
et al., 2006). To test the hypothesis that H2AX is needed to suppress antigen receptor loci
DNA end separation and subsequent translocation formation in Atm–/– cells, I would need
to analyze V(D)J recombination in Atm–/– and Atm–/–H2ax–/– Abelson cell lines. To date, I
have established several independently derived Atm–/–H2axF/F Abelson cell lines, which
can be infected with the pINV retroviral substrate and transduced with TAT-Cre to
generate Atm–/–H2axΔ/Δ cells with single integrants. V(D)J recombination and NHEJmediated DSB repair can then be assayed by flow cytometry (FACS) for GFP expression
and by Southern blotting with an hCD4 DNA probe, while physical separation of RAG-

127

generated DNA ends can be assayed by FISH using probes that hybridize to genomic
sequences on either side of the pINV integrate site.

Several Atm–/–H2axΔ/Δ cell lines have been generated from Atm–/–H2axF/F cells, and
both lines with similar genetic background have been assayed for V(D)J recombination of
the endogenous Igκ locus. I found by Southern blot that Atm–/–H2axΔ/Δ Abelson cells can
be induced to undergo similarly robust Igκ recombination as Atm–/–H2axF/F cells. Thus, a
FISH probe pair that flanks the Igκ locus as described above (Figure 7C) will be used to
evalute whether more cleaved Igκ DNA ends separate in G1-arrested Atm–/–H2axΔ/Δ cells
than in control Atm–/–H2axF/F cells. I’ve also attempted to release these cells from STI571
arrest to test whether H2AX loss leads to more chromosome break/translocation
formation in Atm–/– Ableson cells that re-enter the cell cycle. Both before and during
STI571 induction, Atm–/–H2axΔ/Δ cells proliferated and survived well in culture without
overt cell death, as did Atm–/–H2axF/F cells. However, while all Atm–/–H2axF/F lines
readily recovered from STI571 treatment as previously shown, all three Atm–/–H2axΔ/Δ
lines tested failed to re-start proliferation and showed massive cell death after STI571
withdrawal. Since H2AX is a haplo-insufficient tumor suppressor, Atm–/–H2axF/Δ cells
have also been generated to test whether a 50% reduction of cellular H2AX can support
cell recovery from STI571 treatment and lead to more Igκ-associated genomic instability
in Atm–/– cells.
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Thymus cellularity in LAH mice is significantly reduced compared to that in LA
mice, while both genotypes of mice develop thymic lymphomas at similar latency and
show similar patterns of genomic instability. In this case, the germ line ATM-deficiency
may have dictated the transforming events and their cellular target before the excision of
H2ax, where as somatic H2AX deletion can contribute to additional genomic abberations
(such as clonal or non-clonal translocations) during tumor progression but is not enough
to alter tumor latency. To test this hypothesis, it would be important to monitor and
compare tumor predisposition in mice with ATM conditionally depleted at various
developmental stages and in different compartments. Importantly, in cases of humans Bcell chronic lymphocytic leukemias and mantle cell lymphomas, common somatic
deletions within the genomic region 11q22-11q23 may have inactivated the ATM
(11q22.3) and H2AFX (11q23.2-23.3) (Parikh et al., 2007) genes together (Stilgenbauer
et al., 1996, 1999). Thus, a clinically relevant mouse model with somatic ablation of both
Atm and H2ax in B cells would be desirable to test whether the two genes collaborate to
drive tumorigenesis. These mouse models would also be useful tools to study the
fuctional interactions between ATM and H2AX during CSR, which is comprised in both
Atm–/– and H2ax–/– mice.
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Figure 19. Characterization of thymic and splenic T cell development in LH, LA and
LAH mice. A) Shown are representative anti-CD4 and anti-CD8 flow cytometric analysis
of total LH, LA and LAH thymocytes (upper panel), and splenocytes from the same mice
(lower panel). The percentage of cells within each quadrant is indicated. B) Total
thymocyte numbers in LH, LA and LAH mice. Numbers of mice analyzed for each
genotype and the p value are indicated. C) Shown are absolute numbers of DN, DP, CD4
SP and CD8 SP populations in the thymuses of the same mice analyzed in B). The p
value between absolute numbers of LA and LAH DP populations is indicated. Not
significant, ns.
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Figure 20. Genomic instability of stimulated splenic T cells from one LAH mice
analyzed by SKY. A) In total 98 metaphases were analyzed for stimulated splenic T
cells from mouse LAH#829. Shown are percentages of metaphases with any chromosome
abnormalites (46%), percentage of metaphases with Chr. 14 chromosome abnormalites
(8.2%), and average numbers of chromosome translocations (0.214 per metaphase),
chromosome breaks (0.265 per metaphase), and chromatid breaks (0.214 per metaphase).
B) A representative quadriradial structure between Chr. 5 and Chr. 6 in LAH stimulated
splenic T cells. DAPI, spectral and classified images are shown.
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Figure 21. Conditional inactivation of H2ax in Atm-deficient thymocytes does not
seem to alter thymic lymphoma development or pattern of genomic instability. A)
LAH mice exhibit similar rate of mortality from thymic lymphomas as LA mice. KaplanMeier curves showing the percentage of tumor-free survival of LA (n=20) and LAH
(n=27) mice. A drop in the curve represents the sacrifice or death of an animal diagnosed
at necropsy with thymic lymphomas. Open circles represent the sacrifice or death of an
animal due to other tumors. Log-rank test revealed no significant difference in tumor-free
surviaval. B) LA and LAH tumors arise from the clonal expansion of single thymocytes.
Southern blot analyses of Tcrβ rearrangements in HindIII-digested genomic DNA
isolated from LA and LAH tumor. LN, lymph nodes; Spl, spleen. Kidney (Kid) DNA
from non-tumor mice was used as controls. C) Summary of clonal chromosome
abnormalites in LA and LAH tumors as shown by SKY. Chromosomes with antigen
receptor loci are highlighted.
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Table 7: Characterization of LckCreAtm–/– Cohort Mice
Mouse
26
922
114
875
845
928
920
116
873
867

Age at Death
(Days)

Cause of Death

70
70
75
75
80
84
84
86
86
87
90

Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma

91

Thymic Lymphoma

91

Thymic Lymphoma

104
112
117

Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma

669
560
574
572
562

728
120
582
902
126
872
129
132
877
Note: n.d., not determined.

Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma
Thymic Lymphoma
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FACS Analysis
TCRβ Stain
CD4/CD8
Stain
TCRβ–
CD4–CD8+
TCRβ–
CD4–CD8+
TCRβ–
CD4+CD8+
TCRβ–
CD4+CD8+
–
TCRβ
CD4+CD8+
–
TCRβ
CD4–CD8+
TCRβ–
CD4+CD8+
n.d.
n.d.
–
TCRβ
CD4+CD8+
–
TCRβ
CD4–CD8+
TCRβ–
CD4+CD8–,
CD4+CD8+
–
TCRβ
CD4+CD8–,
CD4–CD8+,
CD4+CD8+
TCRβ–
CD4–CD8+,
CD4+CD8+
TCRβ–
CD4+CD8–
+
–
TCRβ , TCRβ
CD4+CD8+
–
TCRβ
CD4–CD8+,
CD4+CD8+
–
TCRβ
CD4–CD8+
n.d.
n.d.
n.d.
n.d.
–
TCRβ
CD4–CD8+

Table 8: Characterization of LckCreAtm–/–H2axF/F Cohort Mice
FACS Analysis
Age at Death
Mouse
Cause of Death
CD4/CD8
TCRβ Stain
(Days)
Stain
TCRβ+,
629
86
Thymic Lymphoma
CD4+CD8+
TCRβ–
TCRβ–
630
86
Thymic Lymphoma
CD4+CD8+
CD4–CD8+,
–
TCRβ
589
83
Thymic Lymphoma
CD4+CD8+
int
TCRβ
759
82
Thymic Lymphoma
CD4+CD8+
–
TCRβ
592
86
Thymic Lymphoma
CD4–CD8+
TCRβ–
762
85
Thymic Lymphoma
CD4+CD8+
TCRβ–
884
73
Thymic Lymphoma
CD4+CD8+
CD4–CD8+,
TCRβ–
631
73
Thymic Lymphoma
CD4+CD8+
CD4+CD8–,
TCRβ–
758
107
Thymic Lymphoma
CD4+CD8+
CD4–CD8+,
TCRβ–
798
95
Thymic Lymphoma
CD4+CD8+
CD4–CD8+,
TCRβ–
591
75
Thymic Lymphoma
CD4+CD8+
CD4+CD8+,
TCRβint
972
78
Thymic Lymphoma
CD4–CD8+
TCRβ+
968
88
Thymic Lymphoma
CD4+CD8+
TCRβint,
CD4+CD8+,
606
145
Thymic Lymphoma
+
TCRβ
CD4–CD8+
682
100
Thymic Lymphoma
n.d.
n.d.
TCRβ–
970
110
Thymic Lymphoma
CD4+CD8+
Enlarged Lymph Nodes and
555
125
—
—
Spleen
TCRβ–,
956
114
Thymic Lymphoma
CD4–CD8–
TCRβ+
TCRβ–,
841
89
Thymic Lymphoma
CD4+CD8–
TCRβ+
839
89
Thymic Lymphoma
n.d.
n.d.
590
74
Thymic Lymphoma
CD4–CD8+
TCRβ–
587
97
Thymic Lymphoma
CD4+CD8+
983
103
Sarcoma
—
—
–
TCRβ
590
116
Thymic Lymphoma
CD4–CD8+
TCRβ–
910
82
Thymic Lymphoma
CD4+CD8+
–
TCRβ
901
105
Thymic Lymphoma
CD4+CD8+
911
116
Thymic Lymphoma
n.d.
n.d.
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Chapter V
ATM-dependent DNA Damage Signals Prevents Biallelic Igκ Chromosome Breaks
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ABSTRACT
The assembly and expression of functional V(D)J rearrangements is restricted to a
single allele, which ensures each lymphocyte expresses antigen receptors of a single
specificity. This phenomenon, termed allelic exclusion, may be important for prevention
of autoimmunity. Despite intense efforts, the mechanisms of allelic exclusion remain
unclear. To explore potential roles of the general DDR machinery in the initiation of
allelic exclusion, I have generated cell lines in which Igκ locus recombination can be
induced in G1 phase cells, and the fates of V(D)J intermediates can be tracked in G1 and
during continued cell cycle progression. Although deficiency of the Artemis repair factor
leads to accumulation of un-repaired IgLκ locus DNA ends, allelic exclusion is observed
in Artemis-null cells. In contrast, Igκ double-strand breaks are generated on both alleles
in a substantial portion of ATM/Artemis double null cells. DSBs generated on both
alleles can persist as chromosome breaks and/or participate in translocations, due to
instability of the post-cleavage complex and defective cell cycle checkpoints conferred
by ATM deficiency. These data are consistent with the notion that ATM-mediated signals
emanating from DSBs generated on one Igκ allele prevent initiation of V(D)J
recombination at the second allele, to provide a time window to test whether the first VJκ
rearrangement is productive. ATM could orchestrate the signaling pathways enforcing
allelic exclusion through its many substrates. I am examining the involvement of H2AX,
p53, MDC1, 53BP1, MRE11/RAD50/NBS1 complex components, and possibly the
endonuclease complex RAG1/2 that catalyzes V(D)J recombination. In addition, in vivo
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model systems are being developed to explore the functions of DDR components in
regulating allelic exclusion of the Igκ locus and other antigen receptor loci.
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INTRODUCTION
Lymphocyte development is an ordered multi-step process that involves
developmentally regulated rearrangement of the antigen receptor gene loci. In T cells, Dto-Jβ rearrangement occurs before Vβ-to-DJβ recombination, and production of the
TCRβ chain in DN thymocytes is necessary to drive cell proliferation and differentiation
in to the DP stage, where TCRα region undergoes recombination. Similarly in B cells, at
the pro-B cell stage, DH segments are joined to JH segments before VH-to-DJH
recombination. The light chain genes only rearrange after progression to the pre-B cell
stage (Bassing et al., 2002a). Most mature B or T cells that arise through this
development process express antigen receptors of only one specificity.

In mammals, monoallelic expression of genes can be either imprinted or random.
The expressed allele of imprinted genes is usually determined in the male or female
gametes through differential DNA methylation, thus these genes only exppress the
maternal or the paternal alleles in zygotes. In contrast, random monoallelic genes are
expressed from the paternal chromosome in some cells and the maternal chromosome in
others. Allelic exclusion of the antigen receptor gene loci falls in the category of random
monoallelic gene exppresion, and the mechanisms of its initiation and mantenance are
poorly understood (Cedar and Bergman, 2008).

Functional allelic exclusion can be achieved at multiple levels, such as locus
accessibility, DNA rearrangement, differential expression and cellular selection. In pro-B
cells, the IgH loci are accessible for recombination, while the light chain loci chromatin
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remain in a relatively closed conformation and thus do not undergo rearrangement even
though the recombinase RAG1/2 is highly expressed. Thus, the choice of which locus
undergoes rearrangement can be determined by local chromatin structures, which in turn
can be regulated by cis-regulatory elements as well as lineage-specific and development
stage-specific trans-acting factors. Analogously, the two homologous alleles may also be
differentially epigeneticaly marked, and/or associate with distinct nuclear enviroment that
determines their accessibility for the recombinase. For example, it has been suggested
that the two Igκ alleles are differentially marked as early and late replicating alleles
(Mostoslavsky et al., 2001). This regulated or deterministic model argues that in pre-B
cells the early replicating allele becomes more transcriptionally accessible through DNA
demethylation and thus is predisposed to rearrange first (Mostoslavsky et al., 2001). In
addition, both Igκ alleles are localized to the center of the nucleus in pro-B cells and
neither undergoes recombination; however, when cells progress to the pre-B cell stage,
the late replicating allele is relocated to the repressive pericentric heterochromatin region
and associate with heterochromatin protein 1 (HP1), while the early replicating allele
becomes highly enriched with acetylated histones (Kosak et al., 2002; Goldmit et al.,
2005; Yang et al., 2005; Fitzsimmons et al., 2007).

Once a productive rearrangement occurs on one allele, feedback signals may
prevent recombination of the second allele as well as further rearrangements during later
stages of B or T cell development (Jung et al., 2006). For example, the pre-BCR can send
feedback signals to suppress simultaneous VH-to-DJH recombination on the remaining
allele. In addition, pre-BCR signaling also drives proliferation and differentiation until
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the IgL rearrangements, during which further IgH rearrangements need to be suppressed.
This suppression could be achieved in a number of possible ways, which are not mutually
exclusive. First, feedback signals can downregulate the recombination machinery,
including RAG1, RAG2 and TdT (Corcoran, 2005). Second, before IgH rearrangement in
pro-B cells, outlying V regions can be brought together with DJ segments into a
conformation that favors recombination. This locus “contraction”, or chromatin looping,
occurs monoallelically when visualized by 3D FISH (Roldan et al., 2005). Importantly,
feedback signals can reverse or prevent looping in a process called “decontraction” (Skok
et al., 2007). Third, relocalization of alleles to repressive nuclear periphery or
pericentromeric heterochromatic regions is also associated with feedback signaling (Skok
et al., 2007). Both chromatin contraction and allele relocalization are likely associated
with epigenetic changes of chromatin, but how these changes are initiated and regulated
are not fully understood.

Although V(D)J recombination is widely recognized as a physiological DNA
damage response, surprisingly, the possibility of DNA damage signals in coordinating biallelic V(D)J recombination has never been explored. Intuitively, this intra-nucleus
suppressive signal would work faster than the feedback signal following productive
rearrangement on one allele. Here, I attempt to uncover roles of the DDR machinery in
allelic exclusion. If my hypothesis is trure, DNA damage signals emanating from one
rearranging allele might prevent initiation of V(D)J recombination on the second allele,
providing a time window to test whether the first rearrangement is functional before
feedback signals from the cell surface receptors are available.
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RESULTS
ATM prevents biallelic RAG-mediated cleavage
Treatment of v-Abl-transformed (Abl) pre-B cell lines deficient in nonhomologous
end-joining with the Abl kinase inhibitor STI571 leads to G1 arrest, expression of Rag1
and Rag2 and accumulation of unrepaired RAG-generated breaks, which activate ATMdependent signals. To directly evaluate whether ATM prevents biallelic RAG-mediated
cleavage, I treated Rag2–/–, Artemis–/– and Artemis–/–Atm–/– cells for 1-7 days with STI571
and analyzed the Igκ locus by Southern blot of DNA isolated from these cells (Figure
22A). Artemis is a nonhomologous end-joining factor required for opening coding ends
so that RAG-generated DSBs are repaired. The germline Jκ band was retained in the
control Rag2–/– cells, whereas in Artemis–/– cells, I found 30-50% less of the germline Jκ
band and correspondingly more Jκ coding-end bands (Figure 22A). These data
demonstrate that RAG-mediated cleavage occurred on half of the Igκ alleles in these
cells. In contrast, I found 80% less of the germline Jκ band and correspondingly more Jκ
coding-end bands in Artemis–/–Atm–/– cells, which indicated that RAG-mediated cleavage
occurred on more than half of the Igκ alleles in these cells (Figure 22A). I obtained
similar results with independently derived cell lines. These data suggest that cleavage
activates ATM signals that prevent RAG-mediated cleavage of the other Igκ allele until
nonhomologous end-joining-mediated formation of VκJκ coding joints.

ATM prevents the biallelic dissociation of Igκ coding ends and biallelic chromosome
breaks or translocations
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During V(D)J recombination, ATM maintains coding ends in repair complexes and
prevents RAG-initiated genomic instability (Bredemeyer et al., 2006). To investigate
whether ATM prevents the biallelic dissociation of Igκ coding ends and biallelic
chromosome breaks or translocations involving Igκ, I did two-color DNA FISH with the
5' Vκ BAC RP24-243E11 probe and the 3' Cκ BAC RP23-341D5 probe on G1 nuclei
prepared from STI57-treated Artemis–/– pre-B cells also deficient in the tumor suppressor
p53 and Artemis–/–Atm–/– pre-B cells (Figure 22B). I used Artemis–/–p53–/– cells rather
than Artemis–/– cells so that the ATM/p53-dependent G1/S checkpoint was impaired, as in
Artemis–/–Atm–/– cells. I found coincident (< 1.0µm) probe signals on both alleles in 85%
of Artemis–/–p53–/– nuclei, with noncoincident probe signals on one allele in 15% and
both alleles in less than 1% of nuclei (Figure 22B). I found coincident probe signals on
both alleles in 50% of Artemis–/–Atm–/– nuclei, with noncoincident probe signals on one
allele in 41% and on both alleles in 10% of nuclei (Figure 22B). The difference between
noncoincident signals in 1% of Artemis–/–p53–/– nuclei and 10% of Artemis–/–Atm–/– nuclei
was statistically significant (p = 0.005). Next I did FISH with the Vκ and Cκ BACs and a
chromosome-6 'paint' on metaphase spreads prepared from untreated cells or cells that
had been released back into cycle by removal of STI571. I found chromosome-6
translocations in less than 3% of metaphases prepared from untreated cells (data not
shown). I found RAG-induced Igκ chromosome breaks or translocations in 4% of
Artemis–/–p53–/– cells, whereby lesions arose from a single Igκ allele (Figure 22C). In
contrast, I found Igκ chromosome breaks or translocations in 66% of Artemis–/–Atm–/–
cells, with 30% of cells containing lesions arising from both Igκ alleles (Figure 22C). The
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difference between the absence of biallelic Igκ abnormalities in Artemis–/–p53–/– nuclei
and 30% of Artemis–/–Atm–/– nuclei was statistically significant (p = 0.004). Collectively,
these data demonstrate that ATM regulates monoallelic RAG-mediated cleavage of
homologous Igκ loci to prevent biallelic V(D)J recombination.

No single ATM substrates tested fully recapitulates the Atm–/– phenotype
ATM is a versatile kinase that has many known and potentially even more
unknown substrates (Matsuoka et al., 2007). To delineate which subtrates mediate the
ATM-dependent signals in restricting recombination to only one allele, I took a candidate
approach and tested several well-established ATM substrates. These factors include: the
major phospho-H2AX epitope binding protein in mammalian cells, MDC1; NBS1, a
component of the MRN complex, which can function both upstream and downstream of
ATM; and the methylated histone binding protein 53BP1. Since Nbs1–/– mice are early
embryonic leathal, a mutant NBS1 allele Nbs1m was used to generate Artemis–/–Nbs1m/m
Abelson cell lines (Kang et al., 2002); all other Artemis–/– cells were generated from
crosses of germ line deficient mice. I analyzed the Igκ locus by Southern blot of DNA
isolated from Artemis–/–Mdc1–/–, Artemis–/–Nbs1m/m, and Artemis–/–53bp1–/– cells treated
for 1-7 days with STI571. In three indpendent Artemis–/–Mdc1–/– and Artemis–/–53bp1–/–
lines each, and one Artemis–/–Nbs1m/m line, I found the Igκ germ line band intensity
decreased to around 50% of that of the untreated cells (Figure 23). Although in the cases
of Artemis–/–Nbs1m/m and Artemis–/–53bp1–/– cells, the remaining germ line band intensity
could be slightly less than 50% of control, none of three genotypes of cells fully
recapitulated the >80% loss of the germline Igκ band in Artemis–/–Atm–/– cells (Figure
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23). Since at 96 hours in STI571 treatment, none of Artemis–/–H2ax–/– lines resembled
Artemis–/–Atm–/– lines in the loss of germ line band, it is unlikely that H2AX is the sole
factor that mediates ATM-dependent DDR signal to prevent bi-allelic Igκ cleavage.
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DISCUSSION
In this chapter, I took advantage of the inducible V(D)J recombination system,
created persistent DNA DSBs on one of the two Igκ alleles using Artemis–/– cells, and
assayed the recombination status of the remaining allele. Although the prolonged G1
arrest in Abelson cells treated with STI571 resembles the G0/G1 phase of slowly cycling
immature lymphocytes, the Rag1/Rag2 genes are continuously expressed while primary
lymphocytes may turn off the recombinase expression periodically, thus restrict its
cutting on one allele instead of two. In addition, DNA damage signals eminating from
one rearranging allele of the antigen receptor loci in vivo may be too transient to regulate
RAG-cleavage on the other allele.

Expression of two different BCRs/TCRs by one cell (dual receptor) is a potential
mechanism underlying autoimmunity. Since loss of ATM allows biallelic RAG-induced
cleavage, in theory, ATM-deficiency in mice and humans should allow two potentially
productive antigen receptor rearrangements, one on each allele. No overt autoimmune
symptons have been observed in young Atm−/− mice, and work from our lab has shown
IgH allelic exclusion is maintained in Atm−/− mice containing allotypically marked IgH
alleles by flow cytometry analysis of surface and cytoplasmic IgH expression (Hewitt et
al., 2009). However, Atm−/− mice die from aggressive thymic lymphomas by the age of 5
months, preventing the study of autoimmunity that might develop in aged Atm−/− mice. In
addition, recently deficiency in ATM was found to lead to attrition of naive T cells and
an autoimmune-biased T cell repertoire in rheumatoid arthritis (RA) (Shao et al., 2009).
Thus, how relevant is dual receptor production to autoimmune diseases such as RA
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remains to be determined, and whether ATM contributes to the suppresion of TCRβ and
Igκ allelic inclusion in vivo and subsequent development of autoimmunity is still an open
question.

Although there is not yet direct evidence linking my results to autoimmune
diseases, the implications to the maintenance of genomic stability is more apparent. In
experiments where large, often times overwhelming, dosages of DNA damage were used,
the role of ATM signaling from one break to suppress break induction at other genomic
loci was never observed. Nonetheless, ATM-dependent phosphorylation of KAP-1 is
essential for the localized and genome-wide chromatin decondensation, which is
particularly important for heterochromatic DNA DSB repair (Ziv et al., 2006; Goodarzi et
al., 2008), suggesting ATM-mediated DNA damage signals may alter chromatin
dynamics to coordinate break repair. Furthermore, my result provides the first evident
that at physiological DNA damage levels (1-2 breaks per cell), ATM signaling also
coordinates break induction on homologous Ig alleles. Moreover, a recent report suggests
that ATM-dependent mechanisms may also orchaestrate break induction and repair on
different antigen receptor gene loci. T cell progenitors frequently rearrange the IgH DH
and JH segments, although VH to DJH recombination is restricted to B cells. Thus in wild
type mice, rearranging IgH locus may activate ATM to forestall simultaneous TCRα/δ
rearrangement, or vise versa; in contrast, Atm−/− lymphocytes may accumulate unrepaired IgH and TCRα/δ breaks within the same cells where chimeric IgH/TCRα/δ
translocations can form. An increase in potential chimeric TCRγ/TCRα/δ translocations
was also observed in this study (Callén et al., 2009). Crosstalk between different
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rearranging antigen receptor loci through ATM-dependent mechanisms might better
explain why clonal translocations that juxtapose IgH and TCRα/δ loci are frequently seen
in Atm−/− mice thymic lymphomas as well as lymphoid malignancies from A-T patients.

The mechanisms by which different genomic loci cross talk through ATM
signaling are largely unknown. Based on recent reports highlighting ATM functions in
genomic relaxation after break induction and in heterochromatic DNA break repair, it is
possible that ATM alters the global nuclear heterochromatin landscape or localization of
antigen receptor gene loci relative to repressive or permissive nuclear compartments, the
latter of which has been suggested by 3D FISH experiments examining the Ig loci nuclear
dynamics during lymphocyte development. In addition to these more general
mechanisms, it was proposed that the two homologous immunoglobulin loci could
undergo RAG1-mediate homologous pairing, and the physical proximity may contribute
to the coordinated rearrangement. Importantly, both RAG1/2 are putative ATM substrates
and their phosphorylation status may control the degradation, deposition and activity of
the recombinase machinery. Last but not lease, it remains possible that the multiple ATM
substrates, such as NBS1 and 53BP1, among many others, collectively mediate the ATM
function in a redundant manner to ensure mono-allelic recombination.
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Figure 22. ATM prevents the biallelic cleavage and dissociation of Igκ coding ends
and biallelic chromosome breaks or translocations. A) Southern blot analysis of the
Igκ locus of BamHI-digested genomic DNA isolated from Rag2−/−, Artemis−/− and
Artemis−/−Atm−/− Abelson pre-B cell lines treated with STI571 (time, above lanes). Top,
hybridization to a 3′ Jκ probe; arrows and bracket (left margin), bands corresponding to
germline Igκ (Jκ GL) and unrepaired Jκ coding ends (Jκ CE). Below, blots stripped and
rehybridized to a probe for the Tcrβ locus (loading and normalization control). Bottom,
RAG-mediated Igκ cutting, presented as the intensity of the germline Jκ band relative to
that of the Tcrβ band. B) RAG-induced Igκ genomic instability during V(D)J
recombination in pre-B cell lines. Left, light microscopy of two-color FISH of G1-phase
nuclei of STI571-treated Artemis−/−p53−/− and Artemis−/−Atm−/− pre-B cells with a 5′ Vκ
BAC (red) and 3′ Cκ BAC (green), and the DNA-intercalating dye DAPI to visualize
DNA. Right, Artemis−/−p53−/− and Artemis−/−Atm−/− pre-B cells with coincident (< 1.0
µm) and noncoincident (> 1.0 µm) hybridization of the 5′ Vκ and 3′ Cκ signals. Both,
FISH signals separate on both Igκ alleles; One, FISH signals separate on only one Igκ
allele; Neither, FISH signals coincide on both Igκ alleles. P = 0.005, Artemis−/−p53−/−
and Artemis−/−Atm−/− pre–B cells with separated signals on both alleles (Student's equal
variation). C) RAG-induced Igκ chromosome breaks or translocations during V(D)J
recombination in pre-B cell lines. Left, light microscopy of painting of whole
chromosome 6 (red) and FISH analysis of metaphases prepared from STI571-treated and
released Artemis−/−Atm−/− pre–B cells, stained with the 5′ Vκ and 3′ Cκ BACs (green)
and DAPI (blue). Insets (bottom left and right), chromosomes fragments broken at the Igκ
locus; main image, B outlines the two centromeric fragments and A outlines the two
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telomeric fragments. Right, pre-B cell lines with Igκ chromosome breaks or
translocations on one or both copies of chromosome 6. Original magnification, × 1,000
B) or × 600 C). Exp, experiment number. Data are representative of at least three
independent experiments.
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Figure 23. No single ATM substrates tested fully recapitulates the Atm–/– phenotype.
Southern blot analysis of the Igκ locus of BamHI-digested genomic DNA isolated from
Artemis−/−Nbs1m/m, Artemis−/−53bp1−/− and Artemis−/−Mdc1−/− Abelson pre-B cell lines
treated with STI571 (time, above lanes). Top, hybridization to a 3′ Jκ probe; arrows and
bracket (left margin), bands corresponding to germline Jκ (GL) and unrepaired Jκ coding
ends (Jκ CE). Below, blots stripped and re-hybridized to a probe for the Tcrβ locus
(loading and normalization control). Bottom, RAG-mediated Igκ cutting, presented as the
intensity of the germline Jκ band relative to that of the Tcrβ band.
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Chapter VI
Summary and Discussion
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Highly sophisticated and often redundant DNA damage surveillance and repair
mechanisms evolved very early in life since they are at work even in present day
prokaryotic cells. It is suggested that V(D)J recombination may have evolved from an
ancient transposable DNA element (Zhou et al., 2004), therefore DNA damage response
and repair is an integral part of this genetically programed antigen receptor diversification
process in developing lymphocytes of higher organisms. In the previous chapters, I have
utilized V(D)J recombination as a model system for physiological DNA double strand
break repair, and elucidated novel mechanisms by which the chromatin component
histone H2AX and the chromatin-associated kinase ATM coordinately regulate the
recombination reaction, maintain lymphocyte genomic stability and suppress lymphoma
predisposition. I will conclude by discussing important unanswered questions, and the
implications of the novel functions of H2AX and ATM in the context of general cellular
DNA damage response and cancer progression.

Is the DNA strand zipping function of H2AX dependent on Ser139 phosphrylation?
By using either germ line or conditional H2AX-deficient lymphocytes, I have
demonstrated that while H2AX is not essential for the NHEJ repair of chromosomally
integrated substrates, it is necessary to suppress irreversible separation of RAG-cleaved
un-repaired DNA strands in G1 phase Abelson cells. Consistent with the increase in end
separation, loss of H2AX protein also allows more antigen receptor loci chromosome
breaks and translocations to form during continued cell proliferation. In vivo, H2AX also
suppresses formation of chromosome breaks emanating from un-repaired TCRα/δ loci.
Based on the observation that large γH2AX domains flank the DSB sites but are absent at
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the cleaved DNA ends, I propose that γH2AX and associated factors can zip the flanking
chromatin within the higher order chromatin structure to promote positional proximity of
the un-repaired DNA ends. In addition to being phosphorylated, H2AX also becomes
acetylated by the acetylatransferase Tip60 and ubiquitylated by the E3 ubiquitin ligases
RNF8 and RNF168 following DSB induction (van Attikum and Gasser, 2009). Moreover,
the C-terminal Tyr142 was recently identified as a phosphorylation site; Tyr142 is
phosphorylated before DNA damage, and its dephosphorylation precedes and is required
for Ser139 phosphorylation upon break induction (Xiao et al., 2009; Cook et al., 2009).
Although current evidences suggest that both Tip60 and RNF8/RNF168 function
downstream of γH2AX formation, Tyr142 phosphorylation can clearly recruit the proapoptotic kinase JNK1 independent of Ser139 phosphorylation. Thus, it remains to be
determined whether H2AX Ser139 phosphorylation is the primary event that contributes
to H2AX’s end stabilization role. To this end, mice and Abelson cells with nonphosphorylatable 139S->A mutations, or phosphorylation mimicking 139S->E/D
mutations would be needed.

Is there functional redundancy among RAGs, ATM and H2AX in end stabilization?
H2ax−/− cells exhibit increased sensitivity to agents that induce DSBs, elevated
levels of spontaneous genomic instability, and defective NHEJ and HR repair of
chromosomal DSBs. In particular, about 50% of stimulated H2ax−/− splenic T cells
exhibit spontaneous chromosome abbreations, including about equal numbers of prereplicative chromosome breaks and post-replicatve chromatid breaks. In addition,
H2ax−/− B cells are severely defective in CSR when stimulated in vitro, since H2AX is
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required for long-range switch region synapsis and to prevent AID-dependent DNA
breaks from progressing into chromosome breaks/translocations. In postreplicative repair,
γH2AX domain formation also allows binding of the cohesin machinery that is necessary
for sister chromatid cohesion to ensure proper homologous recombination. Therefore,
H2AX is clearly important for general DSB repair and the observation that V(D)J
recombination is not affected in H2ax−/− Abelson cells came as a surprise. V(D)J
recombination NHEJ is unique in that both RAG proteins bind DNA and form a large
protein complexe that can accommodate and shepherd the DSB intermediates during the
joining step. Moreover, the RAG1/2 complex may also cooperate with other DDR
mediators and effectors, such as ATM/MRN and DNA-PK, and together form a larger
complex to tether cleavage DNA ends and funnel them into NHEJ, thus diminishing the
need for γH2AX domains to zip the flanking chromatin. If this is the case, RAG1 K980A
and RAG1 R838A/K839A/R840A mutants that display joining defects due to unstable
post-cleavage complexes could be used to uncover the role of H2AX (Lee et al., 2004).
Furthermore, NHEJ products by these two RAG1 mutations are characterized by short
sequence homologies and excessive deletions, indicative of an alternative NHEJ repair.
NBS1 is required for alternative NHEJ of hairpin coding ends and promotes proper
resolution of inversional recombination intermediates, but which other factors are
involved has not been determined. By preventing irreversible separation of the DNA ends
released from the unstable post-synaptic complex, H2AX may also be important for the
alternative NHEJ pathways.
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In addition, the RING domain of RAG1 has been shown to bind to and monoubiquitylate histone H3 and this ubiquin ligase activity of RAG1 is important for V(D)J
recombination efficiency both in vitro and in vivo (Grazini et al., 2010). Since at general
double strand breaks, H2AX and H2A have been shown to be ubiquitylated by RNF8 and
this ubiquitylation signal is further amplified by RNF168, it would be curious to
determine the spatial and stoichemical relationship between these two types of histone
modifications around RAG-induced DSBs, and their relative contributions to V(D)J
recombination efficiency.

Does γH2AX recruit cohesin-like complexes to regulate V(D)J recombination?
In yeast, phosphorylation of the H2AX homologue at S/G2 phase DSBs promotes
re-localization of cohesins around broken DNA ends. This process is likely important for
stabilizing broken DNA strands along the undamaged sister chromatid, shuttling DNA
ends away from SSA into SCR and preventing chromatid breaks. Recently it was found
that cohesin is recruited to CCCTC-binding factor (CTCF) sites throughout
immunoglobulin loci during B lymphocyte development in a developmental stagespecific manner (Degner et al., 2009). CTCF is a transcription factor that regulates gene
expression by long-range chromosomal looping. The differential binding of cohesin to
CTCF sites may promote formation of multiple loops and thus effective V(D)J
recombination. It is important to note that even in wild type Abelson cells induced to
undergo Igκ recombination, large γH2AX chromatin domains form around the breaks as
assayed by ChIP, albeit the amplitude is lower than those in Artemis−/− cells (Savić et al.,
2009). Based on these evidences, I hypothesize that in the G0/G1 phase of cycling
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immature lymphocytes, γH2AX domains formed around rearranging antigen recepter loci
may recruit the cohesins or similar complexs to tether the flanking chromatin in
proximity. The chromatin “zipping” may or may not coincide with the cohesin-CTCFmediated chromatin looping. One intriguing possibility is that the developmental stageregulated chromatin looping can position the V, D, and J segments in a pattern that
facilitates RAG deposition, cleavage and γH2AX chromatin zipper formation.

Do other DDR factors have structural functions similar to H2AX?
In a current model, γH2AX is central for the propagation of DDR factors along
chromatin and amplification of DNA damage signals. The hierarchal assembly of factors
in chromatin around DSBs can be illustrated by the observations that H2AX is required
for normal DSB-induced foci of MDC1, RNF8/RNF168, 53BP1, and BRCA1; MDC1 is
required for normal DSB-induced foci of RNF8/RNF168, 53BP1, and BRCA1; whereas,
RNF8 is required for normal DSB-induced foci of RNF168, 53BP1 and BRCA1. Recent
reports suggest that MDC1 is the major γH2AX-binding protein in mammals, and MDC1
mediates chromatin retention of at least two groups of proteins: NBS1-containing
complex (MRN) and RNF8-containing complexes. The RNF8-containing complexes may
include RNF168, BRAC1/Rap80, and 53BP1, all of which involve the ubiquitin pathway
(Stewart, 2009). The MRN components have been shown to function in the same
pathway as ATM during NHEJ of RAG-induced breaks, but none of the other
aforementioned factors have been characterized as to their involvement in the NHEJ
pathway. First, given the intrinsic complexity and diversity of protein functions, it is of
great interest to examine the NHEJ roles of the individual factors in G1-arrested Abelson
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cells. Based on phenotypes of mutant mice and known molecular interactions, I anticipate
MDC1 and 53BP1 loss to phenocopy H2AX deficiency. Although 53BP1 or MDC1
might not be critical for chromosomal end joining per se, given their presence in DNA
damage foci and the ability of 53BP1 to oligomerize (Zgheib et al., 2009), it could be
critical for end stability and suppression of translocations when un-repaired breaks persist
in G1 phase or beyond. To test this hypothesis, Artemis−/−53bp1−/−p53−/− and
Artemis−/−Mdc1−/−p53−/− Abelson cells may be utilized as described for studying H2AX
functions in Chapter II. Consistent with a possible role of 53BP1 in NHEJ, it was recently
found that 53BP1 is required for usage of distal V gene rearrangements by promoting
chromatin dynamics, and loss of 53BP1 protein leads to increased antigen receptor loci
DNA end degradation and micro-homology mediated repair instead of normal NHEJ.

Does H2AX function in signaling cell cycle checkpoint activation and cell death?
Although H2ax−/− cells display normal activation of cell cycle checkpoints and
apoptotic responses upon induction of large numbers of DSBs, H2ax−/− cells are
defective in the G2/M checkpoint following induction of only a few DSBs, possibly due
to an inability to assemble signaling complexes in chromatin around DSBs and amplify
DDR signals. In addition, when induced to undergo V(D)J recombination,
Artemis−/−H2ax−/− Abelson cells fail to upregulate the anti-apoptotic factors such as Pim2
and Bcl3 as robustly as Artemis−/− cells. If this mechanism holds true in primary T cells
in vivo, it can at least in part explain the delayed tumor development in LAHP than in
LAP mice, as well as the altered pattern of genomic instability (Figure 24).
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One potentially relavent signaling pathway is the mitogen-activated protein kinase
(MAPK) p38 pathway. ATM and ATR Ser/Thr protein kinases orchestrate multiple
aspects of the DNA damage response via phosphorylation of effectors such as Chk1 and
Chk2 protein kinases. MAPK p38 also regulates cell cycle checkpoints in response to
DNA damage. The p38-mediated G2/M checkpoint mechanism is essential to prevent
catastrophic mitosis entry in the absence of p53 (Reinhardt et al., 2007). MAPK p38
directly phosphorylates and activates MK2, which, like Chk1 and Chk2, phosphorylates
and inactivates Cdc25B and Cdc25C, thus preventing cell cycle progression. However,
how p38 is activated by DNA damage is not known, although ATM/ATR might directly
phosphorylate and activate the thousand and one amino acid (TAO) kinases, leading to
p38 activation down the cascade (Raman et al., 2007). Curiously, mice lacking either
H2AX or 53BP1, but not Chk2, manifest a G2/M checkpoint defect close to that observed
in Atm−/− cells after exposure to low, but not high, doses of IR. In V(D)J recombination
the amount of DNA damage is analogous to low doses of IR. In DN3 thymocytes,
activation of p38 leads to the phosphorylation and accumulation of p53, resulting in the
G2/M checkpoint induction. Thus, it is important to test whether RAG-generated breaks
can activate p38 and whether H2AX is required for this checkpoint activation.
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Figure 24. Proposed model to explain delayed tumor development in LAHP mice
compared to LAP mice. Upper panel, bi-allelic deletion of H2AX results in higher
percentages of thymocytes with un-repaired TCRα/δ locus chromosome breaks (cells
shown in red). However, the survival of thymocytes with persistent un-repaired breaks is
compromised in the absence of H2AX, thus during subsequent transformation LAP mice
succumb to tumors with clonal TCRα/δ locus chromosome translocations faster than
LAHP mice. Instead, LAHP thymocytes need to acquire other oncogenic hits (cells shown
in green) to be fully transformed. Lower panel, Artemis−/−H2ax−/− Abelson cells fail to
upregulate the anti-apoptotic factors such as Pim2 and Bcl3 as robustly as Artemis−/−
cells.
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Concluding Remarks
DSBs could be resolved as oncogenic chromosome breaks or translocations if
improperly repaired. Yet DSBs are purposely induced within G1 phase of the cell cycle
by the site-specific RAG1/2 endonuclease complex during V(D)J recombination, and
subsequently repaired to generate the large repertoire of antigen receptor specificities. In
mice, both the core histone variant H2AX and kinase ATM are required for proper DSB
repair, maintenance of genomic stability, and suppression of tumors, including
lymphomas with translocations involving the antigen receptor loci. ATM and H2AX are
also required for checkpoint activation in response to low doses of IR, which is similar to
the amount of DNA damage during V(D)J recombination. In this thesis, I have elucidated
that H2AX, in collaboration with ATM, maintains genomic stability in developing
lymphocytes by holding RAG-generated DNA ends in proximity to facilitate repair. In
addition, H2AX may have additional functions in signaling to checkpoint activation
and/or cell death to coordinate the timing of DSB repair and cell cycle progression. My
results suggest that H2AX functions in lymphoma suppression may depend on the
cellular context. Moreover, I have uncovered a novel function of the extensively studied
kinase ATM in regulating mono-allelic V(D)J recombination of the immunoglobulin loci.
My results provide the first evidence that DNA damage signals mediated by ATM can
contribute to the long-standing question of the initiaion and mantenance of allelic
exclusion. Future efforts would include developing corresponding animal models to test
whether the mechanisms that I discovered in cell line based systems hold true in vivo,
and whether they can be exploited in prevention and therapies for diseases such an cancer
and autoimmune diseases.
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Chapter VII
Materials and Methods
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Mice
All mice were bred and maintained under specific pathogen-free conditions within the
Laboratory Animal Facility of the Children’s Hospital of Philadelphia. All mouse
experiments were performed in accordance with relevant institutional and national
regulations and guidelines and were approved by the Children’s Hospital of Philadelphia
Institutional Animal Care and Use Committee. H2ax–/–, H2axF/F, Artemis–/–, p53F/F, LckCre transgene, and Eµ-Bcl-2 transgene mice were previously described (Strasser et al.,
1991; Jonkers et al., 2001; Lee et al., 2001; Bassing et al., 2002b, 2003; Rooney et al.,
2002). Generation of the Lck-CreH2axF/Fp53F/F, Lck-CreArtemis–/–p53F/F and LckCreArtemis–/–H2axF/Fp53F/F mice were performed on the 129SvEv background.

Flow Cytometry
Single cell suspensions from primary thymuses and spleens of 4-6 week old mice or
thymic lymphomas when they arose were stained with antibodies in PBS with 2% FBS.
For analyses of CD4, CD8, and TCRβ expression, cells were stained with FITCconjugated anti-TCRβ, PE-conjugated anti-CD8, and APC-conjugated anti-CD4 (BD
Pharmingen). For analyses of DN thymocyte subsets, cells were stained with a mixture of
PE-conjugated antibodies for TCRβ, TCRδ, CD8α, CD45R, CD19, CD11c, CD11b,
Ter119, and NK1.1, as well as PE-Cy7-conjugated anti-CD25 and allophycocyaninconjugated anti-c-kit antibodies (BD Pharmingen). Data was acquired on a FACSCalibur
(BD Biosciences, San Jose, CA) using CellQuest software (BD Biosciences) and
analyzed using FlowJo software (Tree Star).
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Generation and culture of abl pre-B cell lines
Bone marrow from 3-5 week-old H2ax–/–, H2axF/F, H2axF/Fp53F/F, Artemis–/–H2axF/F,
Artemis–/–p53F/F, or Artemis–/–H2axF/Fp53F/F mice harboring the Eµ-Bcl-2 transgene were
cultured and infected with the pMSCV v-abl retrovirus to generate abl pre-B cell lines of
each genotype as previously described (Bredemeyer et al., 2006). Generation of the
Artemis-/-Rag2-/- abl pre-B cells was previously described (Savić et al., 2009). H2ax–/–,
H2axF/F, H2axF/Fp53F/F and Artemis–/–H2axF/F abl pre-B cells (106/mL) were transduced
with pMX-DELCJ retroviral recombination substrate by co-centrifugation at 1800 rpm for
90 minutes. Limiting dilution into 96 well plates and Southern blot analysis was used to
isolate clonal cell lines with single pMX-DEJCJ integrants. Cells were treated with 3µM
STI571 for the indicated times at a density of 106 cells/ml. For STI571 release
experiments, cells were collected, washed, and then plated into media without STI571
and cultured for approximately 10-14 days prior to metaphase preparation.

Southern blot analysis
Genomic DNA (20-30 µg) of Abelson cells, primary thymocytes, tumors, or kidney
controls was digested with 100 units of the indicated restriction enzymes (New England
Biolabs). Digested DNA was separated on a 1.0% TAE agarose gel, transferred onto
Zeta-probe membrane (BioRad), and hybridized with 32P-labeled DNA probes as
previously described (Sleckman et al., 1997). The Southern blot probes used are as
follows: C4 probe for pMX-DELCJ, the 3' Jκ probe for Igκ loci, and a TCRβ VDJ probe
for loading control (Bassing et al., 2000; Bredemeyer et al., 2006; Helmink et al., 2009).
The extent of Jκ cleavage was calculated by the following formula:
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[ (

Percentage of Jκ Cleavage = 1−

Igκ GL+STI
TCRβ GL+STI

)(

Igκ GL–STI
TCRβ GL–STI

)]

×100%

where the Igκ germline hybridization intensity using the 3' Jκ probe before or after
STI571 treatment (Igκ GL–STI and Igκ GL+STI, respectively) was normalized to the
corresponding TCRβ germline hybridization intensity using the VDJ probe (TCRβ GL–
STI

and TCRβ GL+STI, respectively). The H2AX probe was generated via PCR with

primers 5’-CTCTGGATCCCGTAGAGGGCAGAAGG-3’ and 5’GCGCGGATCCTGATTTCAAACTGTATGCCAGGG-3’. The p53 probe has
previously been described (Jonkers et al., 2001). The 3'Jβ1 and 3'Jβ2 probes have been
previously described (Khor and Sleckman, 2005).

Western Blot Analysis
Lysates of primary thymocytes were prepared as previously described (Savić et al.,
2009). Samples were separated on a denaturing SDS gel and transferred to Immobilon
membrane (Millipore). Membranes were first incubated with an anti-H2AX antibody
(Upstate Biotech) in 5% milk overnight, the same membrane were then stripped and
probed in the same manner with an anti-tubulin antibody (Fischer 05829MI) as a loading
control. Western blots were visualized as previously described (Bassing et al., 2008).

Chromatin immunoprecipitation
All data points represent average values with standard deviation error bars obtained from
experiments conducted three times on cells of two independently derived Artemis–/– pre-B
cell lines. ChIP assays were conducted and data analyzed exactly as described previously
167

(Savić et al., 2009). The sequences of the primers used for qPCR analysis of each
genomic location relative to Jκ1 were either described (Savić et al., 2009) are as follows:
-250 kb, 5'-CCATCATCAGAACCCAGCATT-3' and 5'GCCCTTCTTGACATCCTCTATCA-3'; -650 kb,
5'AATGGCACAATCCTAGAGGTACAAG-3' and 5'CCCTGCTGACTCACTCTCACAT-3'; -1 Mb, 5' GACCCAAAGAAACAAAACAAT
AAGG-3' and 5'-CCCCATCCCCCTCCTAGTT-3'; -1.3 Mb, 5'AAATGGACATCTTACCGAA
AGCA-3' and 5'-CCTGGGTTTCTTGTTATTCCAAA-3'; -1.6 Mb, 5'AGCCAGGTTGGATGT
GCTATAAA-3' and 5'-CACCCAGTCTCCAGCAATCA-3'.

Cytogenetic analyses
Kits for spectral karyotyping (SKY) and whole chromosome painting were used for
metaphase analysis according to manufacturers' instructions (Applied Spectral Imaging,
Vista, CA). BAC FISH probes were labeled with Biotin (Biotin-Nick Translation Mix,
Roche), and were applied to G1 phase nuclei or metaphase spreads prepared as
previously described (Hewitt et al., 2009). The 5' Vκ (RP24-243E11) and 3' Cκ (RP23341D5) BACs used for 2C-FISH analysis were previously described (Hewitt et al., 2009).
The TCRCβ-164G11, TCRVβ17a-23N16, TCRCα-232F19, TCRVδ3/Vα6-46G9, and
5’IgH BAC207 BACs used for FISH analysis of translocations in primary thymocytes
were previously described (Liyanage et al., 2000; Franco et al., 2006). The c-myc BAC
454G15 was a gift from Dr. Kevin D. Mills, The Jackson Laboratory. All images were
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captured and analyzed on a SKY workstation using Case Data Manager Version 5.5,
installed and configured by Applied Spectral Imaging. The 2C-FISH experiments to
assay for DSB positional stability were conducted independently on three different lines
of Rag2–/–, Artemis–/–, and Artemis–/–H2ax–/– abl pre-B cells. To avoid observer bias, these
data of these experiments were conducted and obtained blind of the genotypes, with the
exception of one Artemis–/– line that was not scored blind.

OP9-DL1 co-culture
Bone marrow cells from 4-6 week old mice were harvested and red blood cell lysed.
Progenitor cells were enriched using MACS purification columns (Miltenyi Biotech,
Bergisch Gladbach, Germany) and antibodies specific for mature hematopoietic lineages
(CD24, B220, Mac-1, Gr-1, NK1.1, CD11c, and Thy1.2). Approximately 2 million cells
were cultured per well using 24 well plates. Cultures were otherwise treated as described
(Schmitt and Zúñiga-Pfl̈ücker, 2002), except for supplementation with 5 ng/mL of
murine IL-7 and human Flt-3L (R&D Systems, Minneapolis, MN).

Statistical analysis.
The Kaplan-Meier curves were generated in SAS Version 9 (SAS Institute Inc.). All
other statistical analysis was performed with two-tailed unpaired Student’s t tests in Excel
(Microsoft). p<0.05 was considered to be statistically significant.
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